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 Abstract  
The sensor kinase PhoQ and its cognate response regulator PhoP constitute a two-
component system, which is primarily responsible for sensing and responding to 
Mg2+ starvation in Escherichia coli. Additionally, there is growing evidence of 
regulatory links between PhoPQ and constituents of the outer membrane. 
Furthermore, it has been shown that PhoPQ is regulated negatively by MicA, an 
sRNA controlled by sigmaE. Encoded by rpoE, sigmaE is an alternative sigma factor 
that is activated in response to extracytoplasmic stress, specifically misfolded outer 
membrane proteins. Surprisingly, it was not possible to generate ȴphoP mutants, 
using P1vir transduction under standard conditions and kanamycin as the selective 
agent. Furthermore, a statistical analysis of these results indicates they cannot be 
explained by chance alone. The results show that PhoP is required for sigmaE 
activity in an RseA-independent manner, thereby suggesting that PhoP is a chief 
regulator of sigmaE activity. It is likely that diminished sigmaE activity in a phoP 
mutant, extracytoplasmic stress and OM deformation, caused by the reagents used 
in P1vir transduction, are responsible for the inability to transduce the phoP allele. 
Finally, evidence has been found relating to a second mechanism through which 
PhoP directly represses rpoE expression, thereby introducing further complexity 
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1.1 Escherichia coli 
 
Escherichia coli (E. coli) is a gram-negative rod-shaped facultative anaerobe 
associated with the lower gut of animals, though it can persist in the 
environment[1]. Furthermore, it is a commensal organism in humans and colonises 
the mucosal layer of the lower intestines hours after birth[1]. This colonisation 
benefits both organisms, as E. coli is a successful competitor of pathogens 
attempting to establish themselves within its niche. These commensal E. coli can 
only cause disease in cases where the host has become immunocompromised, or 
where gastrointestinal tract barriers are breached[1]. However, more virulent 
strains of E. coli are responsible for many common human afflictions. When a 
specific set of virulence factors is accumulated by a bacterium, that organism is able 
to adapt to a new function and persist as a pathogen. Numerous strains of E. coli, 
known as pathotypes[3], have adapted to a variety of niches via the use of an 
assortment of virulence factors[1].   
Pathotypes arise when beneficial virulence factors are incorporated into the 
bacterial genome. Genetic analysis of various pathotypes has shown the 
importance of horizontal gene transfer in the successful evolution of virulence and 
adaptation to new environments[3]. Newly acquired DNA can be obtained from a 
variety of sources such as plasmids, bacteriophage or transposons[4], and the new 
genetic material acquired by a potential pathogen often becomes integrated into 
the chromosome at insertion hotspots, which in turn can form pathogenicity 
islands[3]. 
Pathotypes are able to cause a wide array of diseases in and outside of the gut and 
according to their virulence mechanism, they are categorised into two groups: 
diarrhoeagenic E. coli and extraintestinal E. coli. Diarrhoeagenic E. coli, which is one 
of the most common etiologic agents of diarrhea[1], is further sub-classified into six 
groups, namely enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), 
enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. 
coli (EIEC) and diffusely adherent E. coli (DAEC, diarrhoeal disease and enteric 
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disease)[1], [3]. Pathotypes associated with extraintestinal infections are 
uropathogenic E. coli (UPEC) and meningitis-associated E. coli (NMEC)[3]. 
Pathogenic E. coli can also be categorised by serogroup, a type of grouping based 
on the lipopolysaccharide O antigen and the flagella H antigen[3]. However, 
pathotypes can contain many different serotypes and serotypes can be part of 
several different pathotypes. However, serotyping remains an important method 
for establishing the virulence of an E. coli isolate[3], [4]. 
Diarrhoeagenic E. coli pathotypes can be characterised by the cytoskeleton 
rearrangements it causes the host cell, such is the case with EHEC, EPEC, and the 
production of enterotoxins and endotoxins[3]. Enterotoxins are diverse in 
conformation and mechanism of action. These toxins can cause both diarrhoeal and 
non-diarrhoeal diseases[3].  For example, the Shiga toxin, produced by Shiga-toxin 
producing EHEC (known as STEC  and verotoxigenic E. coli (VTEC)), is responsible for 
causing haemorrhagic colitis, bloody diarrhoea, non-bloody diarrhoea and 
hemolytic uremic syndrome (HUS)[3].  However, many non-diarrhoeal symptoms 
are caused by endotoxins, also known as lipopolysaccharide. LPS can cause a 
number of symptoms but is most often associated with endotoxic shock[5].   
Pathotypes utilise many of their surface structures as virulence factors[3] and can 
damage the host cell but benefit the pathogen[3]. Fimbriae are bacterial surface 
structures that are important virulence determinants[3]. They are large, rod-like 
appendages anchored to the bacterial outer membrane. Similar in structure to pili, 
fimbriae are distinct, as they play no role in conjugation or the transfer of genetic 
material between bacteria[3].  
Some pathotypes utilise the type III secretion system, which is found in a variety of 
gram-negative bacteria[3]. The type III secretion system is made up of structural 
proteins and translocators, the latter of which function to translocate effector 
proteins into the host cell cytoplasm[3]. The type III secretion system gives 
pathogens the ability to inject toxins and effector proteins directly into the host 
cell. its basic structure is that of an inner and outer membrane ring[6], each of 
which helps to provide a continuous path from the cytoplasm to the exterior of the 
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cell. Finally, a needle-like structure, associated with the outer membrane ring, 
projects out from the bacterial cell surface[1] 
Fast-growing, robust and oxygen-tolerant E. coli has become a favoured organism, 
widely used to research the many fundamental and basic principles upon which 
modern microbiology is based. Much of what is known about microbial DNA 
replication, gene expression and protein synthesis is derived from work on this 
organism[7], with E. coli K12 and its derivatives being some of the most widely used 
strains in this regard[8].  
E. coli ?Ɛ relativity simple nutritional needs and rapid growth rate make it an 
invaluable asset for molecular biology and biochemistry and due to its long history 
of study, it is one of the most well researched and best understood organisms, 
though many aspects of its cellular physiology and genetic regulation still require 
illumination. 
1.2 The E. coli inner and outer membrane  
 
All cells have a cytoplasmic membrane, a fluid lipid bilayer with associated proteins. 
Gram-positive, monoderms, have a single cytoplasmic membrane[9] and utilise a 
(comparatively thicker) peptidoglycan barrier and the cytoplasmic membrane only 
as their primary barrier between the environment and the cytoplasm[10]. While the 
cytoplasmic membrane is conserved in all domains of life, many bacterial cells have 
developed complementary structures and architecture through the cell wall[11], 
which contributes greatly to protecting (from detrimental environmental 
conditions) and structuring the cell[12]. Gram-negative, diderm, bacteria have a 
secondary lipid bilayer, known as the outer membrane (OM). In between these two 
membranes is the periplasmic space, which contains a thin layer of peptidoglycan. 
The OM and inner membrane (IM) are structurally distinct, in that although both 
are composed of phospholipids and proteins, the IM contains an symmetric 
phospholipids bilayer, while the OM has an asymmetric bilayer[13]. Another 
important distinguishing feature of the OM is the presence of lipopolysaccharide 
(LPS)[13].  
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Lipids play a significant role in bacterial membranes. Most bacterial lipids are 
derivatives of long-chain fatty acids and can be split into two groups[14], namely 
neutral lipids, which are hydrophobic, and complex lipids[14], which are 
amphipathic and contain a hydrophobic moiety, usually in the form of a charged 
head group[14]. Phospholipids are the most abundant lipid in bacterial cell 
membranes[15] and consist of two fatty acid chains linked to a charged phosphate 
group[15]. They are important for membrane structure and flexibility, and their 
modification, such as variations in fatty acid residues and head group composition, 
can help the cell adapt to certain conditions[16]. The majority of lipids in the inner 
membrane are a class of phospholipids known as Phosphatidylethanolamine[17], 
while the outer membrane has a much greater variety of lipids, containing 
phosphatidylcholine, phosphatidylethanolamine, cholesterol and others in smaller 
amounts[14]. 
 
Phospholipids provide the basic structure of the bacterial cell membranes but 
proteins are employed to carry out most of the specific functions. These proteins 
can be broken down into two groups, i.e. integral membrane proteins and 
peripheral membrane proteins[18], the latter of which only associate with the 
membrane temporarily, are not embedded within the lipid bilayer and are often 
associated with integral membrane proteins[18], which are embedded into the lipid 
bilayer and permanently associated with the membrane[18]. Some integral 
membrane proteins are also known as transmembrane proteins, spanning the inner 
and outer leaflet of the membrane[19]. Portions of these proteins are exposed on 
both sides of the leaflet. Transmembrane proteins are amphipathic, with 
hydrophobic-sided chains interacting with the fatty acids in the phospholipids 
bilayer and the hydrophilic portion exposed to the aqueous environment of the 
cellular compartments[18].  
 
The inner membrane, which encloses the cytoplasm, and its associated proteins are 
involved in a wide variety of different processes, such as the movement of 
molecules, macromolecules and proteins between cellular compartments, 
environmental sensing and the biosynthesis of a range of molecules such as lipids, 
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peptidoglycan, LPS, etc.[20]. The inner membrane contains lipoproteins and both 
integral and peripheral proteins[20]. Peripheral proteins may exist on either side of 
the membrane, and those residing on the cytoplasmic side interact with the 
proteome of the cytoplasm and play a role in cell metabolism[21]. Inner membrane 
proteins (IMPs) are complex and diverse in function.  
The OM (Figure 1.1) acts as a barrier for diffusion and grants additional resistance 
to antibiotics and detergents[13]. This is of particular relevance for pathogens, 
where the OM bestows greater protection for surviving inside parts of the 
mammalian body, for example the gastrointestinal tract. Moreover, because of the 
nature of the OM, diffusion of many important metabolites, such as amino acids, 
ions, oligosaccharides and waste products[22], is facilitated by integral OM proteins 
(OMPs)[23]. They are important for transport and assembly of structures on the 
inner and outer faces of the OM[24] ?dŚĞŵĂũŽƌŝƚǇŽĨKDWƐĂƌĞɴ-barrel 
proteins[24]. To date, only two OMPs have been categorised as essential in E. coli, 
namely the LptD-LptE complex, which is responsible for inserting LPS into the OM, 
and the BamA[24]. ůƚŚŽƵŐŚƚŚĞƐƚƌƵĐƚƵƌĞƐŽĨKDW ?ŝ ?Ğ ?ɴ-barrels, are similar, they 
are nevertheless quite diverse. Non-specific OMPs, for instance, function as porins 
and form channels for hydrophilic molecules up to 600Da in size[11]. Although 
denoted as non-specific, some of these porins show a preference for molecules 
based on their charge and size[11]. OmpF and OmpC, for example, allow for the 
diffusion of positively charged molecules[11], while, conversely, PhoE has a 




















Other OMPs form channels for specific (usually large) molecules; LamB allows for 
the diffusion of maltose and other sugars and FhuA for Fe3+[26]. Some of these 
specific channels allow passive diffusion, while others require facilitation from 
active transport systems. OMPs can also be used as channels for the exportation of 
solutes and proteins from the cell, and some have enzymatic capabilities, such as 
the PhoP-regulated OmpT[27]. Other OMPs play a role in maintaining the structure 
of the OM, an example of which is the BAM complex, while others help form the 
LSP, such as LptD[28].  
OMPS are synthesised in the cytoplasm. Therefore, OMP (or OMP precursors) must 
be transported through the inner membrane, the periplasm, and inserted correctly 
into the OM[24]. This is achieved by periplasmic chaperones and complex, 
membrane-embedded translocation proteins[29]. Transportation of unfolded 













Figure 1.1. Showing a cross-section of the OM and peptidoglycan chains in the periplasmic 
space.  
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The Sec-translocon is a heterotrimeric complex[29], The main channel of the 
translocon is formed from SecYEG and peripheral protein, SecA, which is an ATPase, 
and provides energy for the translocation of the proteins[29]. The cytoplasmic 
chaperone SecB delivers unfolded OMPS to secYEG for translocation across the 
membrane[29], though proteins may be delivered co-translationally and targeted 
to the SecYEG by an N-terminal signal peptide[29]. Once in the periplasm, OMPS 
are prone to aggregation and misfolding. To prevent this issue, the OMPS are 
escorted through the periplasm by chaperones that bind to unfolded OMPS. 
Additionally, the periplasm also contains protease, which degrades misfolded 
OMPs[30]. Survival protein A (SurA), Seventeen kilodalton protein (SKp) and DegP 
are three well studied examples of periplasmic proteins that perform these 
functions[30]. 
SurA is peptidyl-prolyl isomerase and required for folding OMPs, as well as 
interconverting the cis and trans isomers of peptide bonds[31]. Strains lacking surA 
see an increase in misfolded OMPs and a decrease in OMP density, compared to 
surA positive strains[31]. SKp binds to unfolded OMPs and acts as an anti-
aggregator and chaperone[32], and it also targets OMPs with rich hydrophobic and 
aromatic residues, binding them and shielding the protein from the surrounding 
environment[32].DegP is a protease that seeks misfolded and aggregated[33]. Once 
chaperoned through the periplasm, OMPs are delivered to the BAM (ɴ-barrel 
assembly machinery) complex. 
BAM is responsible for the insertion and folding of OMPs and consists of BamA and 
ĨŽƵƌůŝƉŽƉƌŽƚĞŝŶƐ ?ƌĞĨĞƌƌĞĚƚŽĂƐ “ĂD ? ?tŚŝůĞĂŵŝƐĂŶĞƐƐĞntial and 
integral transmembrane protein, BaMBCDE are anchored to the inner leaflet of the 
OM[34]. The BAM complex recognises the C-terminal motif, which acts as a signal 
for insertion[34].  
Other OM proteins that have important functions are lipoproteins much work has 
been done on Lpp  W the most abundant protein in the cell and which anchors the 
peptidoglycan to the OM[35].  
Lipopolysaccharide (LPS) is a glycolipid[36] found exclusively in gram-negative 
bacteria, embedded in the outer leaflet of the OM. The LPS is essential for almost 
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all gram-negative bacteria and is a large constituent of the OM[36]. It is made of 
three domains: lipid A (endotoxin), core oligosaccharide (subdivided into inner and 
outer variants) and a variable O-antigen (Figure 1.2). Lipid A consists of two 
glucosamines with  attached fatty acids, making LPS a saccharolipid. The inner core 
has a conserved structure, while the outer core is more variable in this respect[37]. 
However, the LPS core structure is known to be variable among E. coli serotypes.  
There are five well defined core structures, namely R1, R2, R3, R4 and K-12. These 
core differ slightly in regard to the sugar residues that make up the inner and outer 
core[38].  While these core types are found among commensal isolates certain core 
structures are associated with pathogenic strains. For example the R1 core 
structure is frequently encountered in extraintestinal isolates, while R3 is 
predominate STEC and VTEC [38]. 
A Kdo (3-deoxy-d-manno-oct-2 ulosonic acid) group is the first residue that links the 
inner core to lipid A[36]. Modification of the Kdo group can affect the cell ?Ɛ 
resistance to antimicrobial peptides[39]. EptB modifies the Kdo group by adding a 
phosphoethanolamine (pEtN) moiety[39], which reduces the anion charge of the 
molecules, decreases electrostatic repulsion between the LPS molecules. EptB is 
positively regulated by sigmaE[39]. The Kdo groups are followed by heptose, which 
are phosphorylated, then finally, in E. coli K-12, three glucose residues.        
The immunogenic O-antigen is at the terminal end of the LPS molecule and also acts 
as a virulence factor to help the cell evade and escape the host immune system[40]. 
The O-antigen extends, from the cell surface, into the environment and constitutes 
the hydrophilic portion of the LPS[37]. The O-antigen consists of repeating 
oligosaccharides, making units of 3-5 sugars. These units can repeat up to 40 
times[37].   
The interaction between LPS molecules, facilitated by divalent cations binding to  
negative charges on the Kdo carboxylate and glucosamine phosphates groups, can 
cause neighbouring molecules to bridge the stabilisation of the overall OM 
structure[37]. 
 



















LPS is synthesised in cytoplasm and on the cytoplasmic face of the inner membrane. 
LPS synthesis starts with lipid A[37]. Lipid A is synthesised from the precursor UDP-
N-acetylglucosamine. Subsequent reactions by LpxA, LpxC and LpxB convert UDP-N-
acetylglucosamine into UDP-diacyl-GlcN[37]. The uridine- ?഻-monophosphate motiy 
is cleaved from UDP-diacyl-GlcN by LpxH and it is converted to lipid X (2,3-
diacylglucosamine-1-phosphate). Next LpxB encodes an inverting glycosyl 
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 O-antigen  
 
lipidA  
Glucose   
Heptose  
 
 Glucosamine  
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Kdo (3-deoxy-d-manno-      
oct-2-ulosonic acid) 
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diacylglucosamine-1-phosphate ( Disacharide-1-P) from LipidX and UDP-diacyl-GlcN.  
The kinase, LpxK phosphorylates disaccharide-1-P, this forms lipid IVA[37]. The 
enzyme KdtA incorporates two 3-deoxy-D-manno-octulosonic acid (Kdo) residues 
into lipid IVA, subsequent reactions by LpxL and LpxM form Kdo2-lipid A[37]. 
The core oligosaccharide region of LPS varies between E. coli strains but a common 
feature is a core set of sugars, which variable regions attached. These are a linear 
set of six sugars  and are most often e Kdo, Hep, D-glucose and D-galactose. The 
core is synthesised by several enzymes, WaaG, WaaB, WaaO, WaaR, WaaF, and  
WaaC[37] . The enzyme encoded by waaL is essential for attachment of core-lipid A 
complex to the O-antigen[37].  
Sugar-nucleotide act as precursors for the synthesis of the O-antigen. The 
precursors are synthesised by glycosyltransferases and polymerases  and finally 
attached to the core-lipid A complex[37]. O-antigen synthesis happens on the 
periplasmic face of the inner membrane[37]. The core-lipid A is transported to the 
periplasm by, integral IMP, MsbA[37]. The O-antigen is transported across the inner 
membrane by the Wzx protein[37].  Assembly is carried out in the periplasm by 
enzyme encoded by waaL (O-antigen ligase)[38].  Several proteins expressed from 
the lpt operon, such as chaperones, IMPs and OMPs function to transport the 
nascent LPS to the OM[37]. LptBFG form a ABC transporter that, with assistance 
from LptA and LptC, translocate the LPS molecule to the inner leaflet of the OM[37]. 
It is believed that LPS molecules are transported to outer leaflet of the OM by LptD 
and LptE[37].  
1.2.1 Peptidoglycan    
 
The periplasm is interposed between the inner and outer membranes and is an 
oxidising, viscous, gel-like compartment[12] containing a diverse soup of proteins 
and molecules necessary for vital functions[12]. 
Peptidoglycan, situated in the periplasm, forms a sacculus and gives the envelope 
its rigidity. Cells lacking peptidoglycan are prone to lysis[12]. The peptidoglycan 
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sacculus has a (hydrated) thickness of approximately 2.5-7nm and has high 
elasticity[12], which allows the surface area of the sacculus to stretch  W necessary 
to withstand turgor osmotic pressure placed on sacculus by the cytoplasm[12]. 
Moreover, the sacculus contains pores (approximate radius of 2.1nm) which aid the 
diffusion of proteins up to 50KDa in size, thereby acting as a molecular sieve[12].  
Peptidoglycan is formed from cross-linked chains of glycans, which in turn are 
connected via short peptides[21] and formed alternating units of ɴ-1,4-linked N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) to create the bulk 
of the peptidoglycan structure[21].  
Peptides link the chains GlucNac & MurNac together with neighbouring chains[21]. 
The peptides are amide-linked to the lactoyl group of MurNAc[21]. E. coli has a 
peptide structure L-alanine (L-Ala)-gamma-D-isoglutamic acid (D-iGlu)-meso-
diaminopimelic acid (m-Dap)-D-alanine (D-Ala)(Figure 1.3)[21].  
Synthesis and translocation of peptidoglycan is a complex, multifaceted, process.   
The first steps take place in the cytoplasm, while the subsequent steps take place 
on the inner and outer side of the inner membrane[21].  
In the initial steps, precursors such as UDP-Nacetylglucosamine, UDP-N-
acetylmuramic acid, UDP-N-acetylmuramyl-pentapeptide and D-glutamic acid are 
synthesised. Biosynthesis of UDP-GlcNAc from fructose-6-phosphate is facilitated by 
proteins transcribed from the glm operon (GlmS, GlmM and GlmU)[41]. UDP-
GlcNAc can be catabolised into GlcNAc-6-phosphate and then into fructose-6-
phosphate, which is carried out by NagA and NagB, respectively[41]. It has been 
found that the nagA promoter responds to the concentration of extracellular 
divalent cations via the regulator PhoP[42]. In this way, PhoPQ influences the 
availability of the peptidoglycan precursor UDP-GlcNAc. 
In the next set of reactions, UDP-GlcNAc is used as a precursor for UDP-
MurNAc[41]. This step is the first committed move towards peptidoglycan 
formation. These reactions are carried out by MurA and MurB in a two-step process 
that yields the product UDP-MurNAc[41]. Like UDP-GlcNac and UDP-MurNAc, 
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smaller peptides, used to link glycan chains of peptidoglycan, are also synthesised in 














The later steps in peptidoglycan synthesis take place within and at the interface of 
the cytoplasmic membrane[41], including the translocation and polymerisation of 
the peptidoglycan precursors. Lipid II is the final peptidoglycan precursor before the 
peptidoglycan polymer is formed and consists of one GlcNAc-MurNAc-pentapeptide 
subunit[21]. Initially anchored in the inner leaflet, lipid II is flipped to the outer 
leaflet of the cytoplasmic membrane by the proteins RodA and FtsW[33]. PG 
synthases then polymerise the glycan chains via glycosyltransferase (GTase) 
reactions and form the peptide cross-links that make up peptidoglycan[41].  
Figure 1.3. The peptidoglycan structure shown above is made of alternating chains of N-
acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc). MurNAc has a stem of 
peptides, L-alanine (L-Ala)-gamma-D-isoglutamic acid (D-iGlu)-meso-diaminopimelic acid 
(m-Dap)-D-alanine (D-Ala). This peptide stem cross-links the glycan chains horizontally 
ĂŶĚǀĞƌƚŝĐĂůůǇ ?ŶŽƚƐŚŽǁŶ ?ƚŽĐƌĞĂƚĞƚŚĞƉĞƉƚŝĚŽŐůǇĐĂŶ ?Ɛ ?ƐƚƌƵĐƚƵƌĞ ? 
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1.3 Gene regulation 
 
Gene expression in bacteria is influenced primarily by two extracellular factors, 
namely nutrient availability and environmental conditions. These two factors must 
be monitored closely by the cell, as they can change quickly and dramatically, and 
so overcoming these changes is often necessary for the transmission, survival and 
pathogenesis of an organism. For example, E. coli must move from the nutrient-rich 
environment of the gut to the harsh outside environment, in order to colonise new 
hosts successfully. To survive such changes, the bacteria must utilise a number of 
methods to effect genetic and phenotypic changes that help  them adjust rapidly to 
their new conditions. 
 
Gene expression can be controlled at both the transcriptional and post-
transcriptional levels. Promoter specificity, transcription factors or sigma factors, 
can influence the expression of genes on transcriptional level. While post-
transcriptional regulation is often carried out by small non-coding regulatory RNAs 
 
Gene regulation in E. coli is arranged hierarchically. Genes, with a similar function, 
are grouped into operons. Individual operons are often regulated by cis- and trans-
acting regulators, or by the abundance of a pathway-specific precursor or end 
product[43]. Multiple operons that contribute to a similar function in the cell, and 
share a common regulator, are grouped into regulons[44]. These shared regulators 
often recognise a DNA target sequence that is shared by all members of the 
regulon[45], multiple collections of which are grouped into stimulons. Stimulons, 
i.e. multiple overlapping regulons, allow the cell to react broadly to changes such as 
osmolarity or nutrient deprivation. Hierarchical regulation allows for broad and 
specific responses, fine-tuning gene expression and the integration of multiple 
environmental and nutritional signals into a global transcriptional network[46].  
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1.3.1 RNA polymerase and sigma factors  
 
RNA polymerase has broad specificity, though not all promoters are bound with the 
same affinity[47]. The promoter sequence has an effect on the affinity of RNA 
polymerase binding, in that promoters that bind to RNA polymerase with a high 
affinity and are transcribed with a high frequency are strong, while those that are 
transcribed at a low frequency are weak. A highly conserved characteristic of 
promoter architecture are the  W10 and  W35 hexamers, located 10 and 35 base pairs 
upstream from the transcription start site.  The consensus sequences of these 
ŚĞǆĂŵĞƌƐĂƌĞ ?഻-TATAAT- ?഻ĂŶĚ ?഻-TTGACA-3. Deviation from the consensus 
sequences or the optimum spacer between them, 17bp, is associated with weak 
promoters[48].   
Other than the -10 and -35 sequences, some promoters have a -16, discriminator 
and UP element. The -16 motif (3-4 bp in length) is found adjacent to the -10 
element[49]. The discriminator is the region between -10 region and transcription 
start site and effects isomerisation of the double stranded DNA molecule during 
transcription initiation[49]. The UP element is a region upstream of the -35 
sequence and binds the ɲ-C terminal domain of RNA polymerase[49]. 
Transcription requires the recruitment of RNA polymerase, but the available 
concentration of RNA polymerase is limited in the bacterial cell[50]. A proportion of 
ƚŚĞĐĞůů ?ƐZEƉŽůǇŵĞƌĂƐĞŝƐďŽƵŶĚŝŶĂĐƚŝǀĞůǇƚŽƚŚĞĐĞůů ?ƐE ?ǁŚŝůĞƚŚĞŵĂũŽƌŝƚǇ
of active RNA polymerase is occupied by creating transcripts of stable RNA needed 
for translation[50]. RNA polymerase holoenzyme is composed of a several subunits, 
two alpha, one beta and one ďĞƚĂ ?[50]. RNA also requires dissociable subunits 
ĐĂůůĞĚ “ƐŝŐŵĂĨĂĐƚŽƌƐ ? ? RNA polymerase can bind to DNA without sigma factors; 
however, without these subunits, the enzyme will be unable to differentiate 
between sequences, as it relies on sigma factors for consensus sequence 
recognition[51]. The beta subunit is encoded by the rpoB gene and has two catalytic 
sites[52] ?ƚŚĞĨŝƌƐƚŽĨǁŚŝĐŚŝƐƵƚŝůŝƐĞĚƚŽŝŶĐŽƌƉŽƌĂƚĞƚŚĞ “ĨŝƌƐƚŶƵĐůĞŽƚŝĚĞ ?ŝŶƚŚĞ
ZEŵĞƐƐĂŐĞ ?ǁŚŝůĞƚŚĞƐĞĐŽŶĚƐŝƚĞŝƐĨŽƌƚŚĞĂĚĚŝƚŝŽŶŽĨƚŚĞ “ƐĞĐŽŶĚŶƵĐůĞŽƚŝĚĞ ? ?
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which is the elongation site[52] ?dŚĞďĞƚĂ ?ƐƵďƵŶŝƚŝƐĂůĂƌŐĞƉƌŽƚĞŝŶĞŶĐŽĚĞĚďǇƚŚĞ
gene rpoC. This subunit has a DNA binding site, namely a 25 Å groove[47] ?dŚĞďĞƚĂ ?
subunit positions the non-transcriptional strand away from the transcriptional 
strand in such a way that it does not inhibit the process[52]. Assembly requires an 
additional subunit, omega[47], which is required for assembly of the holoenzyme. 
The subunits are assembled sequentially in the following order: alpha, alpha, beta,  
ďĞƚĂ ?ĂŶĚĨŝŶĂůůǇƚŚĞĂĚĚŝƚŝŽŶŽĨƚŚĞƐŝŐŵĂĨĂĐƚŽƌ-ɲ ?ɴɴ഻ʍ [53]. Sigma factors bind to 
the core RNA polymerase in such a way that they are in contact with the RNA 
polymerase subunits ɴĂŶĚɴ ?[54], which in turn forms a holoenzyme. The sigma 
factor, bound to RNA polymerase, directly interacts with DNA in the -35 and -10 
regions[51], following which the complex then binds the promoter region, and RNA 
synthesis ensues. The association between the sigma factor and RNA  
polymerase is reduced during elongation and termination, as the sigma factor is 
unnecessary for these steps[52].  
 
 Transcription starts at the promoter of the DNA template. The holoenzyme binds 
to duplex DNA and rapidly slides along the double helix in search of a promoter, 
forming temporary hydrogen bonds, in search of the promoter sequences[53]. 
Once a promoter is found, a segment of the helix must be open. RNA polymerase 
forms a complex with the section of open DNA[54]. RNA synthesis, unlike DNA 
synthesis, starts de nova. After forming the first phosphodiester bond, the sigma 
factor is lost. The newly synthesised RNA forms a hybrid helix with the template 
DNA strand[52]. This RNA-DNA helix is about 8 bp long, but about 17 bp of DNA are 
unwound throughout the elongation phase[67]. Termination is facilitated by stop 
codons, which are often from a palindromic GC-rich region followed by an AT-rich 
region[67].The palindromic sequence self-complements, forming a hairpin loop that 
causes stalling. During the termination phase of transcription, the formation of 
phosphodiester bonds ceases, the RNA-DNA hybrid dissociates, the melted region 





















 During initiation, -10 and -35  hexameric repeats in promoter regions 
are recognised by the ʍ factor. ʍ70   recognises the consensus sequences 
TATAAT and TTGACA.  The ɴ and ɴ ?ƐƵďƵŶŝƚƐĂĚŽƉƚĂĐůŽƐĞĚ
conformation during initiation. The DNA RNA polymerase open 
complex when the ɴʍ subunit triggers melting of the DNA. NTP bind to 
the template strand, as subsequent NTPs enter they form 
phosphodiester bonds. When chain of NTPs reaches a length of 10pb 
the ʍfactor will fall away allowing closer association between RNA 
polymerase and the DNA molecule. 
Initiation  
Elongation   
During elongation the RNA chain will form a duplex with the template strand. Nucleotides 
are addeĚƚŽƚŚĞ ? ?ŽĨƚŚĞZEĐŚĂŝŶĂƚƚŚĞĂĐƚŝǀĞƐŝƚĞ ?dŚĞĂĐƚŝǀĞƐŝƚĞŝƐĐŽŵƉŽƐĞĚŽĨƐŝƚĞƐ
j and j+l. RNA chain is situated in the j site. NTP are held in j+l site. Mg2+ initiates 
nucleophilic attack on the NTP allowing for the formation of a phosphodiester bond 
between the NTP and the RNA chain. The elongation complex will move one base pair 
down position in the newly added nucleotide in the j site. The RNA-DNA duplex will pivot 
as nucleotides are added. This allows the duplex to break apart allowing the RNA chain to 
exit and the DNA strands to reanneal.  






















RNA polymerase acts as a gateway for regulation. The steps in RNA synthesis can be 
regulated, though this regulation can affect the elongation and termination steps, 
such as through attenuation (conditional termination) and riboswitches[55], albeit 
most regulation happens in the initiation step. An important part of initiation 
regulation is the recruitment of sigma factors to the holoenzyme. While specific 
transcription factors allow E. coli to respond to discrete intra- and extracellular 
signals, sigma factors provide a much broader response by acting as dissociable 
subunits of RNA polymerase[54]. E. coli contains two structurally distinct sigma 
factor families: the sigma54 family recognises promoters that have conserved 
elements near -12 and -24 upstream from the transcriptional start site, while the 
sigma70 family is more numerous and includes the primary and essential sigma70 
factor[56]. All bacteria contain a primary sigma factor, necessary for the 
Termination  
Termination is caused by inverted repeats, 
typically six adenine nucleotides followed 
by a uracil repeats. These cause the 
formation of a hairpin loop in the RNA 
chain. This causes transcription to stall and 
the RNA chain to separate from the 
template strand and terminating 
transcription.  
Figure 1.4. ZEƉŽůǇŵĞƌĂƐĞ ?ƐĚŝƐƚŝŶĐƚƐƵďƵŶŝƚƐɲ ?ɴɴ഻ʍĂŶĚRNA polymerase holding the 
open DNA (black) complex, and formation of the RNA(Red)-DNA duplex. Outlining the 
three steps of RNA synthesis, initiation, elongation and termination  
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transcription of genes associated with survival and growth[54]. These primary 
sigma factors regulate the transcription of essential genes important for healthy cell 
growth[69]. The sigma70 family also contains alternative sigma factors that are 
important regulators of various stress responses[56]. E. coli has six alternative 
sigma factors, namely sigmaS, sigmaN, sigmaH, sigmaF, sigmaE and sigmaFecI 
(Table 1.1)[56]. An alternative sigma factor redirects RNA polymerase to promoters 
within their regulons. RNA polymerase cannot bind more than one sigma factor, so 
there is competition between sigma factors[57], which makes the tight regulation 
of alternative sigma factors necessary. Regulation is accomplished via a number of 








Sigma factors   Gene  
 
Primary Function/regulon  
ʍ70  rpoD Housekeeping  
 
ʍE rpoN Nitrogen-regulated genes  
 
ʍ, rpoH Heat-shock genes  
 
ʍ rpoE Envelope stress response  
 
ʍ& rpoF Flagella 
synthesis/chemotaxis  
 
ʍ^ rpoS Starvation/general stress 
response 
 
ʍ&ĞĐů fecL Iron transport  
Table 1.1. The different sigma factors in E. coli, the genes encoding them and their 
function. 
 
20 | P a g e  
 
1.3.2 Regulatory RNAs  
 
RNAs are often utilized as regulators within the cell. RNA regulators are less 
resource intensive for the cell to produce and do not need to be translated. They 
can be deployed quickly, to shut off gene expression. So, regulatory RNAs offer 
several advantages compared to protein regulators.  
Small, non-coding RNAs (sRNAs) are an important regulatory tool ranging from a 
few nucleotides to hundreds[58]. The majority of sRNAs act post-transcriptionally 
and negatively regulate target genes by base pairing to the mRNA 
message[58].Great numbers of sRNAs are dependent on Hfq, which is an RNA 
binding protein. Hfq binding increases sRNA stability and, in many cases, it is the 
Hfq-sRNA complex which allows sRNAs to become active and bind to their 
targets[59]. The majority of sRNAs bind ƚŽƚŚĞ ? ?hdZŽĨƚŚĞŝƌƚĂƌŐĞƚƐand often 
occlude the ribosome-binding site. This method, along with the increased 
frequency of RNaseE-mediated degradation, is the most common way of preventing 
the sRNA-mRNA duplex from being translated[60].  
 A minority  of sRNAs activate expression of their targets. This is achieved by sRNA 
binding disrupting secondary structures of the target that would otherwise 
sequester the ribosome-binding site[61].  
sRNAs can be either trans or cis-encoded. Trans-encoded sRNAs have limited 
complimentary with their targets[62], [63]. Hfq-binding is used to facilitate binding 
in spite of limited complimentary[63]. Cis-encoded sRNAs are encoded on the 
opposite strand of their target genes, because of this they are, largely, 
complementary to their targets. Although, many, cis-encoded sRNAs have the 
ability to function in trans[63].   
ĞƌƚĂŝŶƐĞƋƵĞŶĐĞƐĂƚƚŚĞ ? ?ĞŶĚŽĨŵZEƐƚŚĂƚĐĂŶĂĚŽƉƚĚŝĨĨĞƌĞŶƚĐŽŶĨŽƌŵĂƚŝŽŶƐŝŶ
response to environmental signals such as temperature changes, ligand binding, 
ribosome stalling, etc ?ĂƌĞĐĂůůĞĚ “ƌŝďŽƐǁŝƚĐŚĞƐ ? ?ǁŚŝĐŚhave two parts, namely the 
aptamer (the ligand binding region) and the expression platform, the latter of which 
can adopt alternative secondary structures which regulate gene expression by 
affecting translation[64].  
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Examples of these secondary structures are hairpin structures that disrupt 
transcriptional terminators or antiterminators, or which occlude or expose 
ribosome-binding sites[63]. The majority of riboswitches require ligand binding to 
function.  
1.3.3 Transcription factors  
 
Transcription factors (TFs) influence the frequency which RNA polymerase binds to 
a promoter[65]. There are approximately 300 genes in E. coli that encode DNA-
binding ƉƌŽƚĞŝŶƐŬŶŽǁŶĂƐ “ƚƌĂŶƐĐƌŝƉƚŝŽŶĨĂĐƚŽƌƐ ?[66]. The majority of these 
proteins bind specific promoter or enhancer sequences[45]. Transcription factors 
are activated in response to ligand binding or covalent modification, which allows 
TFs to respond to endogenous or extra-cellular signals[65]. The active form of many 
TFs is a homo-dimer or homo-multimeric[65]. Endogenous signals, to which TFs 
respond, are often metabolites produced by the cell, while examples of exogenous 
signals are extremely varied and include metabolic by-products of other cells, ions 
or changes in temperature or osmolality[49]. Often TF networks will include 
transcription factors that are sensitive to both types of signals, this is logical as 
exogenous and endogenous signals are often closely linked. For example, the 
availably of a metabolite synthesised internally may depend on the availability of an 
extra-cellular precursor molecule[49]. LacI and TrpR are, well studied, examples of 
transcription factors that are regulated by exogenous and endogenous metabolites, 
respectively.  
Most transcription factors can be characterised by their domains. The majority of 
TFs have two domains, a DNA-binding domain and a regulatory domain[65]. 
However, some TFs contain three domains and a minority contain one or four 
domains. 90% of transcription factors, found in E. coli, have a single DNA-binding 
domain, the other domains being regulatory or related to auxiliary function[65]. 
Two-component systems are a broad exception to this rule as the DNA-binding 
domain and the regulatory domain are on two separate protei
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The majority of DNA-binding domains, in E. coli, can be grouped into 11 different 
families, which contain variations of the helix-turn-helix motif, alpha helixes joined 
by peptide chains[65]. Although this motif is common in DNA-binding domains it is 
not exclusive to them. The size of DNA-binding domain families varies, the largest 
ĨĂŵŝůǇ ‘ǁŝŶŐĞĚ-ŚĞůŝǆ ?ĐŽŶƚĂŝŶƐ ? ? ?ŵĞŵďĞƌƐǁŚŝůĞdƌƉZŝƐŝƚƐĨĂŵŝůǇ ?ƐƐŝŶŐƵůĂƌ
member[65].    
Transcription factors are regulated both transcriptionally, via expression and 
subsequently by their total protein concentration, but also via their regulatory 
domains. The non-DNA binding domains can be categorised by function. Small 
molecule-binding domains are the most common, second to enzymatic 
domains[65]. There are protein-protein interaction domain families, which facilitate 
binding with other TFs, RNA polymerase or covalent modification, and receiver 
domains found in the response regulators of Two-component systems[65]. These 
diverse Non-DNA-binding domains can be found disrupted among the DNA-binding 
domain families[65].  
Transcription factors can affect gene expression via a number of mechanisms. Some 
TFs influence the activity of RNA polymerase by remodelling the holo-enzyme to 
recognise promoters[67]. For example ^Žǆ^ŝƐĂŶ ‘ĂƉƉƌŽƉƌŝĂƚŽƌ ?ƚhat is expressed in 
E. coli in response to oxidative stress, which binds to the C-terminal domain of both 
ɲ-subunits of RNA polymerase and promotes transcription of genes with specific 
sequences called Sox-boxes[67]. 
The majority of transcription factors affect gene expression by interacting with the 
promoter region of a gene, although the mechanism they use is diverse. The 
regulatory control that a TF can exert is dependent on TF concentration and TF-DNA 
affinity[67]. TF can bind to consensus sequences with a strong or weak affinity, 
weak consensus sequences require a higher concentration of TF for regulation, 
while the opposite is true for strong consensus sequences[67]. 
TFs can positively or negatively regulate their targets[68]. They can block RNA 
polymerase through steric hindrance or by recruiting co-repressors[27] that 
decrease the affinity of RNA polymerase ĨŽƌƚŚĞŐĞŶĞ ?ƐƉƌŽŵŽƚĞƌƌĞŐŝŽŶ[69]. 
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Conversely, TFs can also recruit co-activators or increase the concentration of RNA 
ƉŽůǇŵĞƌĂƐĞĨŽƌƚŚĞŐĞŶĞ ?ƐƉƌŽŵŽƚĞƌ ? ? ? ? ?
To accomplish repression via steric hindrance TFs bind to operators, a short 
sequence of DNA, this allows the TF to physically block the -10 and -35 regions of 
the promoter[70]. Promoters often contain several operators next to each other, 
which allow several of the same TF to bind for an aggregative effect or different TFs 
to bind so gene expression can be mediated by multiple signals. Some TFs bind to 
distal operators and can affect the local DNA topology, causing loops that prevent 
RNA polymerase binding[70] ?^ŽŵĞƌĞƉƌĞƐƐŽƌƐĨƵŶĐƚŝŽŶĂƐ ‘ĂŶƚŝ-ĂĐƚŝǀĂƚŽƌƐ ? ?ǁŚŝĐŚ
disrupt the activity of TFs that promote transcription, which is accomplished by a 
combination of DNA and/or protein binding[70].   
There are several classes of transcription factors that enhance transcription 
(activators). Class I activators bind to operators and recruit RNA polymerase[70]. 
Class I operators normally bind positions   W61,  W71,  W81 or  W91 upstream of 
transcription start site[70]. The C-ƚĞƌŵŝŶĂůĚŽŵĂŝŶŽĨZEƉŽůǇŵĞƌĂƐĞ ?Ɛɲ-subunit 
interacts with a region on the activator ( called the activation region), this protein-
protein helps to stabilise RNA polymerase DNA-binding, specifically the 
transcription closed complex[70]. Class II activators bind to operators that overlap 
the -35 region of the promoter. They can interact with either the N-terminal 
ĚŽŵĂŝŶŽĨƚŚĞɲ-subunit or the sigma factor of RNA polymerase[70]. This 
interaction can facilitate the transition of RNA polymerase-DNA from closed to 
open complex. A third class of activators bind to operators between the -10 and -
35, promoter regions that bind activators of this class usually have non-optimal 
spacing between these sequences. Binding of these types of TFs helps to better 
orientate the region so the local DNA topology can better facilitate RNA polymerase 
binding[70].    
TF can function as activators of some genes and repressors of others, for example 
some genes that are regulated by the Factor-for-inversion stimulation protein (FiS) 
have two adjacent TF operators[70]. A weak negative consensus sequence, that 
promotes repression, inside the promoter region and strong positive operator 
outside of the promoter which activates the gene[70]. In low concentrations, the TF 
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will bind the strong promoter which will activate transcription, however when the 
transcription factor is abundant the positive site will be saturated and weak 
consensus sequence binds the TF and repressor transcription[70].   
TFs are organised into local networks, which represent interconnected regulations 
of target genes. In E. coli, the most common types of local networks are single input 
modules, in which a TF regulates a group of genes, wherein affinity for the TF can 
vary between genes in the group[71]. These systems are highly sensitive to the 
concentration of TF regulating them[72]. There are also multiple input modules in 
which genes respond to several TFs. In this way, the expression of a single gene can 
be influenced by multiple signals[72] and local transcription networks can take on 
different motifs, a common type of which is the feedforward motif. In this local 
network, a TF will regulate a gene and an intermediate TF, which also regulates the 
target gene[72]. The TF and the intermediate TF may have different effects on the 
target gene, i.e. one may be a repressor and the other an activator, or they may 
have the same effect, but the most common formation seen in this arrangement 
has both the  TF and the intermediate TF acting as activators[73]. This ensures gene 
transcription only when a signal is persistent, thus preventing fluctuation. The 
second most common type of configuration observed is one in which the TF is an 
activator and the intermediate is a repressor[72]. This type of configuration forces 
the pulse-like expression of the target gene. These local networks are integrated 
into the greater whole, forming a global network of TFs.  
 
There is a huge difference in the number of genes that TFs regulate, ranging from a 
large number of genes to just one only. The global TF network is organised 
hierarchically, wherein 20% of E. coli TFs regulate the transcription of the majority 
of genes in the global TF network[72], including TFs associated with redox sensing 
(ArcA), iron transport (Fur), environmental sensing (CspA) and carbon metabolism 
(Lrp)[72]. The majority of TFs are fine-tuners and regulate a small number of 
genes[72]. These networks function to maintain homoeostasis and help the cell 
rapidly respond to changes in the environment.  
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 1.3.4 Two-component systems  
 
Cells have developed complex signal transduction systems that allow them to 
respond to both exogenous and endogenous stimuli, assuring the tight control of 
transcription, translation and, ultimately, phenotypic changes to help them adapt 
to adverse growth conditions[74]. This system enables the cell to adapt its 
phenotype in response to stress and deprivation by coupling gene expression and 
intracellular states to changes in gene expression[75]. One of the most important 
ways this is achieved in E. coli is via two-component systems (TCSs), which are 
activated in response to one more extracellular stimuli and usually have large and 
complex regulons that overlap with many other regulators and transcription 
factors.[76] TCSs usually consist of an, integral, membrane-bound sensor kinase and 
a cytoplasmic DNA-binding response regulator[74]. In most instances, the 
membrane-bound sensor kinase will autophosphorylate a histidine residue when it 
is activated by a specific signal[29], which will then cause the cytoplasmic sensor 
kinase domain to phosphorylate a key aspartic residue of the response regulator, 
thus causing a conformational change[29]. This conformational change allows the 
response regulator to bind efficiently to DNA [74], [77]. These systems are very 
common and exist in all domains of life[78]. In E. coli, there are 29 histidine kinases 
and 32 response regulators[77].  
 
Phosphotransfer  W the phosphorylation of the response regulator by its cognate 
histidine kinase  W is an integral part of the TCS activation process. In the majority of 
these cases, phosphoryl group transfer happens on a one-to-one basis, though one-
to-many (one histidine kinase activating many response regulators) or many-to-one 
(many histidine kinases activating a single response regulator) transmissions are not 
uncommon[79]. The latter type of system allows different signals or stressors to 
activate the same gene or the coordination of multiple signals so that subthreshold 
activation of many pathways triggers the response regulator. 
Specificity between histidine kinases and their cognate regulators is important, 
because unwanted cross-talk between histidine kinases and non-cognate regulators 
can cause noise during signal transduction, and there is impetus to avoid this to 
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maintain the integrity of signal transduction[79]. The specificity of phosphotransfer 
is driven primarily by molecular recognition and the specificity of the histidine 
kinase[74], which is dictated by key amino acid residues that are necessary for 
docking the kinase with the response regulator[80]. 
While response regulators often hydrolyse on their own, they often have dedicated 
phosphatases, even those with short phosphoryl group half-lives[79], which 
prevents unnecessary noise in signal transduction. In many cases the response 
ƌĞŐƵůĂƚŽƌ ?ƐĐŽŐŶĂƚĞŚŝƐƚŝĚŝŶĞŬŝŶĂƐĞƐǁŝůůĂĐƚďŝ-functionally as both kinases and 
phosphatases. However, many TCS are also regulated by other phosphatases[81].  
 
Prototypically, histidine kinases are homodimeric transmembrane proteins, with 
each protomer having several domains. The sensor domain  differ greatly between 
sensors kinases, though some common structural folds infer a conserved method of 
signal sensing[82]. The extracystolic sensor domain is connected to two 
transmembrane helices[34], the N-terminus of which are located in the cytoplasm 
and connected to the HAMP domain. The HAMP domain, approximately 50 residues 
ŝŶůĞŶŐƚŚ ?ĐŽŶƐŝƐƚƐŽĨƚǁŽɲ-ŚĞůŝĐĞƐ ?ƌĞĨĞƌƌĞĚƚŽĂƐ “,ɲ ? ?ĂŶĚ “,ɲ ? ? ) ?The HAMP 
domain is then connected to the dimerisation and histidine phosphorylation 
ĚŽŵĂŝŶ ?,Ɖ ) ?ǁŚŝĐŚĐŽŶƐŝƐƚƐŽĨƚǁŽŚĞůŝĐĞƐĐĂůůĞĚ “ɲ ? ?ĂŶĚ “ɲ ? ? ?&ŝnally, at the 
C-terminus of the second DHp domain, is the catalytic (and ATP-binding) domain. 
dŚĞ,ƉĂŶĚĐĂƚĂůǇƚŝĐĚŽŵĂŝŶŝƐƌĞĨĞƌƌĞĚƚŽĐŽůůĞĐƚŝǀĞůǇĂƐƚŚĞ “ŬŝŶĂƐĞĚŽŵĂŝŶ ? ?
which has several conserved residues, such as a conserved histidine residue that is 
phosphorylated and donates a phosphoryl group to activate the response regulator 
(&ŝŐƵƌĞ ? ? ? ) ? ? ? ? ?Signal transduction through the sensor kinase starts by stimulating 
the sensor domain, which causes a cascade of conformational change that starts 
with the sensor domain, following which the signal is then transmitted through the 
transmembrane helixes to the HAMP domain and then finally to the kinase 
domain[77], [82]. Signal transduction through the transmembrane helixes is 






















Response regulators have two domains: a receiver domain (this domain accepts the 
phosphoryl group from the sensor kinase) and an effector domain. Some response 
regulators, such as CheY, only have a receiver domain, and conformational changes 
in the single domain allow for interaction with the target[78]. Receiver domains 
have well-conserved structures ? ? ? ?, while effector domains have more diverse 
functions, reflected by their structural diversity. The defining feature of the receiver 
domain is the conserved aspartate phosphorylation site, as this motif accepts the 
phosphoryl group from the sensor kinase[83].  
 
All receiver domains adopt a conserved alpha/beta fold, in which a five-stranded  
beta sheet is surrounded by five amphipathic alpha helices, with helices 1 and 5 on 
one side and 2,3 and 5 on the other[83]. Alpha helix 1 is essential for binding to the 
DHp domain of the sensor kinase. Many conserved residues are situated at the C-
terminus of ɴ1 and ɴ3. Here, at the end of the ɴ3 strand, the conserved aspartate 
residue which  functions as a ƉŚŽƐƉŚŽĂĐĐĞƉƚŽƌ ?ĞƐƐĞŶƚŝĂůĨŽƌƉŚŽƐƉŚŽƌǇůĂƚŝŽŶŽĨƚŚĞ
ƌĞƐƉŽŶƐĞƌĞŐƵůĂƚŽƌ ?ĐĂŶďĞĨŽƵŶĚ ? ? ? ? ?DŽƌĞŽǀĞƌ ?ƚŚĞƚǁŽƐƉ ?Žƌ'ůƵ )ƌĞƐŝĚƵĞƐƚŚĂƚ
 
 


















Figure 1.5. Example of a prototypical sensor kinase protomer. Showing the extracytosolic 
sensor domain, the transmembrane helices (TM1&2), the HAMP domain, consisting of 
ƚǁŽɲ-ŚĞůŝĐĞƐ ?,ɲ ? ? ? ? ?ƚŚĞĚŝŵĞƌŝƐĂƚŝŽŶĂŶĚŚŝƐƚŝĚŝŶĞƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ?,Ɖ ?ĚŽŵĂŝŶ ? 
ǁŚŝĐŚĐŽŶƐŝƐƚƐŽĨ ?ɲ ? ?ĂŶĚ ?ɲ ? ? ? and the catalytic domain. These domains are 
connected by small linker polypeptides. Adapted from Wang et al. 2012[82]. 
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ĨŽůůŽǁɴ ? ?ĂůŽŶŐǁŝƚŚƚŚĞƐƉƌĞƐŝĚƵĞďĞƚǁĞĞŶɴ ?ĂŶĚɲ ? ?ĂƌĞĂůƐŽŝŵƉŽƌƚĂŶƚĨŽƌ
ƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ?dŚĞƐĞƚŚƌĞĞƌĞƐŝĚƵĞƐĂůůŽǁĨŽƌĚŝǀĂůĞŶƚĐĂƚŝŽŶƐ ?DŐ ?A?ŽƌDŶ ?A? ? 
binding ǁŚŝĐŚŝƐĞƐƐĞŶƚŝĂůĨŽƌƉŚŽƐƉŚŽƌǇůĂƚŝŽŶ ? ? ? ? ? 
ɴ ?ĞŶĚƐǁŝƚŚĂĐŽŶƐĞƌǀĞĚdŚƌ ?^ĞƌƌĞƐŝĚƵĞ ?ĂůŽŶŐǁŝƚŚ ŚĞWŚĞ ?dǇƌƌĞƐŝĚƵĞ
ĂƐƐŽĐŝĂƚĞĚǁŝƚŚɴ ? ?ƚŚĞƐĞƚǁŽƌĞƐŝĚƵĞƐĨĂĐŝůŝƚĂƚĞƐŝŐŶĂůƚƌĂŶƐĚƵĐƚŝŽŶďǇŝŶƚĞƌĂĐƚŝŶŐ
ǁŝƚŚƚŚĞƉŚŽƐƉŚŽƌǇůŐƌŽƵƉĚĞůŝǀĞƌĞĚƚŽƚŚĞɴ ?ƐƉƌĞƐŝĚƵĞĂŶĚĂƌĞŬŶŽǁŶĂƐƐǁŝƚĐŚ
ƌĞƐŝĚƵĞƐ ? ? ? ? ?dŚĞƐǁŝƚĐŚƌĞƐŝĚƵĞƐĨĂĐŝůŝƚĂƚĞƚŚĞĐŽŶĨŽƌŵĂƚŝŽŶĐŚĂŶŐĞ ?ŽĨƚŚĞ
ƌĞƐƉŽŶƐĞƌĞŐƵůĂƚŝŽŶ ?ŶĞĐĞƐƐĂƌǇĨŽƌĂĐƚŝǀĂƚŝŽŶ(&ŝŐƵƌĞ ? ? ? ) ? ? ? ? ? 
 
These conformational changes, propagated through a series of highly conserved 
residues, cause the receiver domain to homodimerise or affect protein-protein 
interaction and allow the response regulator to activate. The majority of bacterial 
effector domains function as TFs with DNA binding capability [77], although others 
have a different mechanisms, such as enzymatic activity[83]. 
 
TCS with DNA-binding output domains can be sub-classified into three groups based 
on the mechanism through which they bind DNA, OmpR-like, NarL-like and NtrC-
like, although significant diversity can exist between members of the same group 
[84]. NarL-like response regulators are autoinhibitory[84], while the 
phosphorylation of the NarL N-terminal receiver domain releases the otherwise 
sequestered C-terminal output domain that subsequently binds specific DNA 
promoter sites, in order to repress or activate gene expression[84]. NtrC-like 
phosphorylation causes a rearrangement from an inactive dimer to an altered 
active dimer[84]. OmpR-like phosphorylation causes dimerisation, leading to tighter 
binding of the target promoter, PhoP, from the PhoPQ TCS is an example of a 
response regulator from this group[85].  
 
The second most common type of response regulator domain is involved in cyclic-
di-GMP signalling[84]. Cyclic di-GMP is an important messenger in bacteria, helping 
to regulate many functions such as biofilm formation, motility and virulence[86]. 
These, non-DNA binding domains exhibit enzymatic activity, they can synthesise 
cyclic-di-GMP ĂŶĚĂƌĞĐĂůůĞĚ “''& ?ĚŽŵĂŝŶƐ[84].  




























PhoPQ consists of the membrane-spanning sensor kinase, PhoQ, and PhoP, the 
cytoplasmic response regulator[39]. First discovered in Salmonella enterica, PhoQ 
was initially thought to be a regulator of PhoN, an acid phosphatase [87], [88]. 
PhoPQ showed homology to other two-component systems, and it was soon 
 
Figure 1.6. Cartoon representation (not to scale) of a prototypical response regulator receiver 
ĚŽŵĂŝŶ ?ɲ-ŚĞůŝǆĞƐ ?ɲ ?- ? ?ĂƌĞĚĞƉŝĐƚĞĚĂƐƉƵƌƉůĞĐǇůŝŶĚĞƌƐ ?ĂŶĚɴ-ƐŚĞĞƚƐ ?ɴ ?-5) are represented by 
thick blue arrows. The N-terminus and C-terminus are denoted bǇEĂŶĚ ?ƌĞƐƉĞĐƚŝǀĞůǇ ?ɲ-
ŚĞůŝǆĞƐĂŶĚɴ-sheets are linked by amino acid sequences portrayed as grey arrows. Where grey 
arrows cross, the lighter arrow indicates it is further from the foreground. Specific amino acids 
outlined in the text are denoted by three-letter abbreviations. The phosphoacceptor aspartate 
 ?ƐƉ ?ƌĞƐŝĚƵĞ ?ĨŽůůŽǁŝŶŐɴ ? ?ŝƐŚŝŐŚůŝŐŚƚĞĚŝŶƌĞĚ ?dǁŽŵĞƚĂůŝŽŶ-binding aspartate (Asp) residues 
ĨŽůůŽǁŝŶŐĨƌŽŵɴ ?are highlighted in light blue. Switch residues, denoted above as threonine 
(Thr) anĚƉŚĞŶǇůĂůĂŶŝŶĞ ?WŚĞ ? ?ƐŝƚƵĂƚĞĚďĞƚǁĞĞŶɴ ?ĂŶĚɲ4 ĂŶĚŝŶƚŚĞŵŝĚĚůĞŽĨɴ ? ?ƌĞƐƉĞĐƚŝǀĞůǇ ?
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discovered that it consisted of a single transcriptional unit and that PhoP and PhoQ 
were transcriptional regulator and membrane-bound sensor kinases, respectively. 
Later, PhoQ homologs were found in E. coli. The E. coli homolog of PhoPQ is 86% 
identical to protein first discovered in Salmonella enterica [76]. PhoPQ responds 
primarily to low concentrations of Mg2+, though other metal ions, Ca2+ and Mn2+, 
also induce PhoPQ, albeit to a lesser degree [88]. phoPQ is expressed as a 
polycistronic transcript from one of two promoters. P1 is active in a PhoP-
dependent manner, while P2 is constitutive, ensuring that there is a low level of 
phoPQ expression when Mg2+ concentrations are high[88]. 
 
Like many sensor kinases, PhoQ exists in E. coli as a transmembrane homodimer 
and contains four main regions. The cytoplasmic histidine kinase and HAMP 
domains[89], the  periplasmic sensor domain and membrane-spanning antiparallel 
helices(Figure 1.7)[89]. Periplasmic Mg2+ starvation will initiate signal propagation, 
which in turn causes the autophosphorylation of PhoQ from ATP at the conserved 
histidine 277 residue, situated in the cytoplasmic kinase domain[89]. This is 
followed by the transfer of the phosphoryl group to the conserved aspartate 51 
residue on the PhoP receiver domain[89]. PhoQ can also act as a phosphatase, 
causing dephosphorylation of the PhoP aspartate 51 residue when Periplasmic Mg2+ 




























Figure 1.7. The PhoQ protein sequence taken from E. coli MG1655. The N-terminus is 
highlighted in blue,  transmembrane helixes in orange,  the sensor domain in green, the HAMP 
domain in grey and the kinase  domain in purple. The conserved histidine 277 residue is 
highlighted in green[89].  
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PhoP is an OmpR-like response regulator, part of the OmpR/PhoB subfamily of 
response regulators, characterised by  an N-terminal receiver domain and a C-
terminal helix-turn-helix DNA-binding motif[74]. Once phosphorylated, the active 
PhoP dimerises and modifies gene expression by binding directly to the gene 
promoters within its regulon. The PhoP protein comprises two domains, namely a 
DNA-binding domain and a receiver domain. While the crystal structure of the 
receiver domain has been resolved, the secondary structure of the DNA binding 










Among E. coli, there are a number of common PhoP homologues that are found in 
both pathogenic and non-pathogenic isolates (Appendix Figure F.1). The most 
frequently encountered example is one in which leucine residue 45 is replaced with 
isoleucine, though a fraction of these may also have arginine residue 65 replaced by 
cysteine.  
PhoP is well conserved among the order enterobacteriales (Figure 1.9), particularly 
among members of the Enterobacteriaceae family[90]. However, PhoPQ 
homologues that perform a similar role, namely enhancing survival in low Mg2+ 
conditions, have been well characterised in Pseudomonas aeruginosa[91], 
Mycobacterium tuberculosis[92] and Vibrio species[93].When comparing the PhoP 
sequence of E. coli MG1655 to PhoP homologues found in other species of the 
order enterobacteriales, it can be seen that the E. coli  K-12 MG1655 PhoP 




Figure 1.8. The PhoP protein sequence taken from E. coli MG1655. The receiver domain is 
highlighted in blue, the Į-helix in bold and ȕ-folds underlined in italic. The DNA-binding 
domain is highlighted in pink and the conserved aspartate 51 residue is highlighted in 
green. 






















1.4.1 The PhoPQ regulon  
 
WŚŽWY ?ƐŵŽƐƚŽďǀŝŽƵƐƌŽůĞŝŶƚŚĞĐĞůůŝƐƚŽĂƐƐŝƐƚǁŝƚŚŵĞƚĂůŝŽŶŚŽŵĞŽƐƚĂƐŝƐĚƵƌŝŶŐ
divalent cation starvation. E. coli has a number of Mg2+ transporters, namely CorA, 
MgtE and MgtA. PhoPQ regulates the P-type TPase magnesium transporter 
MgtA[94]. CorA and MgtE are constitutive Mg2+ transporters, while MgtA is only 
expressed when the cell is starved of Mg2+[94].  
 
Figure 1.9. Bubble graph comparing similarities between different PhoP homologues found in 
species of the enterobacteriales order. The data were generated from a HMMER analysis of 
PhoP sequences taken from MG1655, using tools available at ebi.ac.uk/Tools/hmmer along 
with an E-value threshold of <1E-30. The diameter of the bubbles represents the range of 
scores and of sequence found in each species,as absolute value. Scores range from 344.6 to 
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However, PhoPQ has an expansive regulon, playing a role in, acid and antimicrobial 
peptide resistance, and LPS modification[42].PhoP regulates a large number of 
genes indirectly through other TCSs, regulatory sRNAs and transcription factors. It 
has been found that in a phoP mutant, under non-Mg2+ starved conditions, the 
expression of 31 genes significantly altered compared to the wild type[95]. Four 
genes were upregulated and 27 genes were downregulated[22]. However, 
microarray experiments carried out in a low Mg2+ environment found that the 
expression of 232 genes was altered  in a PhoPQ-dependent manner[42]. 
 
Analysis of the PhoPQ TCS showed that it binds to a distinct sequence, (T/G)GTTTA-
nnnnn-(T/G)GTTTA, which constitutes the PhoP box, which is often found -35 
upstream from the start codon[96]. Of the 232 genes found to have their 
expression influenced by PhoPQ, 26 of these genes were found to have the PhoP 
box tandem repeat[42]. These 26 genes have a variety of functions, including pili 
chaperones, utilisation of alternative carbon sources, helicases, lipoproteins and 
LPS modification[5]. Moreover, it was found that PhoP binds to these genes with 
different affinities[42]. PhoP bound mgtA and vboR with the highest affinity, and 
hemL and nagA with the lowest affinity[42]. Out of these 26 genes, nine, 
phoPQ, mgtA, mgrB hemL, nagA, rstAB, slyB, vboR and yrbL, were denoted by 
Minagawa et al. as the Mg2+ stimulon in E. coli[42]. 
PhoP exerts indirect regulatory control over most of its genes in part due to cross-
talking with otherTCSs. It was found that PhoP-regulated genes share similar 
expression profiles with a number of different TCS. EvgAS-PhoPQ and PhoPQ-
yedWV were found to have the highest regulatory overlaps, though the signal to 
which EvgSA responds is unknown [97]; however, it has been found that cells in 
which EvgsA is constitutively expressed show an increased multi-drug resistance 
phenotype and acid resistance[98]. A small inner membrane spanning protein, SafA, 
connects EvgS and PhoQ and facilities signal transduction between the two 
systems[99]. Thirteen PhoPQ-regulated genes show enhanced expression when 
EvgAS is active: crcA, hemL, mgtA, ompT, proP, rstA, rstB, slyB, ybjG, yrbL, mgrB and 
phoPQ itself[94].  
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While PhoPQ is not considered as a virulence determinant in commensal strains of 
E. coli, it has been found to be associated with virulence in some pathotypes[1]. 
UPEC strains (CFT073) lacking PhoPQ were attenuated and no longer able to cause 
infection in mice. It was found that, in this strain, 36 flagella and chemotaxis genes 
(not normally found in commensal strains) and acid fitness genes were all repressed 
in the absence of PhoPQ[90]. Furthermore, PhoPQ has an established role in 
resisting cationic antimicrobial peptides (CAMPs) in both pathogenic and non-
pathogenic strains. 
 
CrcA, regulated by PhoPQ, transfers a palmitate residue from a phospholipid to the 
proximal unit of lipid A. Acylation of lipid A prevents insertion of CAMPs, and 
subsequent disruption, of the bacterial membrane[100]. CAMPs are able to bind to 
the hydrophilic region of  LPS via electrostatic interaction[100]. Once bound CAMPs 
 ‘ĨůŝƉ ?ƐŽƚŚĂƚƚŚĞŚǇĚƌŽƉŚŽďŝĐƌĞŐŝŽŶŝƐďƵƌŝĞĚŝŶƚŚĞůŝƉŝĚůĂǇĞƌŽĨŽƵƚĞƌůĞĂĨůĞƚŽĨ
the OM. Acylation of lipid A helps to diminishes the rate of insertion of CAMPS into 
the lipid A layer by increasing hydrophobic interaction between neighbouring lipid 
A acyl tails[100]. 
 
It has been found that phoP mutants are unable to survive treatment with 
mastoparan or cecropin P1, while survival is diminished following exposure to 
magainin 2. However, survival, when treated with melittin, was not dependent on 
phoP in E. coli but it was in Salmonella enterica serovar Typhimurium (S. 
Typhimurium)[101]. It has been suggested that the difference in the PhoP-
dependent response to antimicrobial peptides might be due to the proposed 
difference in cross-talk between the TCS PmrAB and PhoPQ in E. coli and S. 
Typhimurium[102].  
 
In S. enterica, the protein PmrD allows for cross-talking between PhoPQ and 
PmrAB, the latter of which is a TCS that senses cationic antimicrobial peptides, high 
Fe3+ concentrations and acidic PH[101]. PmrAB also regulates LPS modification and 
resistance to antimicrobial peptides and regulates genes such as eptA and arnT. 
These genes encode phosphoethanolamine (pEtN) transferase and a 4-amino-4-
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deoxy-L-arabinose (L-Ara4N) transferase, respectively, and these enzymes are able 
to modify the lipid A group of the LPS, by adding pEtN or L-Ara4N groups[103]. This 
helps diminish the charge on the lipid A anionic phosphates, reduces the net charge 
of the LPS molecule and helps to protect the outer membrane from attack by 
positively charged cationic antimicrobial peptides[103]. In E. coli, it was found that 
PmrAB-regulated genes were transcribed in a low Mg2+ environment in the absence 
of PhoPQ[103], therefore inferring that PmrAB is not dependent on PhoPQ in E. coli.  
Conversely, it has also been found that PmrD does have a similar role in both E. coli 
and S. enterica and that a second, unknown system exists and is responsible for 
transcribing PmrAB under conditions of low Mg2+ in the absence of PhoPQ, thereby 
explaining the results found initially[101]. This suggests that a similar link between 
PmrAB and PhoPQ may exists in both S. Typhimurium and E. coli.  
 
A link between these two systems, PhoPQ and PmrAB, in E. coli would not be 
surprising, as PhoPQ has a well-established role in regulating both LPS modification 
and resistance to antimicrobial peptides. Aside from CrcA PhoPQ also regulates 
negatively regulates EptB, a phosphoethanolamine transferase via the sRNA MgrR.  
When not repressed by the PhoPQ controlled MgrR, EptB will add a 
phosphoethanolamine group to the outer Kdo residue of the LPS[94], [104]. 
Interestingly, it has been observed that E. coli cells that are unable to perform this 
LPS modification are less virulent.  
 
Additionally, PhoP also regulates ompT. This protein is activated under conditions of 
stress, heat, ethanol and highly denaturing conditions[27]. OmpT will degrade 
highly denatured proteins and it also favours antimicrobial peptides as 
substrates[105]. Unsurprisingly, SigmaH is also implicated in OmpT regulation. 
OmpT is negatively regulated by OmrA and OmrB, which in turn are activated by 
the TCS EnvZ-OmpR, and it has been associated with virulence factors in urinary 
tract infection and the regulation of nucleotide excision repair during the SOS 
response[105]. OmpT, a prototypical member of the omptin family, is a surface 
membrane serine protease with a 10-strand antiparallel ɴ-barrel conformation and 
extracellular loops that extend beyond the membrane[36]. The enzymatic activity 
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of this protein was found to depend on the presence of LPS, a fully acylated lipid A, 
is a requirement for OmpT activation[36]. It has been suggested that this 
mechanism for OmpT activation is used to stop OmpT attacking cellular proteins 
while it is being translocated to the OM from the cytoplasm[36].  
 
In addition to antimicrobial peptide resistance, PhoPQ plays a critical role in the 
control of acid resistance. gadAB, part of the glutamic acid decarboxylase (GAD) 
system, encodes glutamate decarboxylase proteins and protects E. coli from the 
toxic effects of low pH (pH 2.5 to 4.5)[106]. GadW acts as a transcriptional regulator 
of genes involved in the GAD system, while gadW is unregulated in response to 
acidic conditions. Moreover, gadAB transcription has also been found to be 
influenced by factors such as RpoS, CRP, HN-S and EvgA[107]. PhoP also regulates 
periplasmic proteins HdeA and HdeB, active under acidic conditions, these 
chaperone-like proteins mitigate aggregations of periplasmic proteins [96].  
 
PhoPQ also plays a role in N-acetyl-D-glucosamine metabolism via its regulation of 
nagA, which encodes the protein Nacetylglucosamine-6-phosphate 
deacetylase[18]. This protein serves to catalyse the first cytoplasmic reaction of N-
acetylglucosamine metabolism, which is a multi-step process that starts with N-
acetyl-D-glucosamine-6-phosphate and through a series of steps can yield glucose-
6-phosphate, an important metabolite which can be used in glycolysis or the 
synthesis of nucleotides via the pentose phosphate pathway[108].   
1.4.2 PhoPQ regulation   
 
Mg2+ has several important biochemical roles within the cell, one of the primary 
ones being stabilisation of ribosome. The 70s unit of ribosome of E. coli contains 
over  170 Mg2+ atoms, and Mg2+ is essential for its formation[109] by stabilising the 
secondary and tertiary structures of rRNA. Mg2+ starvation causes the disassociation 
of ribosomal subunits and the unfolding of rRNA[110]. Mg2+ (and Ca2+) also helps 
neutralise the charge between LPS molecules on the outer membrane and acts as a 
cofactor for several enzymes, some of which are involved DNA replication, 
transcription and translation[109].  
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Mg2+ plays an essential role in regulating PhoQ. The periplasmic domain of PhoQ 
responds to low Mg2+ concentrations, the presence of which stabilises the inactive 
conformation of PhoQ[87] and releases the inhibition of the DNA binding domain 
on the PhoP response regulator[76]. PhoQ can also respond to Ca2+ starvation. The 
domain responsible for binding Mg2+ and Ca2+ seems to be distinct, and evidence 
suggests that the absence of both of these metal ions has a stronger effect on 
PhoPQ induction compared to each of these alone[42]. Once active, PhoP will act as 
a transcriptional regulator, enhancing its own expression[4].  
 
Aside from Mg2+ concentration, PhoPQ is regulated post-transcriptionally by two 
sRNAs, i.e. the sigmaE-controlled MicA and GcvB[111]. GcvB is regulated positively 
by GcvA and negatively by GcvR. These proteins regulate the gcvTHP operon, 
responsible for encoding enzymes for the glycerin cleavage system (important for 
maintaining glycerin concentrations in the cell)[111]. GcvB regulates approximately 
20 mRNA targets, including the periplasmic transporter components DppA and 
OppA[39], [98]. MicA is positively expressed during extracytoplasmic stress, under 
the control of sigmaE, linking PhoP with the extracytoplasmic stress response[112].  
 
PhoPQ is also regulated by MgrB, a PhoPQ-regulated protein sensitive to the redox 
state of the cell[113]. PhoPQ also auto-regulates itself from PhoPp1 and requires 
both PhoP and PhoQ for activity; conversely, a second promoter, PhoPp2, has 
shown to be constitutively actively independent of the phosphorylation state of 
PhoP, which provides a constant basal level of expression and provides a pool of 
unphosphorylated PhoP to be activated by PhoQ during cation 
starvation[115],[121].  
1.5. Specific stress responses  
 
Bacterial stress can encompass any physical or biological stimulus that hinders 
unrestricted growth. This broad definition exemplifies physical changes in 
temperature, pH, osmolality and biological changes such as nutrient 
deprivation[114], [115]. Indeed, nutrient-limited stress is induced as a cell 
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population moves from the exponential to the stationary phase[116]. During 
nutrient-limited stress, metabolic processes are shut down and the rate of growth is 
slowed [117]; in fact, bacteria rarely have access to ideal growth conditions outside 
of specially created laboratory environments. E. coli has many mechanisms that 
allow the organism to respond to single stresses (examples of which are mentioned 
above). These single stress-induced responses usually allow the bacteria to 
eliminate the stressor or diminish its effect while also repairing damage caused by 
the stressor[114], [117]. This is achieved by using a number of different methods 
pertaining to gene regulation and expression.  
1.5.1 Heat and cold shock  
 
High temperatures have a variety of effects on cellular physiology, such as breakage 
in DNA and damage to the cytoplasmic membrane and ribosomes[118]. However, 
the primary signal for the activation of the heat shock response (HSR) is unfolded 
proteins[118], which has been demonstrated by the overproduction of unfolded 
proteins activating the HSR, in the absence of a temperature shift [119]. When       
E. coli is exposed to heat above what is optimal for growth, proteins will be less 
likely to take the proper conformation. The protein structure is dynamic and can be 
influenced by environmental conditions, and so increasing the temperature can 
cause a shift in conformational equilibrium, which results in incorrect protein 
folding and protein aggregates[120]. The cell responds by upregulating a group of 
ŐĞŶĞƐĐĂůůĞĚ “ŚĞĂƚƐŚŽĐŬŐĞŶĞƐ ? ?,^'Ɛ ) ?ǁŚŝĐŚĐĂƵƐĞƐŚĞĂƚƐŚŽĐŬƉƌŽƚĞŝŶƐ ?,^W )ƚŽ
be overexpressed, such as proteases and chaperones that mitigate the damage of 
miss or unfolded proteins[121]. Heat shock especially causes damage to DNA and 
rRNA, so many HSP function to protect these molecules as well as tune 
transcription and translation[122]. The HSR has several phases, induction-
transcription of HSP, adaptation-,  fine-tuning of the response consistent with the 
present stimuli, and finally steady-state heat shock proteins are maintained at a 
level appropriate for the growth temperature[118]. 
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It has been observed that cells can pre-adapt to heat stress. Cells that have been 
exposed to a high, non-lethal temperature exhibit a longer lag phase when they are 
exposed to a lethally high temperature, compared with cells that have not gone 
through this process[123]. The primary regulator of the HSR is sigmaH, and like all 
sigma factors, it has a large regulon that includes genes responsible for 
transcription, translation, DNA modification, protein chaperones, protease, 
etc.[118].  
 
As the temperature drops, cells must adapt to the changing biochemistry that low 
temperatures bring. Biochemical reactions slow down as liquid in cells becomes 
more viscous and water ionisation decreases (thereby decreasing the availability of 
H+ and OH- ions)[124]. This affects water diffusion and many biochemical reactions 
that rely on these ions. RNA secondary structures become more stable, ribosome 
assembly is reduced and DNA becomes more negatively supercoiled, these factors 
can have a negative effect on gene expression[124]. Additionally, membrane lipid 
fluidity is reduced[125].  
 
In response to a downshift in temperature, E. coli employs a number of proteins, 
such as cold shock proteins (CSPs), which mitigate damage and loss of 
function[126]. Unlike the heat shock response, the cold shock response is not 
mediated by a single, dedicated transcription factor (such as sigmaH) but is the 
product of several inputs[124]. When the temperature decreases, CSPs are 
transcribed at an increased rate (making 10-13% of transcribed proteins under low 
temperature conditions)[124]. One of the most important CSPs is the protein CspA, 
which is a major cold shock protein and part of a family of homologous proteins, 
which includes, CspB, CspC, CspD, CspE, CspF, CspG, CspH and CspI[127]. The 
function of all of these proteins is not known, and it is in fact thought that some of 
them may be redundant. CspA binds both single- and double-stranded DNA and 
RNA[127], helping to unwind tightly folded nucleic acid molecules, destabilise 
secondary structures and melt double-stranded RNA molecules, thereby making 
them available for RNA polymerase[127]. CspA binding also hinders the RNaseE 
degradation of mRNAs[128], functions as a transcriptional activator and increases 
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the expression of a number of other cold shock proteins[127]. CspA also induces 
rpoS, linking the cold shock response to the general stress response[127].  
  
1.5.2 Envelope stress  
 
The cell envelope stress response is activated under conditions that inhibit or 
perturb the components or function of the cell envelope[129]. This can include 
stimuli that are associated with general stress, such as heat, ethanol, oxidative 
stress or even starvation[129]. Under such conditions, the envelope stress response 
will accompany cytoplasmic stress responses[116]; however, this response and 
cytoplasmic stress responses are distinct [129].  
 
There are five major envelope stress regulators in E. coli: sigmaE, Cpx, Rcs, phage-
shock protein (Psp) and BaeSR responses[129]. The BaeSR two-component system 
is induced by toxic compounds, such as indole, and regulates exporter genes and 
multi-drug transporters[130]. The Psp response is induced by a number of stressors 
such as ethanol, osmotic shock and the mislocalisation of secretion proteins (that 
form export porins) to the inner membrane rather than to the outer 
membrane[131]. Four genes are necessary for this response: pspA, pspB, pspC and 
pspF[131]. PspA inhibits PspF, and upon sensing stress PspF is released from 
inhibition in a PspB- and PspC-mediated manner[131]. PspF is a transcriptional 
regulator, which, once freed from inhibition, will upregulate PspA, and once 
activated, PspA will affect inner and outer membrane stability[131].  
 
The CpxAR response is activated under diverse conditions, such as heightened 
concentrations of alkaline, pH, copper ions and misfolded periplasmic membrane 
mutations or aggregates[132].CpxAR regulates genes that directly relieve envelope 
stress, examples of which are periplasmic foldase, DsbA and PpiD and protease 
DegP[133]. These proteins refold or degrade damaged proteins[133]. Rsc helps to 
regulate capsule synthesis, but also plays a role in the envelope stress response. Rcs 
is activated in response to environmental changes such as increased osmolarity, 
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desiccation, and growth on inorganic surfaces and antimicrobial attack on the outer 
membrane, such as Beta-lactams or antimicrobial peptides.  
 SigmaE is an example of an essential alternative sigma factor, although suppressor 
mutations have been found[134]. SigmaE will respond to misfolded outer 
membrane proteins, but it also plays a role in the normal growth of the cell. During 
non-stressed conditions, sigmaE is constituently active at low concentrations as the 
cell wall grows and expands[134]. SigmaE protects the cell against effects from 
ethanol, overproduction of outer membrane porins, inactivation of periplasmic 
chaperones and damage incurred from heat[114]. Due to its extensive role in 
preventing extracytoplasmic damage, there is a lot of cross-regulation with other 
alternative sigma factors, such as SigmaH and sigmaS[135]. While both sigmaS and 
sigmaE are activated in response to misfolded proteins, sigmaE responds uniquely 
to misfolded OMP[134].  
SigmaE has a large regulon, and its main function is maintaining the outer 
membrane[57] ?ZEƉŽůǇŵĞƌĂƐĞ ?ďŽƵŶĚǁŝƚŚƐŝŐŵĂ ?ɲ2ɴɴ഻ʍE, will recognise and 
transcribe at least 43 genes[136], some of which encode periplasmic chaperones 
such as DsbC, FkpA, HtrA, Skp and SurA[136]. SigmaE also regulates genes that 
encode proteins in the BAM complex[136] and genes important for LPS biosynthesis 
such as lpxD[136].  
SigmaE is transcribed from an operon containing four genes, rpoE, rseA,rseB and 
rseC. These genes are co-transcribed into a polycistronic transcript. SigmaE is 
regulated primarily by the anti-sigma factor RseA  W an integral inner membrane 
protein that inactivates sigmaE by steric hindrance[137]. The N-terminal 
cytoplasmic domain of RseA binds to sigmaE. This domain is necessary for sigmaE to 
bind RNAP and is in direct contact with the RseA protein. SigmaE and RseA bind 
with high affinity, and sigmaE is released from RseA sequestering only by 
proteolysis[137].  
When certain outer membrane proteins are misfolded, due to stress or damage, 
this will reveal a conserved sequence on the carboxyl terminus of OM porins[137]. 
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This sequence will be recognised by the PDZ domain of the DegS protease[137] 
DegS will degrade the periplasmic domain of RseA. Interaction between DegS and 
RseA is inhibited by RseB. RseB will prevent DegS binding. However, the action of 
RseB can be inhibited by LPS binding to RseA.  
After cleavage by DegS, the remaining RseA-sigmaE complex will contain a Gln-rich 
ƐĞƋƵĞŶĐĞƚŚĂƚǁŝůůĂĐƚĂƐĂƐƵďƐƚƌĂƚĞĨŽƌZƐĞW ?ƚŚƵƐĂůůŽǁŝŶŐƚŚĞĐŽŵƉůĞǆ ?ƐĨŝŶĂů
degradation by ClpXP [137].  
RseC, an integral membrane protein, is thought to act as an anti-anti-sigma factor. 
It has been found that increased induction of RseC diminishes the inhibitor effect of 
RseA on sigmaE. The effect of RseC is thought to be mediated through interactions 
with either RseA or RseB[138].  
1.5.3 General stress response  
 
SigmaS is considered the master regulator of the general stress response in E. 
coli.[116]. In E. coli, the stationary phase sigma factor, sigmaS, recognises promoter 
sequences similar to sigma70 [54]. It has been suggested that this overlap may have 
come about out of necessity, as many genes regulated by sigma70 are necessary for 
survival during starvation[139]. The regulatory overlap of these sigma factors 
demands a mechanism of control that allows for diffraction between them, which is 
done by selective promoter utilisation by the sigma factors. A/T-rich regions in the 
promoter or flanking regions of a sigma70/S-regulated gene force a preference for 
one factor over the other[139].  
 
SigmaS is active when a culture moves from the log phase into stationary phase. 
The regulons controlled by sigmaS are diverse and are activated in response to a 
range of changing physiological conditions[116]. SigmaS is regulated 
transcriptionally, translationally and via the transient stability of the protein. Upon 
the induction of sigmaS, the cell becomes resistant to a variety of stressors, which 
offers cross-protection, thus suggesting that sigmaS activates many (perhaps all) of 
the genes it regulates, in response to every individual stress[140]. Evidence of this 
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effect is seen when carbon starvation, for example, leads to temperature or 
osmotic shock resistance[140]. Although E. coli has specific stress responses and 
regulatory genes for these responses, there is a core of stress response genes that 
only require sigmaS for activation[140]. It has been found that many of these core 
genes are induced in a sigmaS-dependent manner, but only after a specific type of 
stress[140].  
  
Transcription of rpoS is low under optimal conditions, and it increases upon 
entering the stationary phase. Expression of rpoS is tightly regulated, and if 
transcription does occur during optimal growth, then translation is shut off and any 
sigmaS that is translated is rapidly degraded[141]. These regulatory blocks are 
inhibited by nutrient starvation (carbon, phosphate, magnesium) or specific shocks 
such as osmolarity, low temperature or DNA damage. Regulation of sigmaS exists at 
the intersection of many regulatory cascades[141].  
 
^ĞǀĞƌĂůƐZEƐƌĞŐƵůĂƚĞƐŝŐŵĂ^ ?dŚĞůŽŶŐ ? ?hdZŽĨƚŚĞrpoS transcript folds into a 
stem loop that occludes the ribosome binding site and minimises rpoS 
translation[142]. This inhibitory structure is overcome by trans-encoded sRNAs, 
DsrA (increases sigmaS activity during low temperatures), RprA (activates rpoS 
translation under conditions of osmotic shock) and ArcZ (stimulates sigmaS under 
anaerobic conditions)[142]. A fourth sRNA, OxyS, negatively regulates rpoS 
translation[142].  
 
SigmaS transcription is also regulated by many proteins and TCS. CRP (cAMP 
receptor protein) acts as a transcriptional regulator for rpoS[143]; moreover, it is a 
global regulator and primarily controls the utilisation of glucose as the primary 
carbon source, such as genes that function to transport and catabolise non-glucose 
sugars[143].  
The BarA/UvrY TCS is induced during the exponential phase and induces rpoS[144]. 
The ArcAB TCS negatively regulates rpoS during the exponential phase[145], and 
ArcAB regulates the transistion from aerobic to anaerobic growth[145]. ArcB 
inhibits the transcription of rpoS by binding to sites near its promoter, thus 
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inhibiting CRP binding. Interestingly, ArcA can negatively regulate rpoS in the 
absence of ArcB[145], which itself regulates RssB (a regulator of sigmaS 
proteolysis)[145] and forms a branched one-to-many TCS. The ArcB-RssB system 
regulates sigmaS via protolysis[146]. SigmaS is degraded via the ATP-dependant 
protease, ClpXp, which degrades sigmaS in an RssB-dependent manner. When 
active (phosphorylated) RssB can bind to sigmaS[146], this RssB-sigmaS complex 
enables sigmaS proteolysis by ClpXP[145]. RssB-dependent ClpXP proteolysis can be 
disrupted by a number of anti-adapters such as IraM and IraP[147], which interferes 
with sigmaS-RssB binding, thereby preventing proteolysis. IraP and IraM is 
regulated by a number of regulators, such as PhoPQ and ppGpp, for example[147].  
The stringent response utilises (p)ppGpp as a molecular messenger for many 
starvation conditions[148]. Aside from regulating IraP, (p)ppGpp has a positive 
effect on rpoS expression. Evidence suggests that (p)ppGpp has a stimulatory effect 
on rpoS transcription and mRNA stability[148]. 
1.6 Horizontal gene transfer and bacteriophages 
 
In the environment, horizontal gene transfer is carried out by three main 
mechanisms, namely transformation, conjugation and transduction[149]. 
Horizontal gene transfer, the act of sharing genetic material between non-prodigy 
cells, is important for pathogenesis and environmental adaption. During 
conjugation, donor and recipient cells come into physical contact, using conjugation 
pilus, to allow transfer. During transformation, naked DNA is taken up from the 
environment[149]. Transduction is the transfer of DNA, using a bacteriophage 
vector. However, there are other methods of horizontal gene transfer. Some 
bacterial species have been observed fusing their OM, at which point bidirectional 
gene transfer ensues[149]. Another example are  gene transfer agents, which can 
transfer random genetic material from a recipient to a donor by delivering them via 
a capsid, and it is thought that gene transfer agents are derived from bacteriophage 
that can no longer package their own DNA[149]. 
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Horizontal gene transfer provides  an important mechanism by which bacteria can 
adapt to their environment, thereby enabling the transfer of virulence 
determinants, antimicrobial resistance and evolution. For example, when the 
recipient cell uptakes foreign DNA, it can integrate into a recipient chromosome via 
homologous recombination or via non-homologous recombination[149]. When 
genetic material is transferred to a recipient cell that has no genetically similar 
material, additive transfer can take place[149]. If the recipient already has an 
homolog of the gene, then it may provide increased fitness or allow divergence of 
function[149].  
Horizontal gene transfer mediated by bacteriophage has been integral to the 
development and evolution of pathotypes and virulence factors in E. coli. The 
artefacts of this genetic transfer can be observed in E. coli pathotypes. Incomplete 
bacteriophage genomes are observable in many pathotypes genomes[1]. 
Moreover, the Shiga toxin (Stx), produced by EHEC strains, is encoded on a 
bacteriophage in the EHEC genome[1]. This bacteriophage is fully functional and 
capable, under the right circumstances, to undergo lytic growth, thus spreading the 
toxin throughout a cell population[1]. Bacteriophages have also been implicated in 
the spread of genes resistant to antibiotics, such as tetracycline ampicillin, 
bleomycin, quinolone and ɴ-lactams, found in the genomes of bacteriophage in 
several different environments, including hospitals[150].  
1.6.1 The lytic and lysogenic cycles 
 
The lytic and lysogenic cycles represent two outcomes of bacteriophage infection 
(FŝŐƵƌĞ ? ? ? ? ). Infection by tailed bacteriophage starts with absorption, which is 
facilitated by viral surface structures that bind to surface molecules on the host cell. 
In gram-negative bacteria, many surface proteins such as oligosaccharides or LPS 
(heptose core) can act as receptors for different bacteriophages[151]. Often, these 
receptors need to be clustered at a specific concentration so that phage tail can be 
ƉŽƐŝƚŝŽŶĞĚĐŽƌƌĞĐƚůǇƚŽƉĞŶĞƚƌĂƚĞƚŚĞŚŽƐƚĐĞůů ?ƐƐƵƌĨĂĐĞ ?^ŽŵĞbacteriophages 
utilise primary and secondary receptors to bind, while many require cofactors for 
binding. In most cases, these are divalent cations such as Ca2+ or Mg2+ that help 
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overcome the competing charge on the host membrane and bacteriophage. 
Divalent cations can also cause the structure of bacteriophage to shift, readying it 
for infection, and extend attachment fibres to attach itself to the host[152].  
 
Some receptors are more prevalent under certain environmental conditions, which 
can affect the efficiency of infection[151]. Host cell populations can develop 
resistance to bacteriophages by selecting for cells with altered receptors or altered 
expressions of receptors used by bacteriophages. However, this can be problematic 
and have a detrimental effect on the cell, as many bacteriophage receptors are 
essential. ĂĐƚĞƌŝŽƉŚĂŐĞƐĐĂŶĐŽŵƉĞŶƐĂƚĞĨŽƌŚŽƐƚĐĞůů ?ƐĂůƚĞƌŝŶŐƌĞĐĞƉƚŽƌƐŝŶĂ
number of ways. For example, P1 encodes multiple versions of the tail fibres[151].  
 
Once attached to the host cell receptor, the bacteriophage will bind irreversibly. In 
most cases, the tail tip of the bacteriophage has enzymatic activity that allows for 
penetrating the peptidoglycan sacculus and inner membrane, ensuring DNA is 
released directly into the cytoplasm[152]. This DNA can be transferred into the host 
cell at a rate as high as 3000 W4000 base pairs per second, which contrasts to other 
genetic transfer mechanisms such as conjugation (100 base pairs per second)[151]. 
DNA inside bacteriophages is densely packaged, inside the procapsid, by an ATP-
powered nanomoter. This places the DNA under high pressure, which facilitates 
DNA injection into the cell[152].  
 
Once inside the host cell, viral DNA is susceptible to host exonuclease and 
restriction enzymes. Bacteriophages have evolved numerous ways to protect 
themselves from this threat, such as by lacking restriction enzyme sites in their 
E ?ƵƐŝŶŐ “ŽĚĚ ?ŶƵĐůĞŽƚŝĚĞƐŝŶƚŚĞŝƌE ?ŚŵĚh ?ŚŵĚ )ŽƌƌĂƉŝĚůǇĐŝƌĐƵůĂƌŝƐŝŶŐ
their DNA by means of terminal redundancies[152]. After the DNA is in the 
cytoplasm, cellular metabolism is redirected to the replications components of the 
bacteriophage. The host RNA polymerase will transcribe early bacteriophage genes 
from strong bacteriophage promoters. These early genes help protect the 
bacteriophage by inactivating host proteases and restriction enzymes, or the 
production of new sigma factors, to redirect host RNA synthesis. Middle genes that 
synthesise new bacteriophage DNA are then transcribed. Finally, late genes are 
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transcribed which encode bacteriophage structural proteins. Bacteriophage DNA is 
then packaged into procapsids. Assembly of the mature virion involves complex 
interactions between scaffolding proteins and major viral structural proteins. The 
viral head is the starting point for virion assembly, serving as a docking site for 
nucleic acid-packing enzymes and binding of the bacteriophage tail.  
The final stage is host cell lysis. Many bacteriophages have two components to 
facilitate lysis  W a lysin capable of lysing peptidoglycan, and holin, a protein that 
creates pores in the inner membrane for the delivery of lysin[152].  
 
Conversely, many bacteriophages exhibit a temperate response. A prophage is the 
dormant bacteriophage DNA inside a host cell, and a host cell that carries a 
ƉƌŽƉŚĂŐĞŝƐĐĂůůĞĚĂ “ůǇƐŽŐĞŶ ?[152]. During this kind of infection, bacterial cell and 
bacteriophage maintain a stable relationship that can remain viable through 
subsequent generations. The temperate response requires the modulation of 
bacterial and phage DNA growth on a molecule-for-molecule basis. During lysogeny, 
the bacteriophage DNA exists as either an integrated part of the bacterial genome 
or a low copy plasmid. The close relationship between host and viral DNA means 
prophages are susceptible to mutation, in the same way as host cell DNA, and can 
become inactive and inert or a beneficial part of the bacterial genome. It is also 
possible for bacteriophage DNA to exist as an episome, a process called 
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Figure  1.10.  The lytic and lysogenic cycle. Adapted from Bacteriphages  Aman et al.[269] 
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The initial stages of the infection of host cells that undergo lysogeny are the same 
as those found in the first stages of the lytic cycle, starting with bacteriophage 
absorption into the cell.  
Lysogens are normally homoimmune, i.e. immune to infection by the same phage, 
but they are nevertheless susceptible to injection by heterologous 
bacteriophages[151]. Host cells can carry multiple (usually heterologous 
ďĂĐƚĞƌŝŽƉŚĂŐĞƐ )ƉƌŽƉŚĂŐĞƐ ?ĂƐƚĂƚĞǁŚŝĐŚŝƐĐĂůůĞĚ “ŵƵůƚŝƉůĞůǇƐŽŐĞŶǇ ?[151]. Early 
genes are transcribed, encoding products such as lytic repressors (C1) and integrase 
protein that allow for the integration of viral DNA into the bacterial 
chromosome[151]. As mRNA synthesis declines, the bacteriophage will physically 
insert itself into the host DNA to form a single integrated molecule[151].  
 
The CI repressor binds a set of operators, repressing the expression of all 
bacteriophages genes, save its own[151]. Multiple lysogeny is able to occur because 
most prophages use repressors, which bind prophage DNA and inhibit the transition 
from lysogenic to lytic infection. Repressors also act on the DNA of new 
bacteriophages that arrive in the cell[151]. It is possible for lysogenic prophages to 
switch spontaneously into a lytic state. The reasons for the switch are not 
completely understood, but it happens at a rate that yields approximately 106 
bacteriophages particles per millilitre. In any lysogenic culture of moderate density, 
lytic bacteriophage will always be found[151]. 
During temperate response, most bacteriophage proteins are not produced, and so 
the host cell survives the infection[151]. The survival of the host cell is important 
for temperate bacteriophages, so any detrimental effect on it in the early stages of 
infection must be mild or reversible. Effects, such as the degradation of the 
nucleoid, are not observed in temperate bacteriophages, which requires a balance 
ǁŚĞŶƵƚŝůŝƐŝŶŐƚŚĞŚŽƐƚ ?ƐďŝŽĐŚĞŵŝƐƚƌǇ[152]. 
 
1.6.2 P1vir transduction 
 
Transduction was first reported in 1952, when genetic exchange occurred between 
different auxotrophic mutants[153]. It was observed that this genetic exchange 
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differed from other conjugations or transformations, in that it did not require 
physical contact between a donor and a recipient organism, and it was not 
disrupted by treatment with DNase[153]. During transduction, foreign DNA is 
transferred from a host bacterium to a recipient, using a viral vector. There are two 
types of transduction: generalised, in which the transducing bacteriophage can 
carry almost any part of the host cell genome[154], and the contrasting specialised 
transduction, in which the bacteriophage can only move specific parts of the 
bacterial genome. Transducing (bacteriophage) particles are by-products of normal 
bacteriophage metabolism[154]. Generalised transducing particles are not normally 
associated with viral DNA and may contain any segment of the bacterial genome, 
although not all sections can be packaged and transduced with the same 
frequency[154]. Specialised transducing particles are associated with lysogeny, and 
transduced bacterial DNA is always associated with viral DNA[155]. Only bacterial 
DNA adjacent to the integration prophage will be transduced, while bacteriophage 
and bacterial DNA are covalently linked[155].  
 
P1 is a temperate bacteriophage and can infect a broad range of hosts. It is the 
major generalised transducing phage used in E. coli[154]. Structurally, P1 has an 
icosahedral head, a 22nm sheath and six tail fibres. The tail tube has a contractile 
sheath. A variable part of the tail fibres, encoded by an invertible segment of DNA, 
determines host specificity[154]. The P1 genome is approximately 93Kbp, double-
stranded DNA[156] and contains approximately 117 genes, the majority of which 
are protein-coding and involved in lytic development[154]. 
 
P1 uses ƚĞƌŵŝŶĂůŐůƵĐŽƐĞŽŶƚŚĞŚŽƐƚĐĞůů ?Ɛ>W^ ?ƚŽĞŶƚĞƌƚŚĞĐĞůů ?ƵƌŝŶŐŝŶĨĞĐƚŝŽŶ ?
calcium ions are necessary for attaching virions to the host cell[156]. Upon entry to 
the cell, DNA circulates via homologous recombination. The P1 genome has a high 
percentage of terminal redundancies, i.e. 9-12% (15kbs), compared to other 
bacteriophages such as P7 (which only has 1% terminal redundancies)[152]. The 
repeated sequences have been implicated in helping the genome move from a 
linear to a circular state[156]. 
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Whether or not the bacteriophage will enter into lytic or lysogenic development is 
dictated by a number intrinsic and extrinsic factors, though this is not completely 
understood. Environmental factors, the state of the cell and the availability of 
nutrients interplay with the expression of the C1 repressor [152]. P1 bacteriophages 
used for P1vir transduction are usually mutants lacking the C1 repressor, which 
prevents them from entering the lysogenic cycle[156].  
 
P1 has several replication origins. Genes expressed during lytic development do so 
from lytic origin (oriL)[156]. The replication of DNA is initially done via the circular 
mechanism but later transitions to the rolling circle mechanism. Viral DNA is 
replicated as concatemers, a protein that recognises pac sites on concatemers and 
cuts making double-stranded ends[156]. The end of the DNA is packaged inside the 
head until it is full[156], following which another is packed; five heads full of DNA 
can be packed sequentially from a single pac site at 100% efficiency; however, 
efficiency gradually decreases[156]. Often, extra genes are packaged into the head. 
P1 has a variable assembly mechanism, which means a significant minority of P1 
heads are smaller and thus are defective (80% have a head diameter of 85nm, while 
20% have a diameter of 65nm)[152]. These defective heads carry a smaller 
proportion of the genome, but these defective bacteriophage can still form a 
progeny virus if several complementary variants infect the same host cell. When 
the head is filled with DNA, a double-stranded cut is made and finally a tail is 
attached. Once the complete virions are assembled, the host cell is lysed, thereby 
releasing the viral particles[156]. 
 
P1 is able to form transducing particles, which contain bacterial DNA rather than 
that of the bacteriophage. These transducing particles are released with lytic 
bacteriophages upon host cell lysis. E. coli contains pseudo-pac sites that are 
recognised by the P1 enzyme pacase[154]. Pseudo-pac sites exist in the bacterial 
genome at a substantially lower frequency than in the bacteriophage genome[156]. 
Sections of the bacterial chromosome that are cut by the viral pacase are packaged 
into phage heads. Transduction can vary up to 25-fold, depending on the 
transduction marker[152].  
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There is little specificity, so any part of the host genome can be packaged with 
almost equal frequency[154]. Some factors, such as distances away from pac sites, 
affect the frequency a certain segment of DNA will be packaged inside the 
bacteriophage head. Once inside the recipient cell, DNA is delivered to the recipient 
cell, as if it were the host viral DNA. This host DNA delivered by the bacteriophage 
may be degraded by nucleases or integrated with the recipient cell DNA[154]. 
However, the rate of recombination is very low, approximately 2% of the 
transduced DNA is recombined into the genome of the recipient cell. The majority 
of transduced DNA exists in the cytoplasm in a form that does not degrade or 
recombine (abortive transduction)[154]. Maintenance of abortive transduction DNA 
is maintained by proteins that are attached to either end of the DNA during 
packaging and facilitate supercoiling in the DNA[154]. Homologous recombination 
of DNA from the donor to the recipient cell is facilitated via RecBCD pathways[157]. 
   
During homologous recombination, part of tŚĞE ?ƐŵŽůĞĐƵůĞŝƐĞǆĐŚĂŶŐĞĚĨŽƌ
identical or similar genetic material from an endogenous or exogenous source. 
Homologous recombination is divided into three steps: presynapsis, synapsis and 
postsynapsis. During presynapsis, a single stranded region of DNA is 
generated[157]. Recombination takes place during synapsis, and recombination 
intermediates are resolved during postsynapsis[157].  
The initial stage of homologous recombination, presynapsis, requires the formation 
of single-stranded DNA (ssDNA)[157]. E. coli has multiple pathways through which 
to initiate homologous recombination. Presynapsis, the production of a single 
ssDNA, can be initiated by the RecBCD pathway or parallel pathways utilising 
exonucleases, such as RecE or RecJ, and helicase, such as RecQ[157]. The RecBCD is 
an enzyme that is part of the main homologous recombination pathway in E. 
coli[157] and acts as a helicase that is able to unwind double-stranded DNA 
(ddDNA). During unwinding, RecBCD can also function as an exonuclease and 
degrade double-stranded DNA in an ATP-dependent manner[157]. It also acts as an 
endonuclease, degrading ssDNA. RecBCD, mediated homologous recombination is 
stimulated by Chi sites in DNA[157] ?ǁŚŝĐŚĂƌĞƐŚŽƌƚƐĞƋƵĞŶĐĞƐ ? ? ?-GCTGGTGG). 
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RecBCD will move along the dsDNA molecule. As it mŽǀĞƐ ?ŝƚƵŶǁŝŶĚƐƚŚĞE ?Ɛ
helix. When the enzyme encounters a Chi site, the enzyme cuts the unwound 
ssDNA and continues along the DNA molecule[157].  
The ssDNA, nicked by RecBCD at the Chi site, is held by the protein RecA[158]. 
Strains deficient in this protein cannot perform homologous recombination. RecA 
binds to DNA as a polymeric fibre, which is necessary for the synapsis step, i.e. the 
pairing and exchange of homologous ssDNA, to take place[158]. The second DNA 
molecule also binds to the RecA filament[157], which is able to bind three or more 
strands of DNA, thus promoting exchange. When the homologous region to be 
exchanged is paired with the single-stranded region, together they may form a 
triplex (ssDNA paired with dsDNA)[158]. When strands are exchanged, it happens in 
ƚŚĞ ? ?- ? ?ĚŝƌĞĐƚŝŽŶĂƚĂƉƉƌŽǆŝŵĂƚĞůǇ ?-10 bp/s[157], and as the region of exchange 
moves towards the ds region of the original DNA molecule, a holiday junction is 
formed[159].  
In the final step, postsynapsis, the holiday junction intermediate is resolved[158].  
The RuvC protein, an endonuclease[158], binds to holiday junctions and cuts at the 
cross-over points to yield two discrete DNA molecules[158]. 
1.7 Project Aims  
 
WŚŽWY ?ƐŵŽƐƚpublicised role involves mitigating the effects of Mg2+ starvation. 
However, its regulon is extensive and its scope comparable to that of a global 
regulator. PhoP regulates many disparate systems and aspects of cellular 
metabolism. In the initial stages of this project, a hitherto P1vir transduction defect 
associated with phoP was observed. The aim of this project was to confirm and 
characterise while also increasing confidence in the initial observation.  
Transduction exposes the cell to divalent metal ion starvation as well as LPS 
disruption and subsequent extracytoplasmic stress. This work aimed to investigate 
the mechanism of the hypothesised transduction defect and consequently provide 
further insights into the role of PhoPQ in cellular function.  
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2.1 Bacterial strains, plasmids and oligonucleotides    
The strains detailed below, and described in Table 2.1, are derivatives of either E. 
coli K-12 W3110 or MG1655. Many of the strains were purchased from the Keio 
Collection, The Coli Genetic Stock Centre (CGSC) and are derivatives of the 
BW25113 strain[160]. Often, these strains were used to produce P1 bacteriophage 
lysate, which was then used to create mutants of either MG1655 or the laboratory 
wildtype (MG1655 fimB-lacZ). The rpoHP3-lacZ (CAG45114) reporter fusion strain 
and the micA and rseA mutants were obtained from Carol Gross [161]. To cure the 
KanR cassette from the Keio collection mutants, the plasmid pCP20 was used 
according to the standard procedure[162]. P1 phage lysates used in this study are 
listed in Table 2.2. Oligonucleotides used in this study are listed in Tables 2.4. 
Plasmids used in this study are listed in Table 2.3.  
Strain number  Genetic background  Origin of strain  
AAEC090 ȴlacZYA::sacB-KanR (Blomfield et al. 
1991)[163] 
AAEC189 ȿ- F- endA1 Thi-1 hsdR17 
supE44 ȴlacU169recA mcrA 
mcrB ȴfimB-H 
(Blomfield et al. 
1991)[163] 
AAEC261A ȴlacZYA fimB-lacZYA (Blomfield et al. 1993) 
[164] 
BGEC085 W3110 Laboratory collection 
BGEC905 ȴlacZYA FimB-LacZ (El-Labany et al. 
2003)[165] 
CAG25198 nadB P PdŶ ? ?ȴƌƐĞůĂĐy ? ?
lambda (rpoHP3-lacZ) 
Carol Gross (Guisbert et 
al. 2007)[161] 
CAG45114 ȴlacX74 lambda (rpoHP3-
lacZ) 
Carol Gross (Rhodius et 
al. 2006)[166] 
CAG62192 micA::CamR Carol Gross (Gogol et al. 
2011)[167] 
EG12976 phoP::KanR Eduardo Groisman ( et al. 
2008)[74] 
JW0052-1 BW25113 surA::KanR Keio Collection (Baba et 
al. 2006)[160] 
JW1115-1 BW25113 phoQ::KanR Keio Collection (Baba et 
al. 2006) [160] 
JW1116-1 BW25113 phoP::KanR Keio Collection (Baba et 
al. 2006)[160] 
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JW1815-1 BW25113 mgrB::KanR Keio Collection (Baba et 
al. 2006)[160] 
JW2663 BW25113 gshA::KanR Keio Collection (Baba et 
al. 2006)[160] 
JW3818-1 BW25113 rfaH::KanR Keio Collection (Baba et 
al. 2006)[160] 
JW5437-1 BW25113 rpoS::KanR Keio Collection (Baba et 
al. 2006)[160] 
JW5660-1 BW25113 eptB::KanR Keio Collection (Baba et 
al. 2006)[160] 
KCEC1627 FimB-LacZ gshA Joanne Roobal, KCEC928 
KCEC3700 rfaH::KanR This study; Bacteriophage 
transduction; JW3818-1 
into AAEC261A 
KCEC4032 phoP:CamR This study; constructed 
via lambda red using 
strain AAEC090 
KCEC4102 rfaH,cured  This study; KanR cassette 
curing; pCP20 KCEC3700 
KCEC4138 FimB-LacZ micA::CamR This study; Bacteriophage 
transduction; CAG62192 
into BGEC905 
KCEC4188 surA::KanR This study; Bacteriophage 
transduction; JW0052-1 
into AAEC261A 
KCEC4192 FimB-lacZ, gshA phoP:KanR This study; Bacteriophage 
transduction; JW1116-1  
into BGEC905 
KCEC4302 phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into AAEC261A 




KCEC4418 rpoHP3-lacZ rseA::TetR This study; Bacteriophage 
transduction; CAG25198 
into  CAG45114 
KCEC4420 FimB-LacZ,rseA::TetR Alex Moores 
Bacteriophage 
transduction  (CAG25198 
into BGEC905) 
KCEC4425 FimB-lacZ,phoP,cured  This study; KanR cassette 
curing; pCP20 KCEC4642 
KCEC4468 surA,cured  This study; KanR cassette 
curing; pCP20 KCEC4188 
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KCEC4534 micA-lacZYA Alex moores (Moores et 
al. 2014)[168] 
KCEC4603 cydD,phoP::KanR This study; Bacteriophage 
transduction; JW1116-1 
into MS109 cydD cured 
KCEC4642 FimB-lacZ,phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into BGEC905. 
KCEC4729 rfaH,phoP::KanR This study; Bacteriophage 
transduction; JW1116-1 
into KCEC4102 
KCEC4925  FimB-lacZ,phoP This study; KanR cassette 
curing; pCP20 into 
KCEC4642 
KCEC4990 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into 
CAG45114. 
KCEC4992 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC4994 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC4996 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5021 micA-lacZYA, ȴlacZYA ɏ, 
lacUV5-phoP 
This study; allelic 
exchange ; plasmid from 
KCEC4534 into  KCEC5277  
KCEC5022 micA-lacZYA, ȴlacZYA ɏ, 
lacUV5-phoP 
This study; allelic 
exchange ; plasmid from 
KCEC4534 into  KCEC5277 
KCEC5023 micA-lacZYA, ȴlacZYA ɏ, 
lacUV5-phoP 
This study; allelic 
exchange ; plasmid from 
KCEC4534 into  KCEC5277 
KCEC5123 rpoHP3-lacZ phoQ::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1115-1 into CAG45114 
KCEC5124 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28°C; 
JW1116-1 into CAG45114 
KCEC5127 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5129 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
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JW1116-1 into CAG45114 
KCEC5131 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5133 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5135 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5137 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5139 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5141 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5143 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5145 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5147 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5149 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction at 28 °C; 
JW1116-1 into CAG45114 
KCEC5166 rpoHP3-lacZ phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into  CAG45114 
KCEC5168 rpoHP3- lacZ phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into  CAG45114 
KCEC5170 rpoHP3- lacZ phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into  CAG45114 
KCEC5172 rpoHP3- lacZ phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into  CAG45114 
KCEC5174 rpoHP3- lacZ phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into  CAG45114 
KCEC5176 rpoHP3- lacZ phoP::KanR This study; Bacteriophage 
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transduction; JW116-1 
into  CAG45114 
KCEC5178 rpoHP3- lacZ phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into  CAG45114 
KCEC5180 rpoHP3- lacZ phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into  CAG45114 
KCEC5239 rpoHP3-lacZ,phoP, 
rseA::KanR,TetR 





This study; Bacteriophage 
transduction; JW1116-1 
into KCEC4420 
KCEC5275 gshA,phoP::KanR This study; Bacteriophage 
transduction; JW1116-1 
into KCEC928 
KCEC5277 lacUV5-phoP  ȴlacZYA This study; Bacteriophage 
transduction; KCEC5281 
H into AAEC090 
KCEC5278 gshA,phoPȴlacɏlacUV5-
phoP 
This study; product of 
allelic exchange between 
pAM001 and KCEC5281 H 
 
KCEC5281 H gshA,phoP,lachs ?ɏsacB-
KanR 
This study; Bacteriophage 
transduction; AAEC090 
into KCEC5275 
KCEC5340 rpoHP3- lacZ mgrB::KanR This study; Bacteriophage 
transduction; JW1815-1 
into  CAG45114 
KCEC5345 rpoS,cured This study; KanR cassette 
curing; pCP20 into 
KECE5432 
KCEC5349 rpoHP3-lacZ rpoS::KanR This study; Bacteriophage 
transduction; JW5437-
1into  CAG45114 
KCEC5354 rpoHP3-lacZ rpoS, 
rseA::KanR TetR 
This study; Bacteriophage 
transduction; CAG25198 
into  KCEC5349 
KCEC5409  ȴƉŚŽW lacUV5-phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into KCEC5277 with IPTG.  
KCEC54329 rpoS,phoQ::KanR This study; Bacteriophage 
transduction; JW115-1 
into KCEC5345with IPTG 
KCEC928 FimB-LacZ, gshA::KanR Laboratory stock (Joanne 
Roobal, BGEC905) 
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KECE4323 phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into AAEC261A, after 48 
hours of incubation  
KECE4324 phoP::KanR This study; Bacteriophage 
transduction; JW116-1 
into AAEC261A, after 48 
hours of incubation  
KECE4484 surA,phoP::KanR This study; Bacteriophage 
transduction; JW1116-1 
into KCEC4468 
KECE5432 rpoS::KanR This study; Bacteriophage 
transduction; JW5437-1 
into AAEC261A  













phoP::KanR  (1) JW1116-1 
phoP::KanR  (2) JW1116-1 
phoP::KanR  (3) JW1116-1 
phoP::KanR  (4) JW1116-1 
phoQ::KanR (1) JW1115-1 
phoQ::KanR (2) JW1115-1 
phoQ::KanR (3) JW1115-1 
phoQ::KanR (4) JW1115-1 




sacB-KanR ɏlacZYA AAEC090 
surA:KanR JW0052-1 
ȴgshA ?ȴphoP ȴlacɏlacUV5-phoP KCEC5278 
 
 
Table 2.2. P1 bacteriophage lysate used in this study  and the strains 
from which they were derived. 
Table 2.1. E. coli strains used during this study. All strains are derivatives of MG1655, exceptions, 
such BW25113 are specified. 
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Plasmid Relevant characteristics Source  Purpose  
pCP20 &>WA?ȿĐů ? ? ?A?ȿWZd^::AmpR, 
CamR 
Laboratory stock, 









PKD4 oriR6Kgamma, bla(ApR), 











pIB462 pIB305:: CamR (Blomfield et al. 
1991); homologies to lac 









pA001 lacUV5-phoP:: CamR This study, 
pIB462 derivative  
Construction of 
lacUV5-phoP 














Table 2.3. Plasmids used during this study, their purpose and relevant 
characteristics 



























  Name  Purpose  KůŝŐŽŶƵĐůĞŽƚŝĚĞƐ ? ?഻- ?഻ ? 
phoP_ʄ-
forward 
Used in the construction 







Used in the construction 





forward   
construction  of lacUV5-





Used in construction  of 
lacUV5-phoP WpAM001 
GATCCTCATCAGCGCAATTCGAACAG 
phoP-forward Screening for the phoP 
gene 
CTTTACCTCCCCTCCCCGCTGG 
phoP-reverse Screening for the phoP 
gene 
CCAACAGAAAACGTACCCGCAGC 
CamR-forward  Screening for the caT 
gene  
CACTGGATATACCACCGTTG 
CamR-reverse  Screening for the caT 
gene 
CTGTTGTAATTCATTAAGCA 
gshA  forward Screening for the gshA 
gene 
TGGCACACTGGCAACAACAGGTC 
gshA  reverse Screening for the gshA 
gene 
CACGCAGCAGATTACGGTAGGCTTC 
Table 2.4. Oligonucleotides used during this study; Screening primers 
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2.2 QIAquick kits   
During the course of this project, several kits were used: QIAquick PCR Purification, 
QIAquick Gel Extraction, QIAprep Spin Miniprep and MinElute Reaction. When 
ƵƐĂŐĞŝƐƐƉĞĐŝĨŝĞĚ ?ĂůůƉƌŽĐĞĚƵƌĞƐǁĞƌĞĚŽŶĞŝŶĂĐĐŽƌĚĂŶĐĞǁŝƚŚƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ
instructions[169] W[172]. 
2.2.1 Media, storage and growth conditions   
Unless otherwise stated, E. coli was grown in Luria-Bertani broth, ( 2.2.2) pH 7, at 
37°C, using a shaking water bath at 180rpm (New Brunswick Scientific, Innova 
3100). A static incubator (DSI series 300DF) was also used to grow bacteria on solid 
and liquid media at the temperatures specified in the individual procedures. Strains 
to be stocked were grown in Luria-Bertani broth overnight. A total of 150µl of 
100%, sterilized, glycerol was added to a cryotube, and 850µl of the overnight 
culture was added and stored at -80°C until needed.  
Solutions used in this study were sterilised either by in-house autoclaving (Prestige 
Medical Autoclave 2100 Series at 121°C for 15 minutes) or by filter sterilisation, 
using a 0.2µm pore filter (Nalgene). Purification of the double-deionised water 
(ddH2O) used in solutions was made by multi-deionising and filtrating through 
Millipore MilliQ® cartridges and then autoclaving for further sterilisation. A static 
water bath (Grant Instruments Sub Aqua 26) was used for experiments not 
requiring agitation. Solutions were stored at the temperatures outlined in specific 
procedures. Media reagents and chemicals were standard laboratory-grade or 
higher and purchased from Sigma-Aldrich UK unless stated otherwise. 
2.2.2 Luria-Bertani media    
Luria-Bertani (LB) broth and agar were used as the default liquid and solid media, 
respectively. LB broth was prepared using the following reagents: tryptone 10g/L 
(Oxoid), 5g/L yeast extract (Oxoid) and 5g/L NaCl (thermo fisher) dissolved in ddH20. 
LB agar was prepared in the same way with the addition of 15g/L nutrient agar 
(Oxoid). Both LB and LB agar were made in distilled ddH20 and sterilised by 
autoclaving, using in-house equipment adapted from standard produces, as 
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previously described Sambrook et al. 1989[173]. Any additional supplements, such 
as antibiotics, were added in working concentrations outlined below (Table 2.5). 
2.2.3 Sucrose media    
Sucrose broth/agar was made in the same way as LB broth or agar, as detailed 
above. However, 150ml/L of ddH20 was replaced with a 40% sucrose solution 
(prepared by dissolving sucrose 400g/L in ddH20, filter-sterilised), added after 
cooling, to create a 6% sucrose medium. 
2.2.4 Agar Supplements 
During this work a number of supplements were added to agar. This was often 
done by creating a concentrated stock solution, which was then sterilised, and 
added to the agar after autoclaving.  
tŚĞŶ/ƐŽƉƌŽƉǇůɴ-D-1-thiogalactopyranoside was used, a concentrated 1M stock 
solution was made using ddH20. The solution was then filter-sterilised and then 
added to the molten agar after autoclaving to yield a concentration of 0.1mM.  
A stock solution of 1M procaine was made using ddH20. The solution was then 
filter-sterilised, and 10ml of agar was removed from 1L after autoclaving and 
replaced with 10ml of 1M procaine stock solution, which yielded LB-agar containing 
100mM of procaine. 
Antibiotics (sigma Aldrich) were dissolved into stock concentrations (Table 2.5) and 
filter-sterilised. Antibiotics were added to media after autoclaving, when necessary. 
The stock and working concentrations of antibiotics used during this study are 
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2.3 Centrifugation  
For larger volumes (50ml+), an ultra-centrifuge (Beckman-Coulter preparative 
centrifuge Avanti) was used at 4°C, unless specified. Centrifugation of medium 
volumes (15ml-50ml) was done using a Sigma 2K15 centrifuge (rotor Sigma 256/97 
Nr. 12149) set at 7°C, unless indicated. A bench-top micro-centrifuge (Eppendorf 
MiniSpin, rotor F-45-12-110), used at room temperature, was employed for smaller 
volumes (1.5ml-2ml). 
2.4 P1vir  transduction  
This method and all other derivatives are based on the standard procedure (Miller 
et al)[174], which uses the P1 bacteriophage as a vector for generalised 
transduction, transferring DNA, a selectable genetic marker, from a donor cell to a 
recipient. The majority of strains in this project were constructed using this 
method.  
It was necessary to first generate a lysate from the donor strain. The aim of this 
step was to obtain a lysate in which the target genetic marker (an antibiotic 
resistance cassette) had been packaged into transducing particles. An overnight 
culture of the donor strain (containing the desired selectable chromosomal marker) 
was grown in LB broth for between 12 and 16 hours at 37°C in a shaking incubator. 
In total, 200µl of the overnight donor culture was inoculated into 15ml of LB broth 
after the addition of 50µl of a 40% glucose solution and 50µl 1M CaCl2. The 
inoculum was then incubated for 30 minutes using a shaking incubator at 37°C. In 
Addition Dissolve in Stock solution Working 
concentration 
Ampicillin (Amp) ddH20 125mg/ml 125ug/ml 
Chloramphenicol (Cam) 100% ethanol  34mg/ml 25ug/ml 
Kanamycin (Kan) ddH20 25mg/ml 25ug/ml 
Tetracycline (Tet) 70% ethanol 10mg/ml 25ug/ml 
Table 2.5. Outlining the different concentrations and solvent used in the preparation of the 
antibiotic solutions used herein. 
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total, 200µl of previously prepared phage lysate was added to the inoculum, which 
was then left to incubate in the same conditions for 2-3 hours. The time waited was 
to allow the bacteriophage in the previously generated lysate sufficient time to lyse 
the culture and generate mature bacteriophage that would carry the desired 
genetic marker of the donor cell. The previously prepared lysate had a different 
selectable marker (usually tetracycline) than the marker in the donor strain. This 
was to prevent selecting mutants generated by the transduction of DNA from the 
previously generated lysate. A no-phage control was also run in parallel. When the 
inoculum turned clear, compared to the control, 200µl of chloroform was added to 
the culture and the inoculum was vortexed. The inoculum was then transferred to a 
50ml falcon tube and centrifuged at 4500rpm for 10 minutes at 4°C. Next, 5ml of 
the lysate was added to a 15ml falcon tube containing 100µl of chloroform. The 
lysate was then stored at 4°C overnight before use. The lysate presumably contains 
transducing bacteriophage, which carry various parts of the donor strain 
chromosome, including the selectable marker of interest.  
The aim of the subsequent step was to transfer the selectable marker to the 
recipient strain. An overnight culture of the recipient strains was grown in LB broth 
at 37°C in a shaking incubator. Then, 200µl of the overnight culture was added to an 
equal volume of a 10mM CaCl2 and 20mM MgSO4 solution, which was used to 
enhance the infectivity of the bacteriophage. Next, 100µl of the mixture was 
aliquoted into three Eppendorf tubes, following which 10µl and 50µl of 
bacteriophage lysate were added to two of the Eppendorf tubes. The third 
Eppendorf, containing only the culture and CaCl2, MgSO4 mixture, was used as a 
control. In addition, 50µl of the bacteriophage lysate alone was added to a fifth 
tube as a final control. All Eppendorf tubes were then incubated in a static 
incubator for 30 minutes at 28°C. A solution of 0.1M sodium citrate was made, 
using LB broth (LB-citrate), and filter-sterilised, after which 1ml of LB-citrate was 
added to each Eppendorf. The citrate acted as a metal chelator forming Ca-citrate, 
thus lowering the infectivity of the bacteriophage and inhibiting exponential lysis of 
culture.  
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The Eppendorf tubes were then incubated statically for 2.5 hours at 37°C. Then, 
100µl of the inoculum was spread onto two LB agar plates (containing the relative 
antibiotic) for each Eppendorf. The plates were then incubated overnight at 37°C. If 
any colonies were present the following day, they were re-streaked onto a fresh LB 
agar plate (containing the relative antibiotic). The re-streaks were then grown 
overnight at 37°C in a static incubator and stocked accordingly. 
2.4.1 P1vir  transduction-derived procedures  
Throughout this work, several derivatives of the standard P1vir transduction 
procedure were used. All of these procedures were based on the original (2.4), 
albeit with some alterations.  
P1vir transduction was conducted at 28°C. The lysate from the donor culture for 
this procedure was generated in the same way as the original (2.4).The initial steps 
of this P1vir transduction were carried out in same way as the original procedure 
(2.4). After 1ml of LB-citrate had been added to the Eppendorfs, incubation was 
carried out at 28°C for 2.5 hours rather than at 37°C. Next, 100µl of the inoculum 
was spread onto LB agar plates (containing the relative antibiotic) for each 
Eppendorf twice, in the same way as the original procedure, though the plates in 
this case were incubated overnight at 28°C. If any colonies were present the 
following day, they were re-streaked onto a fresh LB agar plate (containing the 
relative antibiotic). The re-streaks were then grown overnight at 28°C, In a static 
incubator, and stocked.  
A P1vir  “mock ? transduction was conducted during this study, in which no lysate 
was used. An overnight culture was prepared in the same way as in the original 
procedure (2.4), and then 200µl of the overnight culture was added to an equal 
volume of a 10mM CaCl2 and 20mM MgSO4 solution and incubated at 28°C for 30 
minutes in a static incubator. Next, 100µl of the mixture was aliquoted into three 
Eppendorfs and incubated at 37°C in a static incubator for 2.5 hours along with a 
control containing only overnight culture. A dilution series was made from 10-1 to 
10-6. Finally, 100µl of the 10-5 and 10-6 dilutions was spread onto plain LB agar 
plates, two for each dilution, and incubated overnight at 37°C.  
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Another derivative was carried out, in which P1vir transudation was done using 
protracted incubation. This procedure was the same as the original (2.4), but the 
final incubation was prolonged from overnight to 36 hours.  
Finally, the P1vir transduction procedure was used as a basis for a citrate sensitivity 
test. Overnight cultures were grown in the same way as the original procedure 
(2.4), and then 200µl of the overnight culture was added to an Eppendorf 
containing 1ml of 1.0M LB-citrate. Another 200µl of overnight culture was added to 
a second Eppendorf containing 1ml LB broth. The Eppendorfs were then incubated 
for 2.5 hours at 37°C. A dilution series was made from 10-1 to 10-6, and 100µl of the 
10-5 and 10-6 dilutions was spread onto plain LB agar plates, twice for each dilution, 
and incubated overnight at 37°C.  
2.5 Isolation of genomic DNA    
The isolation and extraction of genomic DNA was done using GenElute Bacterial 
Genomic DNA Kits (Sigma-Aldrich)[171]. In total, 567µl of cells were added directly 
to 30µl 10% SDS (100ml/L) plus 3µl Proteinase K (4mg/ml) and incubated at 65°C for 
2 hours. Then, 100µl of 5M NaCl2 was added and mixed gently, following which an 
80µl solution of hexadecyltrimethylammonium bromide (CTAB) was added. The 
mixture was incubated again at 65°C for 10 minutes, and then 80µl of chloroform 
was added. The sample was then centrifuged at 10Krpm for 5 minutes. The upper 
aqueous phase was extracted into a fresh Eppendorf tube. The extract was then 
mixed with an equal volume of chloroform and further centrifuged for 5 minutes at 
10krpm.The upper aqueous phase of the sample was then removed and placed into 
a fresh falcon tube, after which 600µl of isopropanol was added. The sample was 
then pelleted for 2 minutes at 10krpm. The supernatant was removed and the 
pellet was washed with a 70% (700ml/L) ethanol solution. The pellet was then 
centrifuged for 1 minute at 10Krpm. The supernatant was then removed and the 
pellet left to briefly air dry, before being suspended in TE and stored at 4°C. 
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2.5.1 Isolation of plasmid DNA  
 
A QIAprep Spin Miniprep (Qiagen) was used to isolate plasmid DNA. The kit was 
used as per the manufactureƌ ?s instructions. Overnight cultures were grown in 5ml 
LB broth and in the presence of the appropriate antibiotic, for selection purposes, 
and at the appropriate temperature for the plasmids (37°C or 28°C) in a shaking 
incubator. Overnight cultures were centrifuged for 3 minutes at 8000rpm at 28°C, 
and the resulting pellets were then processed through the Qiagen mini-elute 
protocol[172], which was followed until the final elution step, in which TE buffer 
was used to elute the DNA. Then, 50µl of the isolated plasmid DNA was stored at 
4°C until required. 
2.5.2 Restriction endonuclease digestion of DNA 
 
Reactions and digest conditions, temperature and buffers were used in accordance 
with suppliers ? instructions for each reaction[175]. All restriction endonucleases 
were purchased from either Promega or New England Biolabs. The reaction 
products were incubated for 3 hours at 37°C in a temperature-controlled heat 
block, unless otherwise stated. Purification was done using MiniElute reaction 
purification or a gel-purification kit (Qiagen)[176]. The constituents of the reaction 

















Buffer  10X 2µl 1X Either 2µl of a single buffer 
or 1µl of two buffers if two 
enzymes were used that 
required separate buffers.  
Restriction 
enzyme  
10 uŶŝƚƐ ?ʅů 2µl 1 unit ?ʅů Either 2µl of a single 
enzyme or 1µl of two 
enzymes was used.  The 
ĐŽŶĐĞŶƚƌĂƚŝŽŶ ?hŶŝƚƐ ?ʅů )ĐĂŶ
vary between 
manufacturers. The 
concentration and volume 
specified here refers to 
enzymes purchased from 
New England Biolabs, which 
were the most frequently 





Variable Depending on the size of 
the fragment different 
amounts of DNA was used. 
For plasmid DNA, 10µl was 
used for smaller PCR-
generated fragments up to 
16µl was used. 
Nuclease-
free water 
- 0µl-6µl - Nuclease-free water was 
used to make the reaction 




2.5.3 Ligation     
The ability of T4 ligase to create phosphodiester bonds between detween the 5'-
phosphoryl and 3'-hydroxyl groups of separate double stranded DNA molecules, is a 
routinely utilised as a tool in molecular biology[177].   
In this study PCR products and digested plasmid DNA were ligated using T4 DNA 
ligase (New England Biolabs or Roche), after digestion with restriction enzymes. A 
Table 2.6. Reagents used for restriction enzyme digest. 
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total sample volume of 10µl was used for each reaction, including the DNA, 1µl of 
T4 DNA ligase and 1µl T4 DNA ligase buffer, the final  volume was made up to 10 µl 
using Nuclease-free water. Ligations were performed as either double or triple 
ligations. For double ligation vector to insert ratio used was either 1:1 or 1:3. For 
triple ligation vector to insert ratio used was either 1:1:1 or 1:2:2. All ligation 
reactions were incubated at 16°C for 16 hours. The digested insert was ligated into 
the digested vector, and the product was then transformed into competent cells on 
plates with the appropriate antibiotic and incubated at either 28°C or 37°C 
overnight, depending on the sensitivity of the plasmid. If colonies were present, 
they were grown for 6 hours in LB broth containing the appropriate antibiotic. The 
plasmid was extracted from these cells using a Miniprep elute kit and then digested 
with the same restriction enzymes used to cut the vector and fragment initially. The 
digest was then imaged using gel electrophoresis. If the plasmids released an insert 
of equal size to the one ligated, the ligation was deemed successful. Correctly 
constructed plasmids were then stocked and stored at 4°C in nuclease-free water. 
2.5.4 Production of chemically competent cells   
 
Artificial transformation of competent bacterial cells allows for the in vivo uptake of 
foreign DNA from the immediate environment. In this work, competent cells were 
made using the calcium chloride method originally published by Hanahan et al. 
1991[178].   
Cells to be made competent were Inoculation into 10ml of LB and were grown 
overnight in a shaking water bath (180rpm) at 37°C. A dilution of the overnight 
(28µl into 28ml) was made in LB broth and was grown to an OD600nm of 0.5. Five 
minutes before reaching the desired optical density OD, 3.75ml 100% pre-warmed 
sterile glycerol was added to the shaking inoculum. Once the desired optical density 
had been reached, the cells were transferred to a 50ml falcon tube and chilled on 
ice for 10 minutes, after which the cells were centrifuged (10 minutes, 4000rpm, 
4°C). After centrifugation, the supernatant was poured off and the pellet was re-
suspended in 25ml of ice-cold solution (0.1M MgCl2 and 15% glycerol) and 
centrifuged (for 8 minutes at 3800rpm, 4°C). The supernatant was poured off again 
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and the pellet was re-suspended in 6.25ml of ice-cold T-salts solution (75mM CaCl2, 
6mM MgCl2, 15% glycerol) and incubated on ice for 20 minutes. After incubation on 
ice, the cells were centrifuged again (6 minutes, 3600rpm, 4°C). The supernatant 
was poured off and the pellet was re-suspended in a 1.25ml T-salts solution, and 
then aliquots of 100µl, poured into pre-chilled 1.5ml Eppendorfs, were stored at -
80°C.  
To transform chemically competent cells, 100µl of competent cells was added to 
10µl of DNA on ice, by light pipetting. The DNA-cell mixture was incubated on ice 
for 30 minutes before being transferred to a 42°C water bath for 60 seconds. The 
DNA-cell mixture was then immediately returned to room temperature and 1ml of 
LB broth was added. The cells were mixed well by inverting the Eppendorf tube 4-5 
times and then incubated for 1 hour at 37°C (28°C for temperature-sensitive 
plasmids). This gave the cells time to express any relevant antibiotic resistance 
genes. Next, 200µl of cells were plated out onto LB agar containing the relative 
antibiotic and incubated at the appropriate temperature overnight. Any colonies 
were then picked and grown in LB broth at the appropriate temperature, with the 
relative antibiotic, for between 6-12 hours and then stocked.  
2.5.5 Lambda red re-combineering 
 
This procedure was based on the method originally published by Yu et al. 2000 
[179]. The aim of this procedure is to replace the wild-type copy of the gene with an 
antibiotic cassette (Figure 2.1), which it achieves by making use of a strain that 
contains pKD46, a plasmid that carries a recombinase system used to enhance 
recombination between a gene fragment and chromosomal DNA. pKD46 carries the 
ʄƌĞĚŐĞŶĞƐďĞŚŝŶĚƚŚĞĂƌĂƉƌŽŵŽƚĞƌĂŶĚŝƐƚĞŵƉĞƌĂƚƵƌĞ-sensitive. The araBAD 
promoter makes the ʄƌĞĚŐĞŶĞƐ L-arabinose-inducible. The ʄƌĞĚŐĞŶĞƐ ?gam, exo 
and beta, inhibit the E. coli RecBCD system from degrading double stranded DNA, 
convert the transformed gene fragment into single-stranded DNA and bind to single 
stranded DNA to facilitate its ability to integrate into the chromosome, 
respectively[180].   
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Primers were designed with a 50-70bp homology to the flanking regions (up- and 
downstream) of the gene that was to be replaced, adjacent to sequences of 
homology to an antibiotic resistance cassette (chloramphenicol). These primers 
were used to PCR a chloramphenicol resistance cassette from the plasmid PKD3, 
the aim of which was to create a PCR product containing the chloramphenicol 
resistance cassette with adjacent regions of homology to those flanking the target 
gene.  
A frozen stock of E. coli, carrying temperature-sensitive plasmid pKD46, was grown 
overnight at 28°C in a shaking incubator. In total, 100µl of this culture was then 
added to 50ml of LB, containing 100mg/ml ampicillin and 10µl of 2mM L-arabinose 
(oxoid). The culture was then grown at 28°C to OD600nm of 0.7  and then placed on 
ice for 20 minutes. The inoculum was then centrifuged for 10minutes at 3000rmp at 
4°C. The pellet was then re-suspended in 5ml of ice-cold 10% glycerol this step was 
repeated three times. During the final centrifugation, the pellet was re-suspended 
in 200µl of a 10% glycerol solution. The mixture was then stored at -80°C until used. 
The remaining part of this procedure was carried out on ice, unless otherwise 
stated. In all, 9µl of purified DNA PCR product was added to the side of the electro-
cuvette, and then 40µl of electro competent cells (Thermo Fisher) was added to the 
cuvette, over the area with the purified DNA. The cuvette was then removed from 
ŝĐĞĂŶĚƉůĂĐĞĚŝŶƚŽƚŚĞĞůĞĐƚƌŽƉŽƌĂƚŽƌ ?DŝĐƌŽWƵůƐĞƌ ? )ĂŶĚĞůĞĐƚƌŽƉŽƌĂƚĞĚƵƐŝŶŐƚŚĞ
following conditions:  ?s ) ? ? ? ? ? ?A?& ) ? ? ?ɐ ) ? ? ? ?KŶĐĞƚŚĞĞůĞĐtroporation was 
complete, 1ml of LB was added to the cuvette. The mixture was then transferred to 
an Eppendorf tube and incubated, shaking, for 1 hour at 37°C. Next, 100µl of the 
mixture was plated onto LB agar containing the appropriate antibiotic. The plates 























2.5.6 The polymerase chain reaction  
 
The polymerase chain reaction (PCR) has come to be an invaluable workhorse of 
modern molecular biology[181]. In this study PCR was used to amplify required 
sections of DNA, where oligonucleotides (primers) were designed to flank the target 
DNA to initiate amplification. Oligonucleotides were synthesised by Eurofins MWG 
and stocked at 500µM in ddH2O at 80°C. The stock was then stored at -20°C. A 
working concentration of stock was made of 50pmoles per microlitre by diluting the 
original stock using ddH20.  
Primer. 
Homology regions 
flanking target genes  PCR product containing the 
chloramphenicol resistance cassette, 
flanked by regions homologues to up 
and downstream of the target gene   
Recombination between 
gene fragment and wild-
type gene 
Final product, the target 
gene has been replaced 
by the chloramphenicol 
resistance cassette  
Lambda red primers were 
designed that were 
homologues to the 
chloramphenicol resistance 
cassette and the flanking 
regions of the target gene  
Primer  
Homology chloramphenicol 
resistance cassette  
Figure 2.1. Showing the primer design necessary for lambda red recombineering. 
Generation of the fragment and recombination onto the chromosome. Cam
R
 refers to the 
chloramphenicol resistance cassette.  
PCR 
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Reagent  Volumes added to the reaction mix  
Forward primer  2.5µl 
Reverse primer  2.5µl 
ddH20  17.5µl  
Master mix Taq/Q5 25µl 
Template DNA  Variable between (0.5µl -2µl)  
 
 
dŚĞŵĂƐƚĞƌŵŝǆƵƐĞĚǁĂƐZĞĂĚǇDŝǆ ?dĂƋ (MFCD01635810) or Q5 High-Fidelity 2X 
Master Mix (M0492S, New England Bio labs). Each reaction was set up separately in 
Eppendorf PCR tubes, using filter pipette tips (Promega). ddH20 was added first, 
then the template. The amount of template used was not always consistent but 
ranged between 0.5µl and 2µl, and was dependent one size of the template DNA. 
Forward and reverse primers, corresponding to sense and anti-sense strands of the 
desired amplicon, were added before the master mix  (Table 2.7). All reactions were 
vortexed for 2 seconds before the PCR reaction started. The thermocycler was 
programmed (Table 2.8) using standard settings, unless otherwise stated. 
 
Temperature (°C) Time (seconds)   
94 240  
94 30 These steps was repeated 





4  A?   
           
           
        
Table 2.7. Describing the reagents used in the PCR procedure. 
Table 2.8. Describing thermocycler settings used for PCR 
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2.6 DNA purification 
 
DNA was purified using the Qiagen PCR purification kit, where necessary, after PCR 
reactions[172]. Following endonuclease digestion, a Qiagen MiniElute enzyme 
cleanup kit was used, ŝŶĂĐĐŽƌĚĂŶĐĞ ǁŝƚŚ ƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŝŶƐƚƌƵĐƚŝŽŶƐ[172], to 
remove endonucleases and purify DNA products. 
2.6.1 Curing Keio collection mutants   
 
The Keio collection is a library of strains containing mutations in non-essential 
protein-encoding genes, replaced by a Kanamycin-resistant (KanR) cassette. Multiple 
Keio collection gene deletions were combined by initially curing the KanR cassette 
and leaving a clean deletion, before transducing the second mutation. This was 
done using curing (Cherepanov and Wackernagel, 1995)[162]. with the Plasmid 
pCP20 (temperature-sensitive to  ? ?ȗand CamR/AmpR). This plasmid encodes the 
recombinase flippase (Flp), which recognises a pair of 34bp FRT sequences adjacent 
to the resistance cassette. Flp will bind these sequences and excise the adjacent 
sequence. 
The strain, that was to be cured, was transformed using heat shock with the 
plasmid pCP20 at a ratio of 10µl/2µl. The mixture was then incubated at 28°C for 2 
hours, following which 100µl of the transformants were plated onto amp plates and 
incubated overnight at 28°C. Colonies were then picked using a sterile metal loop 
and placed into 5ml of LB. The inoculum was then grown at 42°C for a minimum of 
3 hours. The inoculum was then diluted down to 10-3 to 10-6 and each dilution was 
plated out in  ? ? ?ʅůquantities ŽŶƚŽƉůĂŝŶ>ĂŐĂƌĂŶĚŝŶĐƵďĂƚĞĚŽǀĞƌŶŝŐŚƚĂƚ  ? ?ȗ ?
Colonies were re-streaked (using a grid system with 6x6 squares) onto plain, Cam 
and Kan plates (36 colonies of each sample). The plates were then incubated 
overnight at 37°C. The colonies that grew on LB agar only were successfully cured. 
Colonies that were resistant to none of the antibiotics used herein were picked and 
re-streaked onto LB agar plates and grown overnight at 37°C. The colonies were 
then picked and grown in LB broth for between 6 and 12 hours and then stocked.   
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2.7. Allelic exchange   
 
Allelic exchange, utilising homologous recombination, allows for the integration of 
plasmid mutation into the host chromosome carried on a plasmid vector, based on 
a procedure published by Blomfield, McClain et al. 1991[182] (Figure 2.2).  
First, it was necessary to create an intermediate strain and plasmid vector, carrying 
the mutation of interest. The plasmid used (a derivative of pIB462) was 
temperature-sensitive, contained a CamR resistance cassette and had homology to 
lac flanking the multiple cloning site  W these characteristics were necessary for 
counter-selection, plasmid curing and integration of the gene fragment into the 
intermediate strain chromosome. This plasmid contained the gene fragment to be 
exchanged into the recipient cell chromosome. The gene fragment was generated 
using PCR and cloned into the multiple cloning site of the plasmid. The intermediary 
strain was created by transducing the sacB-KanR cassette at the lac locus into the 
strain in which the final mutation was to be inserted.  
During the first step, competent cells, made from the intermediary strain, were 
transformed with a plasmid derivative of pIB462 (containing the mutation of 
interest). In all,  ? ? ?ʅůof competent cells were transformed ǁŝƚŚ ? ?ʅů of plasmid, 
using the standard transformation procedure. After the transformation, the aim 
was to select for cells that had integrated the plasmid into their chromosome.  
This was done by incubating the cells at 42°C overnight. Five pre-warmed LB agar 
plates were incubated at 42°C, and one plate was incubated at 28°C. 
 Tranformants were then plated out in  ? ? ?ʅůvolumes onto five pre-warmed LB agar 
plates. They were incubated at 42°C, and one plate was incubated at 28°C. The 
plate incubated at 28°C functioned as a control. The plates were then incubated 
overnight at their respective temperatures. After 16 hours, they were removed 
from the incubator.  
The aim of the next step was to remove all cells containing the sacB-KanR cassette 
by growing on sucrose, thus selecting for successful excision. E. coli expressing sacB, 
exposed to sucrose, will lyse due to the build-up of levans in the periplasm[182]. 
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After incubation, a dilution series was made for each of the inoculums, 10-1 to 10-4. 
In total,  ? ? ?ʅůŽĨ ? ?-1, 10-2 and 10-3 dilutions were plated out onto sucrose plates, 
and then  ? ? ?ʅůŽĨ ? ?-4 dilution was plated out onto an LB agar plate to be used as a 
control. The plates were then incubated overnight at 28°C.   
The aim of proceeding step was to screen colonies for chloramphenicol and 
kanamycin resistance. Sensitivity to chloramphenicol and kanamycin infers the loss 
of the plasmid and sacB-KanR cassette, respectively (successful exchange results in 
cells having neither). Three 6cm x 6cm grids were made on three new plates: one 
LB, one containing chloramphenicol and one containing kanamycin per colony. 
From the sucrose plates, a colony was transferred to the same grid square on each 
of the three types of fresh plates. This was done until 36 colonies had been sampled 
from each clone. All plates were then incubated overnight at 37°C. On the fourth 
day, colonies that grew only on the plain plate were re-streaked to a single colony 




















        
 
                 
 










































Step 1-Integration, by 
two events of 
recombination of 
plasmid into homologues 
regions of  chromosome 
of the intermediate 
strain  
 




by incubation at 42°C 
overnight  
 




Excision of plasmid DNA 
selected by incubation at 
42°C for three hours.   
Possible outcomes of plasmid e 
excision. Unsuccessful excision 
the plasmid containing the 
mutation of interest  while the 
sacB-Kan
R 
mutation remains on 
the intermediate stain. 
Successful excision leads to the 
mutation of interests exchanged 
onto the intermediate 
chromosome.  
  
Successful excision  
Figure 2.2. The possible outcomes of 
integration and excision steps of allelic 
exchange, adapted from Blomfield, McClain, 
et al. 1991[182].  
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2.8 Ⱦ-galactosidase assay 
dŚĞɴ-galactosidase assay allows for measuring the expression of a specific gene 
that is fused to the lacZ reporter. The product of the lacZ gene, ɴ-galactosidase, will 
cleave ortho-Nitrophenyl-ɴ-galactoside into o-nitrophenol and galactose. o-
nitrophenol formation per unit time is proportionate to the concentration of ɴ-
galactosidase and subsequently the expression of lacZ. The product of ɴ-
galactosidase assays was measured in Miller units according to the published 
procedure (Miller, 1972)[183]. ůůɴ-galactosidase assays were performed in LB 
broth.  
A strain containing the gene of interest, coupled to the lacZ gene, was grown 
overnight in 5ml of LB broth at 37°C in a shaking incubator. Next, 15µl of overnight 
culture was added to 15ml of warm LB broth. The inoculum was grown to an 
OD600nm of 1.8 and placed on ice and left for 20 minutes. Next, the OD of the strains 
was recorded. At this point the OD is expected to be approximately OD600nm of 0.2. 
Next, 250µl of cell culture was added to 250µl of Z-buffer (Table 2.9), 5µl 0.1% SDS 
and 10µl chloroform in a glass test tube, this was repeated for four test tubes. In a 
fifth test tube, a control was prepared in the same way, but by replacing cell culture 
with LB broth. The tubes were then vortexed for 10 seconds and then placed in a 
static water bath at 28°C to pre-warm for 5 minutes. The assay was started by 
adding 100µl 4mg/ml of ortho-Nitrophenyl-ɴ-galactoside (ONPG), filter sterilised, to 
each tube at 5-second intervals.  
After 90 minutes (or until the mixture took on a yellow appearance), 250µl of 1M 
Na2CO3 was added to stop the reaction. The Na2CO3 was added in the same order in 
which the assay was started. The OD of each tube was then measured at OD420nm 
and OD550nm, and negative controls were used as blanks. The following equation 
was used to calculate the Miller units.  
 Miller Units = 1000 x (OD420nm  W 1.75 x OD550nm) / (OD600nm x Time of Assay 
(minutes) x 0.25(volume in ml)) 
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The above equation measures the formation of, yellow, o-nitrophenol and thus 
reflects activity  of ɴ-galactosidase per unit of time. This is achieved by measuring 
the absorbance  of the sample at 420nm, the wavelength at which yellow light is 
absorbed. The light scattering effect of cell debris is mitigated by measuring the 
absorbance at 550nm and multiplying it by 1.75, which is equivalent to the 
absorbance at 420nm. The OD600  is a measure of cell density before the start of the 
assay, ostensibly, before cells had been lysed by SDS. This is value is multiplied by 
the time of the assay in minutes and the volume in milliliters. 
The Miller units for the four tubes was calculated and an average of the four 
replicates was then taken to calculate a mean value. dŚĞ^ƚƵĚĞŶƚ ?Ɛd-test was used 
to compare the mean values obtained, resulting in a confidence interval of 95%. A 
significant value was one in which the mean value of the first strain was not 
covered by the second +/- its 95% confidence interval. A 95% confidence interval 
ĨŽƌĨŽƵƌƌĞƉůŝĐĂƚĞƐA? ? ? ? ? ? ?ʍ ) ?A? ? ) ?ʍǁĂƐƚŚĞƐĂŵƉůĞƐƚĂŶĚĂƌĚĚĞǀiation, calculated 









2.9 DNA analysis by agarose gel electrophoresis   
 
1% Agarose gels were made, using 0.3gs of Agarose (Bio-Rad) and 30ml of 1x TAE 
(Table 2.10). The mixture was then microwaved for 2 minutes or until all precipitate 






Final volume was made up to 500ml using ddH20 
Table 2.9. The concentrations and reagents of Z ?buffer. 
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from the mixture had dissolved. The liquid gel was then poured into a gel dock and 
left to dry. Once solidified, the samples were added to the gel, usually at a volume 
of between 5µl -15µl per well. A 1KB ladder (promega) was run on the gel so that 
the DNA fragments could be compared and their size estimated. The gel was then 
run at 80mA 120volts for 26 minutes, in a solution of 0.5µg/ml ethidium bromide. 
The gel was then imagined using a UV imaginer. To visualise the DNA fragments and 
ladder, Kodak 1D software and a UV transilluminator (Hoefer Scientific Mighty 
Bright Transilluminator UV Light Model UVTM-25) were used. If the DNA was to be  
used for cloning  the band of interest was excised from the gel. After the DNA band 
had been excised, it was gel-purified, using a Qiagen DNA purification kit as per the 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ[176]. 
Reagent Concentrations  
EDTA 0.5M pH 8.0 1mM 
2-Amino-2-(hydroxymethyl)propane-1,3-
diol   (Tris) (Fisher Scientific) 
40mM 
Acetic acid 40mM 
Final volume was made up to 1L using ddH20 
             
    
2.10 Whole-cell lysate preparation  
 
Cells were grown overnight in 5ml of LB broth. Then, 100µl of this overnight culture 
was added to 20ml of LB broth and left to grow to OD600nm of 0.3. The inoculum was 
then sonicated at 40Hz for a total of 6 minutes, at intervals of 30 seconds. The lysed 
cells were then subjected to a Markwell assay and diluted down, using ddH20, to 
ensure all the samples (if multiple strains were used) had the same total protein 
count. The lysate was then stored at -20°C until it they were used.  
 
 
Table 2.10. Reagents used to make the TAE buffer. 
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2.10.1 Markwell Assay   
This procedure, an assay to determine protein concentration, is based on published 
work by Markwell,1978[184]. Reagents A (4.9ml) and B (100µl) were mixed in a 
49:1 ratio to form Reagent C (Table 2.11), 1ml of which was placed into Eppendorf 
tubes with 0.25ml of a whole-cell lysate  W three Eppendorf tubes were used for 
each sample and incubated at room temperature for 60 minutes. Next, 75µl of 
diluted Folin's Solution (mixed 1:1 with dH2O) was added to each tube and 
vortexed. The tubes were then left to incubate for 45 minutes at room temperature 
and then vortexed. The OD of each tube, using a spectrophotometer, was taken at 
660nm. The average of the three tubes for each sample was taken.   
A duplicate of this experiment was run in parallel, using bovine serum albumin 
(BSA) at different concentrations to form a standard. The data were analysed by 
plotting a standard curve using the OD of the BSA samples (ʅŐ/ml against 
absorbance OD660). The average OD of the experimental sample was compared to 
the BSA standard curve. This yielded the sample protein concentration. 
 
Reagents  Constituents  
Reagent A 20g/l Na2CO3, 4g/l NaOH, 1.6g/l Sodium tartrate, 
10g/l SDS 
 
Reagent B 4% CuSO4.5H2O 
 
Reagent C Mix reagents A & B in a 99:1 ratio 
 
        
Table 2.11. Describing agents used for a Markwell assay. 
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2.10.2 Western Blot Procedure 
   
An Invitrogen Life Technologies Western Breeze kit was used to carry out all the 
Western blots (WesternBreeze Chromogenic Western Blot Immunodetection Kit 
catalogue no. WB7103)[185]. Blockers/diluents were used throughout the 
procedure (Table 2.12 and Table 2.13), which was carried out according to the 
ŵĂŶƵĨĂĐƚƵƌĞƌ ?ƐŝŶstructions[185]. 
Initially a gel electrophoresis was performed using an electrophoresis cell (Bio-Rad) 
on the whole cell lysate (2.10), using a (EƵW' ? ?-12% Bis-Tris Protein Gels 
ThermoFisher).  
To achieve this, 20ʅů of whole cell lysate was loaded into the precast gel. The gel 
was then run at 150V for 50 minutes using NuPAGE MES SDS Running Buffer 
(ThermoFisher).  
After electrophoresis, proteins were transferred onto a nitrocellulose membrane 
using the ŝůŽƚ ?ƐǇƐƚĞŵ(ThermoFisher) in accordance with manufacture ?s 
instructions[186]. dŚĞŝůŽƚ ?ƐǇƐƚĞŵĐŽŶƚĂŝŶƐĂŶĂŶŽĚĞƐƚĂĐŬ ?ĐĂƚŚŽĚĞƐƚĂĐŬ ? 
blotting filter paper, disposable sponge and Gel Transfer Device. This method was 
chosen because it was comparatively simpler and easier than other methods, such 
as semi-dry blotting.  
The anode stack was placed on the gel transfer device. Subsequently, the gel was 
removed from the cassette and placed on top of the anode stack. Next, blotting 
filter paper was soaked in ddH20 for 2 minutes and placed on top of the gel, 
ensuring there were no bubbles present. Then, the cathode stack was placed on top 
of the filter paper, with the copper electrode aligned to the right of the bottom of 
the stack. Finally, the the disposable sponge was placed on the inner side of the lid.  
The gel transfer device was run for 6 minutes at 23V. The nitrocellulose membrane 
was then removed from the stack. 
The membrane was then placed into 10ml of blocking solution in a covered plastic 
dish and incubated for 30 minutes on a rotary disk set at 1 revolution/sec. The 
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blocking solution was then decanted. The membrane was rinsed with 20ml of 
ddH20 for 5 minutes and then decanted. This washing step was then repeated. The 
membrane was then incubated with 10ml of primary antibody solution on a rotary 
disk set at 1 revolution/sec overnight at 4°C. The antibody solution was then 
decanted and the membrane was washed with 20ml of antibody wash for 5 
minutes. This washing step was repeated three times. The membrane was then 
incubated in 10ml of secondary antibody solution for 60 minutes, following which 
the secondary antibody was decanted. The membrane was then washed for 5 
minutes with 20ml of antibody wash, which was then decanted. This washing step 
was repeated twice. The membrane was then rinsed with 20ml of ddH20 for 2 
minutes. This step was repeated twice. The membrane was then incubated with 
5ml of chromogenic substrate on a rotary disk set at 1 revolution/sec. When purple 
bands started to develop on the membrane, the chromogenic solution was 
decanted. The membrane was then rinsed with 20ml of water for 2 minutes, the 
















5ml  2ml  3ml  0ml 
Primary 
Antibody 
7ml  2ml  1ml  0ml 
Antibody 
Wash 
150ml  0ml 0ml 10ml  
Table 2.12. Describing the concentrations of blocking solutions used for Western 
blotting. 
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Reagent  Constituent 
Blocker/Diluent (Part A) Concentrated buffered saline solution containing 
detergent  
 
B locker/Diluent (Part B) Concentrated Hammersten casein solution 
Antibody Wash (16X) Concentrated buffered saline solution containing 
detergent  
 
Chromogenic Substrate Ready-to-use solution of BCIP/NBT substrate for alkaline 
phosphatase 
Primary Antibody Anti-sigmaE (from the Gross lab UCSF) 
Secondary Antibody 
(anti-rabbit) 
Ready-to-use solution of alkaline 




2.11 Automated growth curve analysis by plate reader  
  
Strains were grown overnight in 5ml of LB broth, and then 1µl of the overnight 
culture was added to 1ml of LB broth pre-warmed to 37°C. During this step any 
additions to media was made. In this study the growth rate of strains with and 
without citrate was assayed by adding various concentrations of citrate to the 
media. Next, 200µl of the inoculum was placed in the well of a BioTek Microplate 
and then repeated five times, generating replicates for each sample. A blank, of LB 
broth, was inoculated into at least five wells, to be used as a control and zero state 
for the plating reader (FluoDia T70). The microplate was then placed in a BioTek 
Table 2.13. Describing the reagents and blocking solutions used for Western blotting. 
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3.1 Introduction  
 
PhoPQ plays an important and varied role in the cell, as it regulates a large number 
of genes. It has been found that over 232 genes, directly or indirectly, respond to 
PhoPQ[42], but despite the expansive PhoPQ regulon, it has not been considered 
essential, and phoP mutants are made routinely by a variety of methods[112],[96]. 
Generalised transduction is a useful tool for genetic manipulation, since it allows 
the movement of genetic elements or chromosomal markers from one bacterium 
to another. Using a bacteriophage as an intermediary, genetic material is moved 
from a donor cell to a recipient cell and then exchanged into the chromosome of 
the recipient via homologous recombination. Although transduction is frequently 
carried out in nature, in laboratories transduction is usually carried out using a 
specific, modified, bacteriophage vector, such as P1 in E. coli. 
Transduction requires control over the infectious nature of the bacteriophage, in 
order to function efficiently. Without some way of restricting the infectivity of the 
bacteriophage, virulent bacteriophage will infect and lyse most recipient cells. The 
method employed to control it involves manipulating available Ca2+ 
concentration[154]. Bacteriophage P1 requires calcium ions to infect a bacterial 
cell, in order to counteract the negative charge on both the bacterial membrane 
and the viral capsid.  
Without calcium ions, the infectivity rate is lowered due to increased electrostatic 
repulsion between the bacteriophage and the recipient cell[154]. Once the 
bacteriophage has had sufficient time to transfer the donor DNA into the recipient 
bacterium, a metal ion chelator is added (often citrate or 
Ethylenediaminetetraacetic acid), which lowers the concentration of free calcium 
sufficiently to effectively prevent further attachment of P1, though not so low as to 
deprive the cells and induce divalent metal ion starvation.  
Surprisingly, previous work carried out in the Blomfield Laboratory found it was not 
possible to isolate phoP transductants under standard conditions (Dr Alex Moore, 
personal communication).  
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In agreement with previous work in the Blomfield Laboratory, during initial 
experimentation it was not possible to make a phoP mutant by standard P1vir 
transduction under standard conditions. This transduction incapacity was found to 
be independent of the wildtype recipient strain or phoP mutant donor strain used.   
The aim of the work outlined in this chapter was to confirm the existence of a 
transduction defect associated with the loss of phoP during P1vir transduction. 
    
3.2 The phoP transduction defect  
 
Several attempts were made to transduce phoP (JW1116-1) and phoQ (JW1115-1) 
mutations into the W3110  wildtype; it was found that phoP could not be 
transduced, but the opposite was true for phoQ (Table 3.1).  
 







phoP 10µl 0,0 0,0 0,0 0 
phoP 50µl 0,0 0,0 0,0 0 
phoQ 10µl 2,4 8,6 3,7 5 





MG1655 and W3110  are two prototypical wildtypes of E. coli K12, and both are 
exploited widely in molecular biology. They have a high sequence similarity; 
however, there are genetic differences between the two strains that manifest in the 
form of insertions, deletions and inversions[187]. Additionally, K12 isolates are 
known to vary genetically between laboratories [188].  It seemed possible that 
these genetic differences may affect the strains ability to act as a recipient for phoP 
during P1vir transduction. To test the hypothesis that phoP transduction defect was 
Table 3.1. The number of phoP (JW1116-1) and phoQ (JW1115-1) transductants  
generated  using P1vir transduction in the wildtype W3310. Replicates for each 
repeat and lysate concentration are displayed in pairs. The average number of 
transductants  is shown for phoP and phoQ lysates concentrations includes all 
repeats and replicates. 
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not limited to W3110, the P1vir transduction experiment was repeated using the 
alternative wild type strain MG1655 and the lysate generated from strain JW1116. 
In agreement with the observation made in 3.2 phoP could not be transduced (data 
not shown).  
It was hypothesised that the transduction defect maybe due to the donor strain 
used. The phoP (JW1116-1) lysate utilised in previous experimentation  had been 
generated from a donor strain from the Kieo collection. The Kieo collection 
distributes single-gene deletion mutants, which have deletions from the second to 
the seventh-to-last codon. Open reading frames are replaced with a kanamycin 
resistance cassette flanked by FLP recognition target sites. To confirm that the 
results demonstrated above were not anomalies caused by the donor strain, or 
their method of construction, an alternative phoP mutant (phoP::Tn, provided by 
the Groisman Laboratory[74] was used (Table 3.2). The same defect was noted 
using the alternative phoP donor strain. The results suggest that the defect initially 
observed with the phoP Keio mutation in W3110  is not specific to the type of phoP 
mutation used. 
Lysate  Repeat 1 Repeat 2 Repeat 3 Average  
phoP 10µl 0,0 0,0 0,0 0 
phoP 50µl 0,0 0,0 0,0 0 
phoQ 10µl 9,7 6,4 8,11 7.5 





3.2.1 Investigating the phoP transduction defect  
 
To further test the validity of this observation the P1vir transduction assay, using 
MG1655 and phoP (JW1116-1) and phoQ ((JW1115-1), was repeated 25 times. 
Different cultures of donor strain were used for each repeat and three different 
preparations of phoP and phoQ lysates were used throughout the 25 experiments. 
Table 3.2. Number of phoP (Eg12976) and phoQ (JW1115-1) transductants  
generated  using P1vir transduction in the wildtype MG1655. Replicates for each 
repeat and lysate concentration are displayed in pairs. The average shown for phoP 
and phoQ lysates concentrations includes all repeats and replicates.  
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25 transductions experiments were done using both 10µl and 50µl lysate for both 
phoP and phoQ. Two replicates were done for each concentration of lysate (full 
data in Appendix Figures B.1A&B.1B). 
           
 









The data show that it was not possible to create any phoP transductants using this 
method (Table 3.3). However, it was possible to transduce a phoQ mutation (donor 
strain JW1115-1) into the wildtype background, which may suggest a transduction 
defect associated with phoP, albeit ŶŽƚǁŝƚŚWŚŽW ?ƐĐŽŐŶĂƚĞƐĞŶƐŽƌŬŝŶĂƐĞ ?WŚŽY ?
This was a surprising outcome, as it would be expected that disrupting either 
component of a TCS, either the response regulator or sensor kinase, would have a 
similar phenotypic effect.  
To test the significance of the results generated above (Table 3.3), ĂƐƚƵĚĞŶƚ ?Ɛƚ-test 
was used to compare the means of average number of phoP and phoQ 
transductants generated using 50µl of lysate.  The null hypothesis tested was that 
there was no significant difference between the means of the two datasets. The 
test was performed using the Microsoft Excel data analysis software package. The 
alpha level chosen was 0.05 (Table 3.4). The analysis shows a small P-value, <0.001, 
smaller than the alpha level and a large divergence between the t-value and the t 
Lysate Mean number of transductants Standard deviation 
phoP 10µl 0 - 
phoP 50µl 0 - 
phoQ 10µl 2 11.43 
 
phoQ 50µl 22.50 2.44 
 
Table 3.3. The average number of phoP and phoQ transductants isolated in the 
wildtype (MG1655) over 25 assays, using both 10µl and 50µl of P1 lysate. Full data in 
Appendix Figures B.1A&B.1B 
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critical value. This suggests that the difference between the means is highly 




The difference in transducability between these two genes is unexpected but not 
entirely surprising. It has been documented that some response regulators 
maintain a certain amount of residual activity in the absence of their cognate 
sensor kinase[189]. For example, in S. enterica it has been shown that PhoP can 
bind to the mgtA promoter in its unphoshorylated state. Although there is a 14% 
dissimilarity between the phoP homologous in S. enterica and E. coli, it is probable 
that PhoP functions in a similar way in both organisms. Alternatively, although not 
documented in vivo, it is possible that PhoP may be phosphorylated by a different 
sensor kinase. Cross-talk between two-component systems is generally considered 
to be low. However, there are several examples of phosphorylation of response 
regulators by non-cognate histidine kinases. The response regulators CheY, CusR 
and YfhA have been shown to be phosphorylated by two, three and four different 
histidine kinases respectively[190].  
  Average phoP 50µl Average phoQ 
50µl 
Mean 0 22.54 
Variance 0 46.75 
Observations 25 25 
Hypothesised mean difference 0  
Degrees of freedom  24  
t value -16.48  
P-value <0.001  
t critical value 2.06   
Table 3.4. t-Test: Two-Sample assuming unequal variances performed on 
transduction results from Appendix Figures B.1A&B.1B.  
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Alternatively, it is possible that the phoP lysate, used for these assays, had a low 
concentration of transducing particles, albeit this is unlikely, as three different 
preparations of phoP lysate were used. Nonetheless, because the viral titre was not 
measured, it remains a possibility. This is further discussed in the final section of 
this work. 
3.3 Complementation of the phoP transduction defect   
 
While the literature suggests that it is possible  W and common practice  W to make 
phoP mutations via P1vir transduction[102][112][96], the primary observation of 
this work disagrees with this notion, thereby suggesting two hypotheses:  
I) phoP is indispensable during transduction and phoP mutants created via 
transduction have additional suppressor mutations that make phoP 
dispensable.  
II)  phoP is indispensable during transduction.  
The transduction defect noted above may in fact be due to the essentiality of the 
gene. In this case, it must be presumed that existing phoP mutants made by others 
contain additional suppressor mutations that compensate for the loss of the gene. 
Alternatively, phoP may be essential under the conditions of transduction. To help 
distinguish between these possibilities, a phoP mutant was constructed containing 
an ectopic copy of phoP controlled by the lacUV5 promoter.   
The lacUV5 promoter is a modified version of the lac promoter. The lac operon is 
vital for the metabolism of lactose in E. coli[191]. and is regulated by a dedicated 
repressor, lacI, and also CRP[174]. The repressor binds to an operator, but  this 
binding is inhibited in the presence of lactose, which allows for the expression of 
the operon[191]. The presence of CRP-cAMP positively regulates the lac operon 
[191], which in turn is negatively affected by glucose.  
 The lacUV5 has several modifications, such as the inactivation of CRP-cAMP 
regulation, meaning that strains containing the lacUV5 promoter can be grown in 
rich media[191]. Furthermore, the lacUV5 promoter recruits RNA polymerase[191] 
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more efficiently and is induced by either lactose or lactose-analogue /ƐŽƉƌŽƉǇůɴ-D-
1-thiogalactopyranoside (IPTG) [191], which is used because, unlike lactose, it 
cannot be degraded by the cell[191] 
It was anticipated that this strain would prove to be a viable recipient for the 
transduction of phoP mutation under inducing (IPTG-present) but not under non-
inducing (IPTG-absent) conditions. 
Construction involved constructing a plasmid, which contained phoP under the 
control of the lacUV5-promoter, and an intermediate strain  gshA,phoP (KCEC5275).  
Previous work in the Blomfield laboratory found it was possible to isolate phoP 
transductants in gshA mutants (Dr Alex Moores, personal communication) (this is 
discussed in further detail in chapter 4). Details of the construction of the 
intermediate strain and plasmid are given below in 3.3.1.   
3.3.1 Construction of the lacUV5-phoP strain 
 
Step 1: Construction of pA001, a temperature sensitive vector containing phoP 
under control of the lacUV5 promoter  
The plasmid pIB462 was used as a starting vector[163]. This temperature-sensitive 
plasmid (Figure 3.2) contains a multiple cloning site downstream from the lacUV5-
promoter as well as regions of homology to the lac operon that flank multiple 
cloning sites, which is necessary for recombination later in the procedure. The 
pIB462 vector was digested with the restriction endonucleases BamHI and HindIII.  
 The phoP gene was amplified from the wildtype (MG1655), but it was important 
not to amplify phoP ?ƐŶĂƚŝǀĞƉƌŽŵŽƚĞƌƐthat exist -60bp upstream from the gene 
start[102]. Primers were chosen that amplified as close as possible to the ATG start 
of the open reading frame while including the ShineDalgarno Sequence (Figure 3.1). 
Furthermore, primers were designed  so that the amplified gene fragment would 
contain HindIII and BamHi recognition sites. The phoP gene fragment was digested 
with restriction enzymes, HindIII and BamHI to create complementary overhangs 
with the digested vector. phoP was cloned into the multiple cloning site, using the 
ligation procedure, downstream of the lacUV5-phoP promoter. The resulting 
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plasmid was designated pA001 (Figure 3.3 step 1). pA001 was digested with BamHI 
and HindIII with the aim of isolating and a gene fragment of a size that  
corresponded to the original phoP gene fragment cloned into the pIB462. This was 
successful (data not shown) and provided confidence that plasmid, pA001, 









Figure 3.1. Showing the position of the primers (Vector_phoP- forward  and Insert_phoP2- 
reverse ) used to amplify the phoP gene ŽŶƚŚĞ ? ?- ? ?ĐŽĚŝŶŐƐƚƌĂŶĚ. Primers were chosen that 
were downstream of the phoP promoter region. Yellow indicates the up and down stream of 
the gene (-61- +721). Green indicates the transcription start site. Light blue indicates the 
Shine-Dalgarn Sequence. Red indicates the start codon. The purple regions indicate the 
primers used. Blue and green indicate where BamHI and HindII recognition sequences were 
placed on the primer, in order to engineer these sites into the amplicon.  
  
 ? ? ? ?
 ? ?  ? ?











Figure 3.2. Showing the plasmid pIB462 5989 Base pairs in length (Blomfield et al. 
1991[182]). The plasmid contains, Chloramphenicol acetyltransferase (Cat) 
(purple),multiple cloning site (BamH1, PstlI, HindIII) and lac homology regions 




























BamHI PstI HindIII 
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Step 2: Construction of the intermediate strain  
The strain gshA,phoP (KCEC5275) was created by transduction (see Chapter 4). A P1 
bacteriophage lysate containing the sacB-KanR cassette was prepared from the 
strain AAEC090. The sacB-KanR cassette is composed of the sacB gene from Bacillus 
subtilis and a Kanamycin resistance cassette. SacB produces levansucrase, an 
enzyme that is necessary for the synthesis of a polymer of sucrose called 
levans[182]. sacB expression is lethal in the presence of sucrose in E. coli and is 
commonly used as a counter-selectable marker [182]. The lysate from strain 
 ? ? ? ?ȴlaczɏsacB-KanR) was used to transduce the gshA,phoP strain, placing 
the sacB-KanR cassette at lac and thereby yielding the strain 
gshA,phoP,ȴůĂĐhs ?ɏsacB-KanR (KCEC5281 H) (Figure 3.3 step 2).  
Step 3: Allelic exchange between gshA,phoPȴlacɏsacB-KanR and pA001  
The strain gshA,phoPȴůacɏsacB-KanR (KCEC5281 H) and the plasmid pA001 were 
then subjected to allelic exchange. This allowed for the transfer of lacUV5-phoP 
from the plasmid into the strain gshA,phoPȴůacɏsacB-KanR at the lac locus, thus 
replacing the sacB-KanR cassette. After the allelic exchange, sucrose was used as a 
counter-selective agent.  
Strains that were able to tolerate growing on LB-sucrose agar and unable to survive 
exposure to kanamycin were assumed to lack the sacB-KanR cassette. These strains 
had undergone allelic exchange, and purportedly they contained the lacUV5-phoP 
at lac. Allelic exchange yielded the strain gshA,phoPȴlacɏlacUV5-phoP 
(KCEC5278)(Figure 3.3 step 3). Each strain was assayed for the absence of both 
wildtype phoP and gshA by PCR (data not shown). The construct was analysed with 
three sets of primers, which were used to confirm the absence of gshA. External 
primers were used to confirm the absence of the native phoP gene, from 30bp 
upstream of the ATG start codon (phoP-forward and phoP-reverse)(Data not 
shown), while internal primers were used to amplify the ectopic copy of phoP and 
confirm its presence in the strain (Vector_phoP- forward  and Insert_phoP2- reverse 
)(Appendix Figure A.1A). 
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Step 4: Transduction of lacUV5-phoP into a strain lacking additional mutations   
It was necessary to move lacUV5-phoP into a strain without the gshA,phoP 
mutations. The aim of this step was to backcross lacUV5-phoP into AAEC090, which 
has a sacB-KanR cassette at the lac locus and contains the wildtype phoP 
allele(Figure 3.3 step 4).  
The strain that was the product of the ĂůůĞůŝĐĞǆĐŚĂŶŐĞ ?ȴgshA ?ȴphoP ȴlacɏlacUV5-
phoP) was used as the donor strain for a P1 lysate, which was then used to 
transduce the strain AAEC090, which has a sacB-KanR cassette at the lac locus 
(Figure 3.3 step 4). All transductants that could grow in the presence of sucrose and 
but were unable to tolerate growth in presences of kanamycin were analysed 
further by PCR, to confirm their correct chromosomal structure. Strains that 
contained the wildtype gshA and phoP genes (data not shown) were successful 
constructs. External primers were used to differentiate between the wildtype phoP 




















Step 1:Creation of pA001 plasmid 
Plasmid pIB462 was modified via cloning, placing phoP under the control of the lacUV5-promoter 
and yielding the plasmid pA001. 
Plasmid pIB462 was cut with BamHI and HindIII endonucleases. The linear plasmid was then 
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    sacB-KanR 
 ůĂĐ  
  
Step 2 (Transduction I):Creation of the intermediary strain ȴgshA, ȴphoP 
ȴlacuV5ɏsacB-KanR 
A lysate containing sacB-KanR was transduced into the strain KCEC5275 ȴgshA, 
ȴphoP. This yielded strain ȴgshA, ȴphoP ȴlacuV5ɏsacB-KanR (KCEC5281 H). It 
was necessary to use a ȴgshA, ȴphoP strain, because gshA suppresses the 
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The plasmid containing phoP under the control of the lacUV5 promoter (pA001) was 
integrated into the chromosome of the strain gshA,phoP, lacUV5ɏsac::KanR(KCEC528). 
The plasmid was then excised, leaving the lacUV5-phoP in the chromosome.  
 






Step 3:Allelic exchange between ȴgshA, ȴphoP ȴlacuV5ɏsacB-KanR and pA001 
Allelic exchange was then used with the strain ȴgshA, ȴphoP ȴlacUV5ɏsacB-
Kan
R


































I) gshA,phoP, lacUV5ɏsacB-KanR 
(KCEC5281 H) used to make a P1 
lysate  






II) Transduction between 





 sacB-KanR   
 
lacUV5 phoP 
Step 4:Transduction 2 creating the strain lacUV5-phoP 
 
The goal of this step was to place lacUV5-phoP at lac. Using the strain ȴŐƐŚ ?
ȴƉŚŽW lacUV5-phoP, a lysate was made, which was then used to transduce 
AAEC090, a strain containing the sacB-Kan
R
 selectable marker at the lac locus. 
After the transduction was complete, all transductants were tested using 
sucrose as a counter-selectable marker. Strains that could not tolerate growth 
on sucrose were analysed by PCR. Strains that had both gshA and the wildtype 
phoP were deemed correct.  
 
Successful 
construction    
Unsuccessful 
construction   






Figure 3.3. Step 1-4: schematic outlining the four primary steps required to create the strain 
lacUV5-phoP (KCEC5277).  
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3.3.2 Testing the complementation mutant lacUV5-phoP  
 
For many genes, essentiality is transient; they are dispensable under some 
conditions but necessary for survival in some environments. Well studied examples 
are genes of the srl, xyl and ara operons. While not considered essential, these 
genes become indispensable when glucose,  ?ĐŽůŝ ?Ɛ preferred carbon source, is 
absent and the cell must utilise alternative carbon sources, such as sorbitol, xylose 
and arabinose, respectively[192].  
Many of these transiently essential genes are linked to stress responses and are 
regulated by alternative sigma factors or transcription factors, placed in the centre 
of regulatory networks; they govern or work in conjunction with many other 
regulatory proteins. There is mounting evidence that PhoPQ is centred in the 
middle of a large and interconnected regulatory network, such as global regulators 
Crp, Fnr, and ArcAB[96], [190].  
PhoP is involved in the regulation of a number of aspects of cell metabolism and 
physiology, aside from responding to Mg2+ starvation. PhoP enhances sigmaS 
stability by acting as a transcriptional activator of iraP, which interferes with RssB 
mediated degradation by ClpXP[193]. Additionally, PhoP plays a role in LPS 
modification by acting as a positive regulator of crcA and post-transcriptionally 
inhibiting expression of eptB, via MgrB[76]. Both EptB and CrcA influence the 
charge disruption of the LPS by acetylation of lipid A or by catalysing the addition of 
palmitate and adding a Kdo group to the inner core, respectively[98], [194].  
It is reasonable to assume that, under the conditions experienced during 
transduction, the viability of phoP mutants would be adversely affected. The cell 
would experience a relative decrease in sigmaS stability. Moreover, there would be 
a decrease in OM stability due to increased repulsion between LPS molecules. 
Negative charges that are present on the LPS, phosphate groups associated with 
the glucosamine residues of lipid A and the carboxyl groups associated with the Kdo 
groups of the inner core, are essential for LPS crosslinking and, in the presence of 
divalent cations, function to increase the stability of the OM[59]. However, these 
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charges are less likely to be neutralised due to chelation and subsequent decrease 
in availability of divalent cations. This affect will be exacerbated by EptB which will 
function to increase the negative charge of the LPS in the absence of phoP.  
The aim of the experiment discussed below was to test the hypothesis that phoP is 
indispensable during transduction. This was achieved by testing the ability of the 
strain containing the ectopic phoP allele, under the control of the lacUV5 promoter, 
to act as a recipient for the phoP mutation, under inducing and non-inducing 
conditions (IPTG+/- ). 
The lacUV5-phoP strain was transduced using the phoP:KanR lysate (JW1116-1), +/- 
IPTG (0.1mM). 50µl of lysate was used and a total of two replicates were done for 
each of the three repeats. +IPTG transductants were plated out on LB-agar 
containing IPTG. It was found that transductants could only be isolated in the 
presence of IPTG when it would be expected that phoP was expressed from the 
ectopic copy of the gene under control of the lacUV5 promoter (Table 3.5). 
These key data shows that PhoP is necessary for successful P1vir transduction but is 
ŶŽƚĞƐƐĞŶƚŝĂůĨŽƌƚŚĞĐĞůů ?ƐǀŝĂďŝůŝƚǇŝŶƚŚĞƐƚƌĂŝŶ ? ? ? ?ĂD' ? ? ?ĚĞƌŝǀĂƚŝǀĞ ?ĂŶĚ
presumably other wildtype backgrounds. Moreover, the data suggests that the 
transduction defect is unlikely to be associated with the transfer or recombination 
of donor DNA in the recipient because the cells were not exposed to IPTG until after 
this stage had been completed. This is unsurprising as there is little reason why 
phoP mutants would be unreceptive to the uptake of donor DNA. It is likely phoP 
mutants are hyper-sensitive to the stresses associated with transduction and have a 
diminished ability to recover. This is likely caused by a reduced ability to respond to 










3.3.3 Construction of a phoP mutant via lambda red 
recombination    
 
Two alternative hypotheses can be proposed to explain the phoP mutation 
transduction defect. First, phoP may be an essential gene, and its inactivation could 
make the cell inviable under all conditions. Alternatively, transduction may expose 
the cell to conditions it cannot tolerate in the absence of phoP. The latter 
hypothesis is supported by the findings from the complementation experiment in 
the section above (3.2.2), which show that phoP mutants remained viable after 
transduction and phoP was, presumably, not being expressed from the lacUV5-
promoter. Creating phoP via another method corroborates the hypothesis that 
phoP is only indispensable during transduction under standard conditions. In an 
attempt to support this hypothesis, an alternative strain construction method, 
lambda red recombination, was used.  
The chloramphenicol resistance cassette was cloned from plasmid pKD3 (provided 
by the Shepherd Laboratory) using PCR. Primers were used with flanking regions 
homologous to, 70bp and 50pb up- and downstream of, the wildtype (MG1655) 
phoP, respectively. This was done to ensure that sufficient homology existed to 
promote recombination between the chloramphenicol resistance cassette and the 
locus into which it was to be inserted. The recipient strain (AAEC090) was made 
competent and transformed with the plasmid pKD46 (provided by the Shepherd 
Laboratory). Ɖ< ? ?ĐĂƌƌŝĞƐƚŚĞʄƌĞĚŐĞŶĞƐ gam, exo and beta, behind the araBAD 
promoter. The transformants were then transformed with the chloramphenicol 
 Number of phoP 
transductants +IPTG 
Average  Number of phoP 
transductants  ?IPTG 
Average 
Repeat 1 9,13 11 0,0 0 
Repeat 2 8,6 7 0,0 0 
Repeat 3 10,6 8 0,0 0 
Table 3.5. The number of successful phoP(JW1116-1 50µl) transductants using the 
strain lacUV5, phoP as the recipient strain(KCEC5292) with and without IPTG, and the 
average of two replicates (shown in pairs) over three assays.  
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DNA hybrid fragment, using electroporation. The resulting transformants were then 
grown at 37°C on LB-agar plates containing chloramphenicol. Successful deletion of 
the wildtype phoP gene (KCEC4032) was confirmed using PCR analysis (data not 
shown), which was also used to confirm the presence of the chloramphenicol 
resistance cassette(Appendix Figure A.2). This experiment confirmed that while it 
was not possible to make a phoP mutant using P1vir transduction, this defect could 
be overcome using lambda red recombineering. 
3.4 Discussion  
 
The transduction defect reported herein is well established by the data, 
demonstrating that phoP mutants could not be successfully isolated using P1vir 
transduction in wildtype E. coli K-12 (MG1655 or W3110 ), but phoQ mutants could 
be.  
The difference in the numbers of phoQ transductants created using 10µl and 50µl 
(Table 3.1, Table 3.2 and Table 3.3) may suggest that phoQ, and presumably phoP, 
mutants are hypersensitive to P1 killing, as it might be expected that the number of 
transductants created using to 10µl will correlate directly with the numbers created 
using 50µl of lysate. However, it is more likely that this effect is a result of the 
optimum volume of bacteriophage lysate for the transduction of phoQ being closer 
to 10µl than to 50µl. The number of transductants generated per microlitre of 
bacteriophage lysate will have a bell curve-like distribution, around the optimum 
concentration of bacteriophage lysate[195]. The number of transductants 
generated by P1vir transduction is a function of the concentration of transducing 
particles in the lysate and the efficiency of recombining DNA in the host cell, which 
is affected by the locus and differs for different genes[196]. However, without 
measurements of the phoQ lysate ?Ɛ viral titers, it is difficult to hypothesise as to 
why phoQ optimum lysate concentration lies closer to 10µl than to 50µl. It is 
possible that the lysates used herein were extremely concentrated, containing a 
high titer of virulent and transducing bacteriophage, in which case a larger volume 
would have caused increased cell lysis. Alternatively, it is possible that the viral titer 
was low but recombination efficiency was high.  
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The number of phoP transductants generated was surprising, as no transduction 
defects associated with phoP have been reported. However, this may be because 
P1vir transduction has fallen out of use in favour of new techniques for genetic 
manipulation, such as recombineering. Moreover, negative results are infrequently 
published. However there are mentions of phoP transductants, made without 
reported difficulty, going back several decades[102]. There are a number of reasons 
why this might be the case. One such reason might be associated with changes in 
methodology over time and variations in laboratory practices. Although there have 
been no large changes in the published protocol for P1vir transduction over many 
decades, it is undeniable that small variations to the published methodology are 
common between laboratories. Discussed further in later chapters, small variations 
in the methodology can have a great effect on the successful transduction of phoP 
using P1vir transduction. 
Perhaps less likely, it is also possible that genetic variations in laboratory strains 
could also account for the observable difference between this work and the 
literature. It is conceivable that SNPs, sufficient to alter the expression or activity of 
proteins, could change the genetic background of the recipient strain enough to 
alter transducibilityin unexpected ways. Using generalised transduction, it is 
possible to transduce most of the E. coli genome, but there are some genes that 
can only transduced at extremely low frequency or not at all, such as with carA, 
which expresses the protein carbamoyl phosphate synthetase[197] and recD, 
respectively[154]. However, the transduction defect associated with carA can be 
overcome in the presence of other secondary mutations.  
Furthermore, E. coli strains exhibit large amounts of variation between subspecies. 
The percentage of shared transcribed proteins between EHEC and UPEC is 
approximately 39%[198]. This is due to different subset of virulence factors 
accumulated by the different pathotypes. It is thought that genes encoding 
virulence factors that are present in pathogenic E. coli originally evolved in 
commensal E. coli  to help increase fitness[6],[22]. For example EHEC (and EPEC) 
carries the LEE pathogenicity island[3] which encodes several important virulence 
factors, such as Tir ( translocated intimin receptor), intimin and the type III 
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secretion system, while UPEC does not. Further, a significant strain diversity can be 
observed among EHEC strains. EHEC is broadly classified into four groups: EHEC1, 
EHEC2, STEC1 and STEC2[3]. However, EHEC is distinct from STEC, as it has a large 
virulence plasmid and additional virulence factors, such as the type III secretion 
system[3]. Conversely a defining characteristic of STEC is the ability to produce the 
Shiga toxin, which is distinct from toxins that utilise the type III secretion system[3]. 
Another interesting example of inter and intra species diversity is EIEC. EIEC is a 
heterogeneous group of pathogens, similar to Shigella with regard to its 
pathogenesis but more closely related to E. coli[3]. Metabolically, EIEC shares traits 
attributed to both Shigella and E. coli. Almost all strains of EIEC lack lysine 
decarboxylase, which is common in most E. coli strains[3]. However, EIEC has the 
ability to ferment xylose to produce glucose, which Shigella species are unable to 
do, though it is a common trait of E. coli[3]. Nonetheless, like Shigella, EIEC has the 
ability to invade epithelial cells[3], has a low infectious dose and is able to cause 
disease in otherwise healthy individuals. 
Furthermore, even metabolic functions that are conserved between subspecies 
have the potential to be polymorphic. Different isolates have been found to use a 
variety of different alleles to express proteins that carry out a similar metabolic 
function[199]. Moreover, long-term studies of E. coli evolution have found a radical 
potential for E. coli to change and adapt in novel and unexpected ways[200]. 
Therefore, it is possible that some isolates of the same E. coli strains could respond 
quite differently to the loss of phoP compared to the strain on which this work was 
carried out.   
The findings presented in this chapter, which suggest that the primary observation 
 W inability to transduce phoP under standard conditions using P1vir transduction  W 
is a generalised phenomenon among E. coli K12 strains. Nonetheless, it is possible 
that this defect only affects a small percentage of isolates. In the absence of data 
from a wide variety of isolates and subspecies, it is hard to make this determination 
with complete confidence. However, the data do strongly suggest that both 
MG1655 and W3110 (two widely used K-12 wildtypes) are affected by the phoP 
transduction defect.   
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Nevertheless, it was possible to create a lacUV5-phoP, phoP mutant. This 
demonstrates that the phoP transduction defect can be overcome by 
complementation with an ectopic, inducible copy of phoP. IPTG is necessary in this 
background for transduction, demonstrating the requirement for PhoP. To confirm 
that phoP is conditionally essential, a phoP:CamR mutant was generated, using the 
alternative method lambda red recombination. The ability to construct the 
phoP:CamR mutant suggests that it is the processes of transduction that cannot be 
tolerated by phoP mutants. These data support the hypothesis that PhoP is 
conditionally essential, but it is inessential for the viability of the cell under 
standard conditions.  
It is likely, when considering the role of PhoP in cellular metabolism, that a phoP 
mutant would be less likely to survive environmental stressors. Divalent cations, 
specifically Mg2+, play dominant roles in the structure and function of biological 
processes, ranging from preventing ribosome degradation to stabilising the 
structure of the outer membrane. Indeed, low levels of Mg2+ are associated with a 
low growth rate in many microbial species[110]. It is not unexpected, then, that 
phoP mutants would be more susceptible to the environmental stress associated 






























112 | P a g e  
 
4.1 Introduction  
Approximately 303 E. coli genes are defined as essential, for growth, under optimal 
conditions[160]. However, organisms seldom have access to optimal conditions, 
outside of specifically created laboratory environments, and so many genes in E. 
coli are conditionally essential[201]. Furthermore, genes that are singly dispensable 
may become essential when others that perform analogous functions are also 
deleted[202]. For example, cells can survive deletion of either outer membrane 
chaperones surA or skp, but deletion of both will lead to an unviable 
phenotype[203]. Moreover, it is sometimes difficult to define a gene as essential, as 
the deletion of some genes may allow growth, albeit at an exceptionally arrested 
rate. 
Cells can acquire suppressor mutations that dispense with the need for a particular 
essential gene, one such example of which is the essential secA. SecM is required 
for the expression of secA, and so it is classed as an essential gene; however, 
mutants have been isolated that constitutively express secA and so do away with 
the need for secM[160]. Alternatively, mutations may also exist in the mutated 
gene; a gene may acquire a mutation effecting a residue of a protein, causing loss 
or diminished function. Nonetheless, a second mutation, causing a change in a 
residue located at a different site in the polypeptide chain, may restore wildtype 
functions[204], known as second site suppressors. 
In the previous chapter it was postulated that PhoP performs an essential function 
during P1vir transduction, but it is nonetheless dispensable under optimal growth 
conditions. In this chapter Mg2+ starvation is explored as a possible cause for the 
transduction defect. Moreover, it was found that changing the conditions, time, 
temperature and recipient strain transduction of phoP was possible. The results 
below support a model in which changing environmental conditions or the 
induction of secondary mutations, specifically those which induce sigmaE, suppress 
the observed phoP transduction defect. 
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4.2 Transduction of  mgtA   
Expression of phoP helps to mitigate divalent cations starvation, during 
transduction the concentration of available divalent cations is limited. It stands to 
reason that the phoP transduction defect could be attributed to divalent cation 
stress. PhoP positively regulates MgtA[205], which is a P-type ATPase is involved in 
the uptake of magnesium and nickel into the cytoplasm across the cytoplasmic 
membrane[42]. It is known that metal ion starvation causes many thousand-fold 
increases in the transcription of mgtA[42], so mgtA expression should be enhanced 
during the chelation step in P1vir transduction. The most obvious hypothesis is that 
the transduction defect can be attributed to cytoplasmic Mg2+ starvation. 
To investigate this hypothesis, the gene-encoding metal ion transporter MgtA 
(mgtA) was tested. Using the standard protocol for P1vir transduction, the PhoP-
controlled gene mgtA was removed from the wildtype strain (AAEC261A) and 
replaced with a kanamycin-resistant cassette. 
It was possible to knock out the PhoP controlled gene (data not shown), mgtA, but 
it is surprising that the loss of mgtA did not induce a lethal phenotype in a similar 
way to the loss of phoP. These data support a model in which cytoplasmic Mg2+ 
stress is not the cause of the phoP transduction defect. However, divalent cation 
stress still remains a valid hypothesis. The transduction defect may be caused by 
extracytoplasmic Mg2+ starvation, leading to LPS disruption, which relies on the 
positive charge provided by divalent cations to maintain stability. If this were the 
case, an mgtA mutant may alleviate extracytoplasmic divalent cation stress, as 
fewer cations would be transported into the cytoplasm. 
4.2.1 Metal ion starvation in phoP mutants   
In the previous experiment, it was shown that the transduction defect is not 
mediated by the expression of mgtA, and thus it is unlikely to be attributed to 
cytoplasmic Mg2+ starvation. However, citrate intolerance remains a cogent 
hypothesis for the transduction defect, as divalent metal ion starvation can cause 
extracytoplasmic stress and OM stability[206].  
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carboxylate groups[206], which helps overcome the repulsive force of the negative 
charges on LPS, allow the molecules to bridge, thereby binding them 
electrostatically. These links can be disrupted by chelation agents or cationic 
antibiotics[207], which causes electrostatic repulsion between the LPS 
molecules[87] and has a deleterious effect on the OM. This can lead to large OM 
deformation of the inner and outer leaflets of the OM, which can merge and alter 
the function and viability of the OM[87], [208], causing rupturing and increased 
permeability[206]. 
It is reasonable to assume that phoP mutants would be especially susceptible to 
divalent metal chelation by citrate and subsequent OM disruption. Increased 
expression of eptB, during P1vir transduction, would presumably cause increased 
repulsion between LPS molecules. Moreover, PhoP positively regulates YneM, a 
putative membrane protein encoded on opposite strands of the PhoP-regulated 
MgrR[209]. The expression of this protein is increased in response to exposure with 
EDTA, a chelation agent, and SDS[209]. It has been hypothesised that this protein 
responds to both membrane permeabilisation and extracytoplasmic divalent cation 
starvation[209]. If true then a decrease in fitness would be expected in phoP 
mutants under the conditions in which it is active.  
To explore further the idea that citrate intolerance is responsible for the phoP 
transduction defect, a phoP:CamR mutant (created via lambda red recombineering, 
Chapter 1) was treated with citrate, the metal chelator used during transduction. 
Both a phoP mutant (KCEC4032) and the wildtype (MG1655) were exposed to 
varying concentrations of citrate, ranging from 0-800mM, over a period of 19 hours. 
While normally in transduction the cells are exposed to a concentration of 100mM 
citrate, it was advantageous to investigate whether or not there was an upper or 
lower limit to the hypothesised citrate intolerance.  
The wildtype maintains a growth rate consistent with that seen in the absence of 
citrate with concentrations of citrate up 100mM. However, the growth rate drops 
significantly once the concentration reaches 300mM. The wildtype is able to 
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continue to grow, even in the presence of the highest concentrations of citrate. In 
contrast, the phoP mutant is unable to tolerate many of the citrate concentrations, 
which are well below those used in transduction (Figure 4.1).  
These data suggest a causal link between metal ion starvation and the transduction 
defect associated with phoP. There are two curious anomalies in the data in which 
phoP mutants suddenly show an increased growth rate, at 300mM of citrate after 
500 minutes and 50mM of citrate after 300 minutes. One possible explanation for 
this phenomenon is that the strain has the ability to develop an adaptive phenotype 
in the presence of a low concentration of citrate (50mM) and a relatively high one 
(300mM), which could be the result of activating a genetic circuit that functions as 
an SOS response in the case of extreme metal ion starvation. Beyond the 300mM of 
citrate, this circuit cannot function and the cells become unviable. Yet, there is no 
evidence in the literature to support the idea of such a robust and specific chelation 
stress response. However, Hemm et al. found a set of four small proteins (<50 
amino acids) that were up regulated in response to chelation and membrane 
permeabilisation[209].  Among these four proteins, the expression of two was 
found to increase in response to chelation alone. One of these proteins the 
aforementioned PhoPQ regulated YneM, and is therefore unlikely to be active 
under these conditions[209]. While the other protein, YkgO, is a putative ribosomal 
protein[209]. However, the most likely explanation for the growth anomalies is that 
it is evidence of phoP mutant populations containing additional suppressor 
mutations outcompeting the original phoP mutant isolate. This assertion is 
supported further by variations in the growth rate of phoP mutants at 50mM and 
300mM observed between replicates (Figure 4.1), indicated by large error bars. This 
variability is consistent with the generation of suppressor mutations, which are 
likely a result of stress-induced mutagenesis.  
The variation in growth rates between experiments is likely a result of fluctuating 
fixation probability, i.e. the probability that the frequency of a mutation in a 
population will reach 100%[210]. Under conditions of stress, when the mutation 
rate increases, beneficial lineages do not necessarily thrive. Fixation probability is 
dependent on a number of different factors, such as the prevalence of deleterious 
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mutations associated with adaptive ones, clonal interference, the competition that 
occurs between different subpopulations carrying independently arising adaptive 
mutations, the presence of phenotypically heterogeneous subpopulations, etc[211]. 
Therefore, it would be reasonable to expect some variation in the frequency with 
which adapted populations arise and are subsequently able to outcompete the 
original isolate successfully. 
The data suggest that phoP mutants are sensitive to citrate, but citrate sensitivity 
does not seem to be dependent on MgtA expression (4.2), which would suggest 
that citrate has a deleterious effect on phoP mutants that is not associated with the 
uptake of extracellular Mg2+ into the cytoplasm. Together, these data support the 
hypothesis that the transduction defect is mediated by extracytoplasmic divalent 
cation starvation.   
  

























4.2.2 Testing the effect of citrate on the viability of phoP 
mutants    
In the previous section it was found that phoP mutants are sensitive to citrate. It 














































Figure 4.1 Growth curves of A) wildtype (MG1655) and B) phoP:CamR mutant (KCEC4032) in 
different concentrations of citrate(0-800mM) over 21 hours. Shown are average cell densities 
for four biological replicates from readings taken every thirty minutes. Error bars show 





118 | P a g e  
 
of transduction. To test this hypothesis, the phoP mutant strain (KCEC4302) was 
incubated overnight. The phoP mutation used in this assay was created using an 
alternative methodology (transduced at 28°C, section 4.4).  
200µl of the culture was inoculated into LB-citrate (100mM), the same 
concentration used during transduction. The culture was then incubated for 2.5 
hours in a static incubator. Conditions and protocols were maintained similar to 
those for P1 transduction, albeit lacking the other reagents. The culture was then 
diluted down to -5, and 100µl was plated onto LB-Kan agar  W this process was 
repeated twice, to produce a total of two replicates. A no-citrate control was also 
prepared. The wildtype (AAEC261A) was grown in the same conditions (+/- citrate) 
and compared to the phoP mutant, this procedure was repeated three times (dĂďůĞ
 ? ? ?).  
 Wildtype 
 control (1)  
Wildtype  
control (2)  
Average wildtype 
Control 
Average wildtype  
difference 
(control- citrate)  
Repeat 1  29 32 30.5 22 
Repeat 2 33 30 31.5 21 
Repeat 3 28 37 32.5 26 
 wildtype  
citrate (1) 
Wildtype 




Repeat 1  8 9 8.5  
Repeat 2 11 10 10.5  
Repeat 3 6 7 6.5  
  phoP  
control (1) 
phoP 
 control` (2) 
Average phoP control Average phoP 
difference 
(control- citrate) 
Repeat 1  16 17 16.5 10.5 
Repeat 2 18 16 17 11.5 
Repeat 3 17 15 16 12.5 
 phoP  
citrate (1) 
phoP 
 citrate (2) 
Average phoP citrate  
Repeat 1  6 6 6  
Repeat 2 5 6 5.5  




Table 4.1. Average number of  wildtype(AAEC261A) and phoP(KCEC4302) colonies after 
being incubated with 100mM of LB-citrate diluted to -5 and then incubated overnight. 
Two replicates were done for both the wildtype and phoP mutant, denoted by the 
numbers 1 and 2 in parenthesis.  
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The results suggest that phoP mutants are sensitive to citrate when compared with 
the wildtype, as the latter has ~50% more colonies compared to the phoP mutants 
when exposed to citrate. These results were analysed using a t-test (dĂďůĞ4.2) that 
was used to investigation the effect of citrate on the viability of phoP mutants and 
the wildtype, which was done by comparing the means of their average differences 
(control-experimental). The alpha level chosen was 0.05. The P-value calculated by 
the test was 0.006. The null hypothesis, namely that the average difference in the 
number of colonies of the wildtype, with and without citrate, would not be 
significantly different when compared to those of phoP mutant, was rejected. 
Although phoP mutants were sensitive to citrate, they were still able to tolerate 
exposure to concentrations used in transduction, which provides an interesting 
juxtaposition with phoP mutant generated via the lambda red system. Those 
mutants (4.2.1) could not survive citrate concentrates strains were subjected to in 
this experiment. This suggests that transduction causes phoP mutants to genetically 
or physiologically adapt.  
Although these data seemed to support the observation that phoP mutants are 
sensitive to citrate, it was logical to conduct a similar test that would be more 
representative of transduction. 
 Average differences (control-experimental) 
  Wildtype  PhoP 
Mean 23 11.5 
Variance 7 1 
Observations 3 3 
Hypothesized Mean Difference 0  
Df 3 
t Stat 7.04 
P value 0.006 




Table 4.2. t-Test: Two-sample assuming unequal variances, alpha level 
0.05, comparing the average  differences (control-experimental) of the 
number of colonies of wildtype and phoP mutants, using data from 
Table 4.1. These data were generated using Microsoft Excel data 
analysis tools. 
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4.2.3 Testing the effect of transduction reagents on the 
viability of phoP mutants   
 
The previous experiments suggest that phoP mutants were intolerant to citrate. To 
further test this hypothesis, a mock transduction was undertaken. Pre-made phoP 
mutants (KCEC4302) and laboratory wildtype (AAEC261A) were subjected to the 
P1vir transduction methodology, but no P1 lysate was used, so that the effect of 
the reagents could be tested.  
Isolates subjected to the transduction reagents (experimental strains) were 
compared to controls, which were not subjected to any of the reagents used in 
P1vir transduction. The control strains were grown for 2.5 hours in LB. Due to the 
lack of bacteriophage killing and the selection of antibiotic-resistant colonies, all 
samples were diluted by factors of 10-5 and 10-6., before being plated onto LB agar. 
For each dilution, two replicates were produced. Three technical ƌĞƉůŝĐĂƚĞƐwere 















(1)  (2) Average  PhoP 
(control) 




Repeat 1 13 19 16 Repeat 1 60 54 57 41.00 
Repeat 2 23 24 23.5 Repeat 2 53 55 54 30.50 
Repeat 3 17 18 17.5 Repeat 3 47 51 49 31.50 
Total Average    19 Total 
Average  
  53.33 34.33 
         
Wildtype 
(Experimental) 
 (1) (2) Average Wildtype 
(control) 




Repeat 1 101 104 102.5 Repeat 1 118 127 122.5 20.00 
Repeat 2 105 91 98 Repeat 2 121 119 120 22.00 
Repeat 3 93 98 95.5 Repeat 3 116 113 114.5 19.00 
Total Average    98.67 Total 
Average  





The data suggest that under normal transduction conditions, the phoP mutant is 
less viable than the wildtype, as the total average difference between control and 
experimental strains was almost 60% higher for phoP than the wildtype (Table 4.3). 
However, it was prudent to conduct several statistical tests, in order to provide a 
ŵŽƌĞƌŽďƵƐƚĂŶĂůǇƐŝƐ ?&ŝƌƐƚ ?ĂƐƚƵĚĞŶƚ ?Ɛƚ-test was performed on the average 
number of colonies generated after exposure to transduction reagents and the 
control, for phoP mutants (dĂďůĞ ? ? ?) and the wildtype (dĂďůĞ4.4B). The alpha 
value chosen was 0.05, in order to test if transduction reagents had a statistically 




Table 4.3. Average number of wildtype (AAEC261A) and phoP (KCEC4302) colonies after 
being subjected to transduction reagents (experimental) and controls, incubated 
overnight and then diluted to -5. One of the wildtype -6 values in the dataset was 
abnormally high (Appendix Table C.1), which was most likely due to contamination. As a 
result of this value, the -6 values were discounted and not used in the analysis of the 
results.  









Analysis (dĂďůĞ ? ? and dĂďůĞ ? ? ?, phoP mutants and the wildtype, respectively) 
showed a significant difference between the experimental and the control strains 
for the phoP mutants and the wildtype (<0.001 and 0.003, respectively). The null 
hypothesis, namely that transduction reagents do not affect the number of colonies 
observed, can be rejected for both phoP and wildtype strains. The analysis 
conducted above suggests that transduction reagents did indeed influence the 
viability of both the wildtype and the phoP mutants. However, it did not test 
whether that effect was significantly different for both strains. This was done by 
performing a second t-test, by analysing the significance between the average 
differences (control- experimental) of phoP and the wildtype (dĂďůĞ4.5). Once 
again, the alpha level chosen was 0.05.  
phoP Experimental  Control 
Mean 19 53.33 
Variance 15.75 16.33 
Observations 3 3 
Hypothesized Mean Difference 0  
Df 4 
t Stat -10.50 
P value  <0.001 
t Critical two-tail 2.78 








   
wildtype  Experimental  Control 
Mean 98.67 119 
Variance 12.58 16.75 
Observations 3 3 
Hypothesized Mean Difference 0   
Df 4 
t Stat -6.50 
P value 0.003 
t Critical two-tail 2.78 
Table 4.4A. t-Test: Two-sample assuming unequal variances, alpha level 0.05, 
comparing the average numbers of  phoP  ‘ĐŽŶƚƌŽů ?ĐŽůŽŶŝĞƐǁŝƚŚĂǀĞƌĂŐĞŶƵŵďĞƌƐ
ŽĨǁŝůĚƚǇƉĞ ‘ĞǆƉĞƌŝŵĞŶƚĂů ?ĐŽůŽŶŝĞƐĨƌŽŵTable 4.3. These data were generated 
using Microsoft Excel data analysis tools.  
 
Table 4.4B. t-Test: Two-sample assuming unequal variances, alpha level 0.05, 
ĐŽŵƉĂƌŝŶŐƚŚĞĂǀĞƌĂŐĞŶƵŵďĞƌƐŽĨǁŝůĚƚǇƉĞ ‘ĐŽŶƚƌŽů ?ĐŽůŽŶŝĞƐǁŝƚŚĂǀĞƌĂŐĞ
ŶƵŵďĞƌƐŽĨǁŝůĚƚǇƉĞ ‘ĞǆƉĞƌŝŵĞŶƚĂů ?ĐŽůŽŶŝĞƐĨƌŽŵTable 4.3. These data were 
generated using Microsoft Excel data analysis tools.  
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Mean 34.32 20.33 
Variance 33.57 2.33 





t Stat 4.05 
P value 0.056 




The P-value was 0.056 while the alpha value was 0.05. Although the results 
approached the borderline of significance, the null hypothesis, namely that 
transduction does not have a significantly different effect on the viability of phoP 
mutants and the wildtype, could not be rejected.  
This was a surprising outcome, as previous experiments (4.2.1 and 4.2.2) suggested 
that phoP mutants were significantly more sensitive to citrate than the wildtype, so 
presumably this should also be true for exposure to transduction reagents, which 
included citrate. It is possible that some of the transduction reagents used in this 
experiment, probably the addition of 10mM CaCl2 and 20mM MgSO4, mitigated the 
effect of citrate on the phoP mutants. However, the possibility still remains that 
these phoP mutants adapted genetically by accumulating suppressor mutations and 
so were less sensitive to transduction reagents.  
4.3 phoP mutants can adapt to the conditions of P1vir 
transduction 
 
Genetic adaptation, through selection of advantageous mutations, will lead to 
greater fitness under altered conditions. The process of genetic adaption allows E. 
coli to thrive in conditions that would normally be sub-optimal. Many studies have 
Table 4.5. t-Test: Two-sample assuming unequal variances, alpha level 0.05, comparing 
the average difference (control-experimental) in numbers of colonies of wildtype and 
phoP mutants, using data from Table 4.3. These data were generated using Microsoft 
Excel data analysis tools.  
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shown how E. coli can adapt quickly to changing environmental conditions. Isolates 
from older cultures of,  10 or 20 days will out-compete isolates from younger 
cultures, by increasing relative fitness via genetic adaption[212]. This is referred to 
ĂƐ “ŐƌŽǁƚŚĂĚǀĂŶƚĂŐĞŝŶƚŚĞƐƚĂƚŝŽŶĂƌǇƉŚĂƐĞ ? ?'^W )ƉŚĞŶŽƚǇƉĞ[212], which is 
associated with a number of mutations, such as rpoS819 which leads to attenuated 
sigmaS activity[212].  
Genetic adaption usually comes about through spontaneous mutation, where genes 
can be silenced, attenuated, duplicated, etc. Some cells are more likely to undergo 
mutation. Within populations of E. coli cells a sub-population of  “ŵƵƚĂƚŽƌƐ ? ?ŝƐ
usually maintained. The mutation rate of these cells is increased due to disruptions 
in DNA replication or repair[213]. Under certain circumstances, such as population 
bottlenecks, these cells can help beneficial mutations become fixed in a population.    
However, it has also been found that environmental factors can cause genetic 
instability, thereby increasing the mutation rate and chances of increased fitness, in 
ĂƉƌŽĐĞƐƐƚĞƌŵĞĚ ‘ ?ƐƚƌĞss-ŝŶĚƵĐĞĚŵƵƚĂŐĞŶĞƐŝƐ ?[214]. There are many different 
mechanisms through which stress-induced mutagenesis is carried out, but they are 
usually linked to stress responses  W the aforementioned rpoS819 mutation, found in 
ageing colonies, is one such example. Along with sigmaS, sigmaE and subsequently 
envelope stress have also been implicated as important mediators for stress-
induced mutation. Gibson et al. for instance, found that defective stress induced 
mutagenesis is associated with an inactivated rpoE promoter (P2)[214], suggesting 
that envelope stress can increase mutation rate.   
It has been demonstrated that phoP mutants made via transduction have a 
different phenotype than those that have not gone through the same process. phoP 
mutants constructed via transduction have a greater tolerance to citrate than those 
constructed via lambda red. One possible hypothesis is genetic adaption. Cells 
lacking phoP undergo genetic adaption, additional suppressor mutations are 
selected for, during transduction dispensing with the need for phoP. To explore this 
hypothesis, phoP mutants were generated at 28°C (KCEC4302) and cured 
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(KCEC4425), in an attempt to test if the mutant could remain viable during 
transduction under normal conditions.  
The phoP mutation used in this assay was created using an alternative methodology 
(transduced at 28°C, section 4.4). The mutant was then cured using the standard 
procedure, which leaves a scar between the FRT sites but does not affect the 
reading frame. This mutant was then subjected to P1vir transduction under normal 
conditions, using a lysate generated from a  phoP::KanR mutant (JW1116-1).  
It was possible to transduce a KanR cassette into the phoP locus (of strain 
KCEC4302) under standard transduction conditions (37°C incubated overnight) 
(data not shown). These conditions would normally prohibit the transduction of a 
phoP-KanR cassette into the wildtype background. An average of 13 kanamycin 
resistant colonies was yielded after three experiments. PCR (data not shown) was 
used to confirm the absence of the phoP gene, which demonstrates that the phoP 
mutants generated via P1vir transduction were pre-adapted to transduction.  
Indeed, these data provide confidence in the primary hypothesis that PhoP is 
indispensable during transduction under standard conditions. The data suggests 
that phoP mutants cannot tolerate the specific conditions of P1vir transduction, and 
phoP transductants are forced to overcome and adapt to the loss of phoP to remain 
viable. Nonetheless, once the cells have adapted accordingly, the P1vir transduction 
of phoP is possible. 
 
4.3.1 phoP mutants can be transduced if the standard 
incubation times are changed 
 
The previous experiment showed that phoP mutants adapted after being subjected 
to transduction, making further attempts of transduction possible and providing 
further evidence that phoP is indispensible during transduction. However, the 
effects of loss or inactivation of an essential gene can vary. Herring et al. in this 
regard, found that mutation of the murA gene caused almost immediate inviability, 
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while a map gene mutation took several generations to cause growth arrest[215]. It 
was thought prudent to explore the hypothesis that a phoP mutation was growth-
inhibitory rather than lethal. It was hypothesised that by extending the incubation 
time the phoP transduction defect could be better characterised. 
The final incubation time was extended from overnight (18 hours) to 42 hours (24 
hours longer than the standard time). phoP  ?JW1116-1)and phoQ  ?JW1115-1)
mutations were transduced into the laboratory wildtype (AAEC261A), and once 
again, phoQ transduction was used as a positive control. All strains were incubated 
for 2.5 hours at 37°C. After the first incubation period, 100µl of each sample was 
plated onto two LB-Kan agar plates. Once plated, the control samples were 
incubated overnight at 37°C and then counted. The experimental strains were 
incubated further for an additional 24 hours. This procedure was repeated three 
times, giving a total of three pairs of plates for each condition. 
Under these conditions it was possible to obtain phoP transductants at 37°C after 
42 hours (Table 4.6). The data suggest that the transduction defect is not lethal but 
growth-inhibitory. The slow growth observed here may be evidence of suppressor 
mutations. It is also possible that phoP is indispensable during transduction, but 
under these conditions, the phoP transductants are able to remain viable for a 
sufficient amount of time to allow for the selection of suppressor mutations. These 
mutations, presumably, compensate for the loss of function of PhoP and allow for 
the generation of transductants.  
Alternatively, it is possible that phoP is not essential during P1vir transduction but is 
important for viability, where transductants are generated but impaired, starved of 
divalent metal ions which are necessary for a host of biological processes[110]. 
However, slow growth was not associated with the mgtA mutation, suggesting slow 









4.3.2 The inability to create suppressor-free phoP 
transductants supports the notion of genetic 
compensation for loss of the gene 
 
The data presented in this chapter suggest that phoP mutants adapt during 
transduction. The simplest hypothesis is that transduction under altered conditions 
allows for the selection of mutants with secondary suppressor mutations. A simple 
assay was developed to test this hypothesis, the aim of which was to confirm the 
presence of expression heterogeneity in phoP isolates. To avoid expensive 
sequencing, an assay based on the expression of rpoHP3-lacZ in phoP mutants was 
developed, which was done by analysing the expression of rpoH from its third 
promoter. rpoH has four promoters, the third of which, P3, is regulated by 
sigmaE[216]. rpoHP3 expression correlates with sigmaE activity and is widely used 
as an indication of sigmaE activity[217]. phoP was transduced into the reporter 
Time of 
transduction  



























































Table 4.6. Average number of AAEC261A phoP and phoQ transductants generated in the wildtype 
(AAEC261A), using 50µl of lysate, after 42 and 18 hours of incubation. Averages generated from 
three repeated experiments. Averages of each set of replicates are shown in brackets. 
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strain rpoHP3-lacZ, at 28°C (4.4), which yielded the strain rpoHP3-lacZ,phoP. Ten 
different rpoHP3-lacZ,phoP isolates were used to test for heterogeneity and 
increase confidence in the result.  
ɴ-galactosidase assay on several different isolates of the strain rpoHP3-lacZ,phoP 
was carried out (Figure 4.2 ) ?dŚĞɴ-galactosidase produced by the mutants ranged 
from 10-fold (0.69)(KCEC5124) to 1.3-fold (4.88)(KECE5129) decreases compared to 
the wildtype (6.74)(CAG45114). All the phoP ŵƵƚĂŶƚƐƐŚŽǁĞĚĂĚĞĐƌĞĂƐĞŝŶɴ-
galactosidase production and thus rpoHP3 expression. These data show that 
isolated phoP mutants, even under non-standard conditions, acquire mutations.  
It is unlikely that these wildly fluctuating expression patterns are indications of 
errors, as there seems to be little standard between the mutants. It is more likely 
that these patterns are emblematic of disparate, heterogeneous, compensatory 
mechanisms.  
Indeed, cells could have any number of suppressors that might compensate for the 
loss of phoP functionality under the conditions of transduction. Finally, these data 
suggest that when phoP mutants can be isolated via P1vir transduction under non-
standard conditions, this is the result of additional mutations that suppress the 
need for phoP. Moreover, this result casts doubt on the validity of any phoP 
mutants created by transduction. 
Finally, all the phoP mutants tested exhibited a lower sigmaE activity than wildtype. 
Considering the loss of divalent cations and the envelope stress of the outer 
membrane that must exist during transduction, it would be expected that sigmaE 
activity would be increased. The possible implications of sigmaE activity being 



















4.4 phoP mutants can be transduced, if the standard 
temperature is changed   
 
Temperature has a profound impact on the physical properties of bacterial 
membranes, and it is mediated by the constituents of the membrane. 
Phospholipids can transition between liquid, disordered, and gel-ordered 
phases[218]. The point at which the transition takes place is dictated by the ratio of 
constituents of the OM, LPS, OMP and phospholipids[23]. 
Phospholipids contain both unsaturated and saturated fatty acid tails. Most 
phospholipids contain fatty acid chains that are saturated or monounsaturated 
(polyunsaturated fatty acid tails appear at a much low frequency)[12]. Unsaturated 
fatty acid tails contain a 30 degree bend. In contrast, when fatty acids are saturated 
they have straighter tails lacking the characteristic bend of unsaturated fatty 




















&ŝŐƵƌĞ ? ? ? ?ɴ-Galactosidase assay in LB, the heterogeneity of expression of sigmaE activity of 
phoP mutants and the wildtype rpoHP3-lacZ(CAG45114). Error bars show 95% confidence 
intervals (n=4).  
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lower temperatures, the membrane undergoes a reversible transition[96], fatty 
acids are compressed together[96]. Straight-tailed saturated fatty acids press 
together and create a dense membrane; however, the bend in unsaturated fatty 
acid tails prevents these molecules from compressing as much as their saturated 
counterparts, which makes the membrane more fluid and helps protect against 
rupturing[25].  
As the cultivation temperature is lowered, E. coli will incorporate more unsaturated 
fatty into its membrane[98], and in the same way as lipids, LPS also exhibits a form 
of thermal dichotomy. It is conceivable that such changes that occur in the 
membrane at lower temperatures may mitigate the effect of the phoP transduction 
defect, presuming the defect is associated with OM instability. Moreover, sigmaE 
also shows enhanced activity at lower temperatures[219]. 
The evidence presented herein supports a model in which the transduction defect 
arises from extracytoplasmic divalent cation stress. By changing the temperature, 
OM fluidity and constituents, it was hypothesised that phoP mutants could be 
isolated via transduction.    
To determine if phoP transductants can be isolated at low temperatures, 
transduction was carried out at 28°C rather than the standard 37°C. It was possible 
to transduce phoQ at 37°C (Chapter Three), so the transduction of a phoQ mutation 
was used as a positive control. phoP and phoQ were transduced into the laboratory 
wildtype (AAEC261A). P1vir transduction was carried out using 50µl of phoP 
(JW1116-1) and phoQ (JW1115-1) lysate at 37°C and 28°C. The experimental strains 
were incubated for 2.5 hours at 28°C. After this incubation period, 100µl of each 
sample was plated onto two plates of LB-Kan agar, forming two replicates for each 
sample, and  each replicate pair had two repeats, so there were three replicate 
pairs in total. Once plated, the samples were incubated overnight at 28°C and 37°C, 
respectively. This procedure was repeated in triplicate.  
Using the procedure outlined above, it was possible to isolate kanamycin-resistant 
colonies at 28°C but not at 37°C (Figure 4.3). PCR was used to demonstrate the loss 
of phoP and the presence of kanamycin-resistant colonies (Data not shown) at 28°C. 
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This result demonstrates that the phoP transduction defect can apparently be 
suppressed under modified conditions. The change in the OM composition and 
general fluidity are well documented in response to temperature [217], [220], these 
data further supports a model in which the transduction defect is mediated by 
membrane stress this provide a cogent explanation for the phoP transduction 












4.4.1 phoP transductants can be isolated under 
standard conditions in suppressor mutant backgrounds   
 
It was hypothesised that the phoP transduction defect was not associated with 
cytoplasmic divalent cation starvation, as there was no transduction defect 
associated with MgtA (4.3). However, because phoP mutants seemed to show 
ŝŶƚŽůĞƌĂŶĐĞƚŽĐŝƚƌĂƚĞ ?ĂŶĚĐŽŶƐŝĚĞƌŝŶŐWŚŽWY ?ƐƉŽƐŝƚŝŽŶŝŶƌĞgulating and modifying 
the genes associated with the LPS, OM stress and disruption seemed logical 
avenues to explore as possible determinants of the transduction defect. To do this 
Figure 4.3. The number of phoP (JW1116-1) and phoQ (JW1115-1) transductants 
generated in the wildtype (AAEC261A), using 50µl of lysate at 28°C and 37°C, 
represented as a bar graph. Three repeats were performed and each had three technical 
replicates (replicates 1-3) for both genes (phoP and phoQ) at both temperatures (28°C 
and 37°C). Each bar represents the average number of transductants from three 
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phoP was transduced into a number of strains with known mutations (Table 4.7). 
This was known to be possible because previous work in the Blomfield laboratory 
had found an initial suppressor mutation.  
In the initial stages of the project, fortuitously it was found that ȴƉŚŽW could be 
transduced successfully into a gshA mutant (Dr Alex Moores, personal 
communication), which is necessary for the synthesis of the low molecular weight 
thiol, glutathione (L-ɶ-glutamylcysteinylglycine)(GSH)[221]. GSH helps protect the 
cell from free radicals and electrophilic compounds, and with the correct folding of 
proteins containing disulphide bonds, covalent bonds formed by oxidation of the 
thiol groups between cysteine residues[221]. GSH is synthesised in the cytoplasm 
by two enzymes, ɶ-Glutamate-cysteine ligase (gshA) and glutathione synthase 
(gshB)[221], and is transported into the periplasm by the ATP-dependent 
transporter CydDC[221]. Once there, GSH works in concert with the Dsb systems 
DsbAB and DsbCD, which are integral for to disulphide bond formation and 
isomerisation. DsbA and DsbC are periplasmic proteins, DsbA is the primary 
disulphide bond donor in the periplasm introducing disulphide bonds into proteins 
or polypeptides that are transported into the periplasm[221], while DsbC performs 
isomerisation of disulphide bonds. Both proteins, DsbA and DsbC, work in concert 
with the integral membrane proteins DsbB and DsbD, respectively[221]. The system 
relies on GSH to help maintain its redox state, either directly in the case of DsbC or 
indirectly by reducing protein thiols, that are then oxidised by DsbA, during which 
GSH is oxidised into glutathione disulphide[221]. PhoPQ activation is dependent on 
the redox state of the periplasm[222]. DsbA activates MgrB, which inhibits PhoQ 
and substantially PhoP activation, via oxidising the several cysteine residues found 
on the protein[222]. It is possible that by inhibiting the synthesis of GSH, by deleting 
gshA, the periplasm is made into a more reducing environment, which in the 
wildtype cell would cause the inhibition of PhoPQ via MgrB. It is possible that under 
these conditions the cell employs another mechanism to fulfil the role of PhoP, so 
under these conditions it is dispensable.  
To find further suppressor mutations, a number of genes that were associated with 
PhoPQ and the OM were assayed. eptB, ompT and treR were chosen as initial 
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candidates. eptB modifies the LPS in a manner that decreases the electrostatic 
charge between these molecules[39], and it is repressed by PhoP via MgrR. It was 
hypothesised that the transduction defect may have arisen from an overexpression 
of EptB and the subsequent effect on the LPS; however, no eptB,phoP 
transductants were generated. To rule out EptB as the cause of the transduction 
defect, an atƚĞŵƉƚǁĂƐŵĂĚĞƚŽƚƌĂŶƐĚƵĐĞȴphoP into an mgrR mutant, but no 
transductants were generated. 
OmpT is an outer membrane protease and targets a broad variety of extracellular, 
cationic peptides such as protamine[105]. Attempts were made to transduce phoP 
into a ompT mutant, but no ompT,phoP transductants were generated.  
treR negatively regulates trehalose transport and catabolism. Trehalose is a non-
reducing sugar, and when synthesised it can be incorporated into the membrane 
and offer protection to the cell from osmotic stress and desiccation[223]. Without 
treR it was hypothesised that the increased presence of trehalose may offer more 
protection to the cell during transduction, but no phoP,treR transductants were 
generated.  
Next, sigmaE-ĐŽŶƚƌŽůůĞĚƐZEƐǁĞƌĞĂƐƐĂǇĞĚďĞĐĂƵƐĞŽĨƐŝŐŵĂ ?ƐƉŽƐŝƚŝon as a key 
regulator of extracytoplasmic stress. While a rybB, phoP mutant could not be made 
successfully, it was possible to create a micA,phoP mutant, the result of which was 
initially surprising. MicA has many targets but none seemed directly relevant to the 
phoP transduction defect, except phoP itself. Nonetheless, as subsequent 
experiments were done, a cogent hypothesis was formed as to why micA mutants 
suppressed the transduction defect. This is discussed later on in this work.  
SigmaE induction was explored as a possible  W direct or indirect  W suppressor for the 
ůĞƚŚĂůƉŚĞŶŽƚǇƉĞ ?EĞǆƚ ?ȴphoP was transduced successfully into an rseA mutant. 
sigmaE is negatively regulated by the anti-ƐŝŐŵĂĨĂĐƚŽƌZƐĞ ?ǁŚŝůĞʍŝƐŚĞůĚďǇ
RseA, in the inner membrane, until it is degraded by DegS[134]. In an rseA mutant, 
sigmaE is not sequestered by RseA, and so the expression of the sigmaE-controlled 
genes increases[136], which suggests that the phoP transduction defect is 
overcome by the hyper-induction of sigmaE.  
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To test further the hypothesis that sigmaE induction suppresses the phoP 
transduction defect, phoP was transduced successfully into a surA mutant 
background. SurA is a chaperone protein that escorts properly folded outer 
membrane porins[203]. The Blomfield Lab has found the loss of surA to be an 
inducer of sigmaE (data not shown). This hypothesis was further tested by 
successfully  making a rfaH,phoP mutant. Mutation of rfaH also causes sigmaE 
induction (Dr Blomfield, personal communication). 
 While sigmaE is essential some suppressors, mutations have been found[109]. 
ydcQ encodes a putative DNA-binding protein[135]. In ydcQ mutant strains, rpoE is 
dispensable[135], hypothetically because essential products downregulated by 
sigmaE are regulated by YdcQ[135]. Alternately, it has also been suggested that 
upon losing sigmaE, the cell triggers a lethal response in the cell, which YdcQ may 
disrupt[135]. It was hypothesised that ydcQ loss may suppress the phoP 
transduction defect, but no ydcQ,phoP transductants could be generated. However, 
because it is not understood as to how ydcQ mutants suppress sigmaE essentiality 
little information can be discerned from this assay.  
 These data support model in which phoP transduction defect is associated with the 
OM rather than the cytoplasm. Moreover, the data shows that induction of sigmaE 
suppresses the transduction defect, inferring that loss of phoP leads to disruption of 
the outer membrane. Conversely, it is also possible that PhoP positively regulates 
the essential protein sigmaE, the induction of which, via genetic mutation, allows 
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successful 
suppressors 
Function of genes  unsuccessful 
suppressors 
Function of genes 
micA  Encodes an ıE 
regulated sRNA.  
rybB  Encodes an ıE regulated 
sRNA. 
rfaH  Encodes a 
transcriptional 
antiterminator.  
rraB  Encodes an antagonist of 
RNase E.  
surA  Encodes an isomerase 
which helps OMPS to 
form the correct 
conformation.  
gadE Encodes operons involved in 
acid resistance and pH 
homoeostasis.  
cydD Encodes part of the 
CydDC protein that 
transports glutathione 
from the cytoplasm to 
periplasm.  
ompT Encodes an outer membrane 
protease. 
rseA  Encodes an antisimga 
factor that inhibits the 
ĂĐƚŝŽŶŽĨʍ ? 
eptB Encodes a 
phosphoethanolamine 
transferase, which modifies 
LPS in response to changes in 
Ca2+. 
gshA Encodes  glutamate-
cysteine ligase, which 
catalyses the first steps 
in the synthesis of  
glutathione 
treR Encodes the Trehalose 
repressor, that regulates 




ydcQ Encodes a sigmaE essentiality 
suppressor  
mgrR sRNA, negative regulator of 
eptB 
ydcQ Encodes a sigmaE essentiality 
suppressor  
Table 4.7. Genes that failed to 
suppress the phoP phenotype and 
genes that successfully suppressed 
the phoP phenotype along with their 
functions. 
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The initial suppressor, gshA, suggest that the redox state of the periplasm is also 
associated with the transduction defect. It is difficult to marry these two 
observations. It is possible that  lack of GSH  W and thus proper disulphide bond 
formation  W may affect the folding of the outer membrane protein, and 
subsequently cause the induction of sigmaE. However, many OMPs lack cysteine, 
and so their folding is not dependent on the Dsb system. Moreover, gshA mutation 
is not associated with increased sigmaE activity (data not shown). It is likely that 
gshA mutation and sigmaE induction represents different mechanisms of 
suppression.  
4.4.2 The effect of Procaine on phoP transduction   
 
SigmaE is active under the range of stimuli, with its primary function being the 
maintenance and protection of the cell envelope. The core set of sigmaE-regulated 
genes is associated with the assembly, synthesis and maintenance of the LPS and 
OMPs, however sigmaE regulates a number of other targets including negatively 
impacting phoP expression, discussed previously[112]. It is possible that during 
P1vir transduction, when sigmaE is hyper-induced, phoP is no longer conditionally 
essential.  
To support the hypothesis that sigmaE induction suppresses the phoP transduction 
defect, transduction was carried out using procaine, a drug that induces sigmaE in 
E. coli via the OmpR/EnvZ two-component system[85], [173]. Transduction was 
done in accordance with the standard protocol used for P1vir transduction, 
whereby phoP and phoQ were transduced into the laboratory wildtype (AAEC261A). 
The samples were plated onto LB-Kan agar containing procaine. The concentration 
of procaine was chosen in accordance with work done previously in the Blomfield 
>ĂďƚŚĂƚƐŚŽǁĞĚƚŚĞĚƌƵŐ ?ƐĂďŝůŝƚǇƚŽĞŶŚĂŶĐĞƐŝŐŵĂĞǆƉƌĞƐƐŝŽŶ ?ĚĂƚĂŶŽƚƐŚŽǁŶ). 
A phoQ transduction was carried out in parallel to act as a positive control. Both 
phoQ and phoP transductants were plated onto LB-Kan agar with and without 
procaine, the latter acting as a negative control. Two biological replicates were 
done for each gene under each condition. The plates were then incubated at 37°C 
137 | P a g e  
 
overnight. Several phoP transductants were subjected to PCR analysis to verify the 
loss of the phoP gene (Appendix Figure A.3). 
Using procaine, it was possible to transduce phoP successfully under otherwise 
standard conditions (Table 4.8), which shows that sigmaE induction via the 
OmpR/EnvZ pathway is sufficient to overcome the phoP transduction defect.  These 
data further corroborating the previous findings and show inducing sigmaE, 
chemically, is sufficient to suppress the transduction defect. This may be because 
the loss of phoP induces membrane stress, and induction of sigmaE is required to 
correct it. Alternatively, PhoP may have a positive regulatory effect on the induction 
of sigmaE; thus, sigmaE hyper-induction compensates for the loss of activity.   
 
 
4.5 Discussion     
 
Essential genes are a balance between compensation and conservation. Under 
some circumstances, essential genes can lose their importance if selection pressure 
is applied[28]. In this chapter, it was observed that altering the standard conditions 
of P1vir transduction (both time and temperature) allows for the mitigation of the 
observed transduction defect (4.3.1 and 4.4, respectively). Moreover, in this 
chapter, evidence was provided that supported the hypothesis that the phoP 
transduction defect is associated with extracytoplasmic stress, rather than as a 
result of cytoplasmic divalent cation starvation.  














Procaine   14,13 15,16 17,15 15 20,23 19,17 15,14 18 
Control 
  
0,0 0,0 0,0 0 
  
14,13  15,12 12,15 13.5 
 
Table 4.8. The average number of phoP (JW1116-1) and phoQ (JW1115-1)  transductants 
yielded over three experiments when grown with the addition of 100mM procaine, with 
two replicates for each mutant and condition per repeat. 
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It was hypothesised that both time and temperature allow for the selection of 
suppressor mutations that compensate for the loss of phoP. Extending this growth 
time allows slow-growing colonies containing secondary suppressor mutations 
sufficient time to adapt to the loss of phoP. While growth at 28°C increases sigmaE 
activity and helps mitigate the effect of losing phoP, presumably under these 
conditions cells with fewer or less extreme secondary suppressor mutations are 
selected. 
To confirm the hypothesis that phoP mutants genetically adapt to transduction, a 
P1vir transduction was carried out successfully on a cured phoP mutant under 
standard conditions (4.3). This assay demonstrated that once phoP mutants had 
successfully undergone transduction, they were no longer subject to the defect, 
which strongly supports the hypothesis that genetic adaption was taking place. This 
notion was supported further by phoP mutants generated by P1vir transduction 
being tolerant to citrate, while phoP mutants created via lambda red where not so. 
It was surprising that phoP mutants were not significantly less tolerant to 
transduction reagents than the wildtype. However, because phoP mutants created 
via transduction are thought to be genetically heterogeneous, it is expected that 
different isolates will have different tolerances to both citrate and the other 
transduction reagents.  
It is expected that phoP mutant would be more susceptible disruption of the outer 
membrane, due to divalent metal ion starvation and subsequent instability of the 
LPS. Therefore, it is likely that phoP mutants are hypersensitive to OM disruptions, 
an idea supported by the observation that induction of sigmaE facilities the 
transduction of phoP under otherwise standard conditions.  
Consequently, it was unsurprising that strains in which sigmaE was induced, rfaH, 
surA, rseA, were able to act as a recipient strain for the transduction of the phoP 
allele. However, with regards to the data presented in 4.4.1, one possible 
hypothesis that cannot be rejected completely is that the curing procedure rescues 
the cells from the phoP transduction defect. All of the genes assayed (Table 4.7) 
were cured, excluding the micA mutant strain. This hypothesis could be further 
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supported by the data in 4.3, which show a cured phoP mutant is able to undergo 
P1vir transduction successfully. Nonetheless, this is unlikely, as there was a direct 
correlation between genes able to suppress the transduction defect and the 
induction of sigmaE.  
Moreover, sigmaE was shown to be associated with the phoP transduction defect, 
in that the transductants created at 28°C all showed heterogeneity of expression 
from rpoHP3 (inferring that sigmaE activity fluctuates between ȴƉŚŽW isolates). Yet, 
it is important to note that from the data generated in section 4.3.2, it is not 
possible to confirm whether it is a lack or overabundance of sigmaE activity that is 
associated with the phoP transduction defect. 
The simplest hypothesis is that PhoP is a negative regulator of sigmaE, and 
transductants acquire suppressor mutations to lower the concentration of sigmaE 
in the cell. This suggestion is supported by the observation that all rpoHP3-lacZ, 
phoP isolates showed diminished expression of rpoHP3 compared to the wildtype, 
although this hypothesis is not at all supported by the observation that inducing 
sigmaE (using genetic induction or chemical induction via procaine) allows for the 
transduction of phoP, nor is it consistent with the idea that transduction causes loss 
of divalent cations and subsequent envelope. SigmaE would be necessary to 
mitigate damage to the OM, so it is more likely that PhoP positively regulates 
sigmaE, either directly or indirectly, and that if a suppressor-free phoP mutant could 
be generated, the expression of rpoHP3 would be uniformly low, compared to the 
wildtype.  
The hypothesis that the phoP transduction defect is a result of divalent cation 
starvation still remains a valid one. Transduction requires adding divalent metal 
ions to the reaction mix, which negates the negative charge on both surfaces of the 
bacteriophage and bacterium and is necessary for efficient binding to occur. 
However, cytoplasmic divalent ion starvation is unlikely to be cause, as it has been 
demonstrated that MgtA does not mediate the PhoP transduction defect. It is most 
likely that, in phoP mutants, sigmaE activity is depressed and is not sufficient to 
compensate for the OM damage caused by divalent cation starvation during 
transduction. Therefore it is probable that the phoP transduction defect is a 
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combined effect between increased extracytoplasmic stress (caused by divalent 
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5.1 Introduction  
 
There is a well-established link between the cell envelope and PhoPQ [112]. For 
example, PhoPQ directly regulates the expression of HdeD, a transmembrane 
protein, which is responsible for acid resistance at high cell density, and several 
lipoproteins, such as SlyB and VboR[96], [42]. Moreover, PhoP indirectly and 
directly regulates the expression of OMPs TolC and OmpT, respectively[42]. TolC is 
an outer membrane protein that acts as a channel for a number different 
molecules, and it enables the efflux of antibiotics, the export of haemolysins and 
bacteriophage absorption[105]. 
Furthermore, PhoPQ plays a prominent role in modifying the LPS, by regulating 
genes such as eptB and crcA, the latter of which functions to catalyse the transfer of 
palmate to lipid A. Moreover, eptB, which encodes phosphethanolamine 
transferase, modifies the LPS core in a Ca2+-dependent manner and decreases 
electrostatic repulsion in the presence of divalent cations [206], which in turn 
increases resistance to antimicrobial peptides such as polymyxin [224]. Finally, 
PhoPQ is negatively regulated by the sigmaE-controlled sRNA MicA [112].  
Interestingly, it has been found that MicA is regulated in an Mg2+-dependent 
manner [225]. Above certain concentrations, MicA will dimerise in the presence of 
Mg2+, the effect of which is hypothesised to inactivate MicA, either by RNase E 
degradation or by preventing normal MicA-Hfq binding. Mg2+ also contributes to 
the regulation of sigmaS, and the general stress response. DsrA is a positive 
regulator of sigmaS[193], Mg2+ -dependent dimerisation increases the activity of 
DsrA by increasing binding efficiency[193]. Perhaps it is not surprising, then, that in 
the absence of the stimulatory effect of Mg2+ on rpoS expression, under low Mg2+ 
conditions, PhoPQ acts as a positive regulator of sigmaS by preventing RssB 
meditated proteolysis [147].  
In the previous chapter, the importance of PhoP during P1vir transduction was 
established and strong evidence of its essentiality under these conditions was 
demonstrated. Furthermore, it was demonstrated that the transduction defect can 
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be suppressed by the induction of sigmaE and membrane perturbation. SigmaE 
mediated suppression was established in numerous different ways: genetically via 
knockout mutants, chemically via procaine and environmentally via lowering the 
temperature.  
In this chapter, the ĚĞƚĂŝůƐŽĨWŚŽWY ?ƐƌĞŐƵůĂƚŽƌǇƌĞůĂƚŝŽŶƐŚŝƉǁŝƚŚƐŝŐŵĂĂƌĞ
elaborated. A novel, positive regulatory link between PhoPQ and sigmaE activity, 
ŝŶĚĞƉĞŶĚĞŶƚŽĨƐŝŐŵĂ ?ƐĐŚŝĞĨƌĞŐƵůĂƚŽƌrseA, is demonstrated. Conversely, 
evidence is also presented that demonstrates a second negative regulatory 
relationship between PhoPQ and rpoE expression, adding further complexity to the 
relationship that exists between PhoP and sigmaE. 
5.2 PhoPQ positively regulates sigmaE activity  
 
It was observed that the induction of sigmaE suppresses the phoP transduction 
defect (Chapter 4). In addition, it was shown that phoP mutants, transduced at 
28°C, exhibit a lower incidence of sigmaE activity when compared to the wildtype 
(Chapter 4.3.2), and it was postulated that these data may have been an indication 
of a positive regulatory relationship between PhoP and sigmaE. To test this 
hypothesis, both phoQ (JW1115-1) and phoP (JW1116-1) were transduced into the 
rpoHP3-lacZ (CAG45114) strain, using P1vir transduction. Both phoP and phoQ 
transductions were carried out at 28°C, using the method outlined in Chapter 4. A 
ɴ-galactosidase assay was done to investigate the expression of rpoHP3 in both 
mutants (Figure 5.1). 
There was a 0.47-fold and a 0.3-fold decrease in expression from the rpoHP3 
promoter in the phoP and phoQ mutants, respectively. These data suggest that 
PhoPQ positively regulates sigmaE activity, which would support the hypothesis 
that the transduction defect is a result of accumulated envelope stress and loss of 
phoP that leads to the insufficient induction of sigmaE, thereby causing inviability. 
Interestingly, the assay shows that the absence of phoQ has a greater effect on 
sigmaE activity than the loss of phoP. The most palatable explanation for this is that 
the phoP mutants contain suppressor mutations and that the level of sigmaE 
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activity shown (Figure 5.1) for phoP is not a true representation of a phoP ŵƵƚĂŶƚ ?Ɛ
effect on sigmaE activity. While the phoQ mutant may contain additional 
suppressor mutations, the fact that there are no associated transduction defects 
ŵĂŬĞƐŝƚůĞƐƐůŝŬĞůǇ ?dŚĞƌĞĨŽƌĞ ?ŝƚŝƐƉƌŽďĂďůǇƚŚĂƚƚŚĞůĞǀĞůƐŽĨɴ-galactosidase 
measured in the phoQ ŵƵƚĂŶƚĂƌĞĂŵŽƌĞĂĐĐƵƌĂƚĞĞǆƉƌĞƐƐŝŽŶŽĨWŚŽWY ?ƐĞĨĨĞĐƚŽŶ
sigmaE activity. Alternatively, it is possible that in the absence of phoQ, PhoP 
retains activity, which would be supported by the absence of the phoQ transduction 
defect. 
 It is likely that this observation, although marred by the appearance of suppressor 







Figure 5.1. ɴ-galactosidase assay showing the effect of phoP and phoQ mutants on 
rpoHP3 expression. Error bars show 95% confidence intervals (n=4). Strain wildtype - 
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5.2.1 The effect of mgrB mutation on sigmaE activity  
 
As it was not possible to make rpoHP3-lacZ, phoP or rpoHP3-lacZ, phoQ strains, that 
lacked suppressor mutations with confidence an mgrB mutant was used to 
investigate the effect of PhoP on sigmaE activity. MgrB is a PhoP-regulated protein 
that inhibits PhoP activity by interacting with the periplasmic domain of PhoQ, in 
response to the changing redox state of the periplasm[222], deletion of mgrB is 
known to effect the expression of PhoP regulated genes [222]. The transduction 
defect, and associated suppressor mutations, were observed in strains that lack 
PhoP, so it was hypothesised that an mgrB mutant would not accumulate 
suppressor mutations, therefore, it was inferred that an mgrB mutant would give a 














Figure 5.2. ɴ-galactosidase assay showing the effect of the mgrB mutant on rpoHP3 
expression. Error bars show 95% confidence intervals (n=4). Strain wildtype - 
CAG45114. rpoHP3-LacZ mgrB; KanR -KCEC5340. 
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An mgrB mutation (JW1815-1) was transduced into the rpoHP3-lacZ strain (CAG45114), 
without any discernible defect, and the effect of the mutation on sigmaE activity was 
explored (Figure 5.2). These data demonstrate an increase in sigmaE activity when 
PhoP is no longer inhibited by MgrB. Importantly, an increase in sigmaE activity is 
observed in a strain where suppressor mutations are not expected. Together, Figures 
5.1 and 5.2 establish that PhoPQ has a stimulatory effect on sigmaE activity. 
5.2.2 The effect of phoP loss on sigmaE, demonstrated 
via complementation 
 
To increase confidence in the previous observations (5.2&5.2.1), the 
complementation strain ȴƉŚŽWůĂĐUV5-phoP was used with the aim of inducing an 
increase in sigmaE activity upon adding IPTG, which would establish that increasing 
PhoP expression has a positive effect in this regard.  
MicA is a well-known inhibitor of PhoP [112], and previously it has been 
demonstrated that the lack of this sRNA acts as a suppressor of the lethal phoP 
phenotype. A ȴƉŚŽW lacUV5-phoP, micA-lacZ strain was constructed via allelic 
exchange. To achieve this  a plasmid, (pAM012), containing micA-ůĂĐz ?ȴůĂĐz 
was transformed into a ȴƉŚŽWůĂĐhs ?-phoP strain (KCEC5409). A ȴƉŚŽW lacUV5-
phoP rpoHP3-lacZ strain was not constructed, due to time and resource constraints; 
however, micA expression is positively regulated by sigmaE, so it provides an 
appropriate surrogate for monitoring changing sigmaE activity in a way similar to 
the rpoHP3-lacZ reporter fusion[226]. The necessary tools to create a ȴƉŚŽW 
lacUV5-phoP, micA-lacZ strain, the micA-ůĂĐz ?ȴůĂĐz (pAM012), was easily 
attainable and already constructed, which meant micA-ůĂĐz ?ȴůĂĐz could be 
transformed into the complementation strain. Creating an rpoHP3-lacZ, ȴphoP 
lacUV5-phoP strain would mean reconstructing the complementation strain in an 
rpoHP3-lacZ background. Once the ȴƉŚŽW lacUV5-phoP, micA-lacZ  strain was 
constructed, it was tested +/- IPTG. It was hypothesised that in the IPTG+ strains, 
phoP expression would be induced and subsequently sigmaE activity would 
increase, which in turn would increase the expression of micA-lacZ (Figure 5.3).  
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 These data show a clear increase in ɴ-galactosidase, and therefore micA 
expression, upon the induction of lacUV5-phoP, while the results show a lowered 
expression of micA in the strains lacking IPTG. These data support the hypothesis 
that PhoP has a positive regulatory effect on sigmaE activity. Unlike the rpoHP3-
lacZ,phoP mutants, is it unlikely that the micA- lacUV5-phoP strains have suppressor 
mutations, because they were not transduced under conditions in which phoP was 
absent or not expressed. This data provides further supports of the hypothesis that 
PhoP positively affects sigmaE activity. Together with Figures 5.1 and 5.2, a clear 
link can be seen between PhoPQ and enhancing not only sigmaE activity, but also a 























Figure 5.3. ɴ-galactosidase assay showing the effect of IPTG on the expression of micA in a 
lacUV5-phoP complementation strain . The wildtype is micA-ůĂĐz ?ȴůĂĐz (KCEC4534). 
Strains 1-3 are micA-ůĂĐz ?ȴůĂĐz ɏ ? lacUV5-phoP (i- KCEC5021 ii- KCEC5021, iii- 
KCEC5021). Error bars show 95% confidence intervals (n=4).  
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5.3 Directly observing the effect of loss of phoP on 
cellular sigmaE concentration 
It was possible to observe a drop in expression of the rpoH P3 promoter (Figure 5.1) 
in both the phoP and the phoQ mutants. Although using the rpoHP3 expression as a 
measure for sigmaE activity is a well-established practice [227], [228], it only allows 
for measuring of activity rather than total protein concentration. This presents a 
number of different hypotheses. PhoP could be activating sigmaE indirectly via an 
unknown FX factor; alternately, it is possible that PhoPQ affects the amount of 
sigmaE, either  transcriptionally by regulating the expression of rpoE or the post-
transcriptionally, by regulating proteolysis of sigmaE, in the same way that PhoPQ 
regulates sigmaS[ 72]  
dŚĞƌĞĨŽƌĞ ?ŝƚǁĂƐĂĚǀĂŶƚĂŐĞŽƵƐƚŽĂƚƚĞŵƉƚƚŽůŽŽŬĂƚWŚŽW ?ƐĚŝƌĞĐƚĞĨĨĞĐƚŽŶƐŝŐŵĂ
protein concentration in vivo. In order to measure levels of sigmaE directly, a semi-
dry colorimetric Western blot was used with primary sigmaE polyclonal antibody 
(donated by the Gross lab). Four strains were chosen for this assay: a sigmaE 
protein control 10ug/ml (donated by the Ades lab), used as a control for the 
antibody used, the wildtype (CAG45115), an mgrB mutant (KECE5340) (in which 
PhoP activity is enhanced) and an rseA mutant (KCEC4420). The rseA mutant was 
used as a control for this experiment, because without RseA, sigmaE is no longer 
sequestered to the inner membrane. It has been shown that rpoE is autoregulated, 
so it would be expected that in an rseA mutant  rpoE expression would be 
enhanced[229].  
The strains outlined above, excluding the pure sample of sigmaE protein, were first 
prepared in accordance with the lysis protocol. Once lysed, the samples were 
assayed for their protein concentration, using a standard Markwell assay, and then 
diluted down to the same total protein concentration of 1.5ug/ml. The colorimetric 
Western blot was then carried out on these samples (Figure 5.4A).  
These data were then subjected to an image enhancement the aim of which was to 
increase clarity.  The location in the original image (Figure 5.4A) where the sigmaE 
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protein was expected to be, just above the 22kDa band, was coloured corrected by 
a 400% increase in saturation(Figure 5.4B).  
Once data for the Western blot was completed, the results were quantified using a 
readily available protocol, utilising the software ImageJ[230]. The ImageJ plugin 
 “ƐƵďƚƌĂĐƚďĂĐŬŐƌŽƵŶĚ ? ?ǁĂƐƵƐĞĚƚŽŵŝƚŝŐĂƚĞƚŚĞĞĨĨĞĐƚŽĨƚŚĞŚŝŐŚďĂĐŬŐƌŽƵŶĚ
ƐŝŐŶĂůŽŶƚŚĞĂŶĂůǇƐŝƐ ?dŚŝƐƉůƵŐŝŶƵƐĞƐĂ “ƌŽůůŝŶŐďĂůů ?ĂůŐŽƌŝƚŚŵƚŽĐŽƌƌĞĐƚĨŽƌ
uneven background signal[231]. Bands were selected manually and their intensities 
converted to peaks. The area under these peaks was then given an arbitrary value, 
with higher intensity bands corresponding to larger peaks and a greater area. These 
ǀĂůƵĞƐǁĞƌĞƚĞƌŵĞĚ “ƌĞůĂƚŝǀĞŝŶƚĞŶƐŝƚǇ ? ?ďĞĐĂƵƐĞƚŚĞǇǁĞƌĞĞǆƉƌĞƐƐĞĚŝŶĂƌďŝƚƌĂƌǇ
units and so were only directly comparable to each other. The value for each band 
peak area was as follows: protein control-29643.25, rseA-25172.76, wildtype-
15725.46 and mgrB- 9402.054. These values were then normalised using the 
standardise function of the Microsoft Excel software package. This function returns 
a Z-score for each intensity value by subtracting the population mean from the 
value and then dividing this number by the population standard deviation (Figure 
5.4C).  
sigmaE is a 24kDa protein[114], the protein bands in that position suggest the 
protein control and rseA mutant have the highest concentration of sigmaE. This is 
not unexpected, as rpoEP6 responds to sigmaE and allows autoinduction[229].  
While the lowest concentration of sigmaE is associated with the mgrB mutant in 
which PhoP is uninhibited(Figures 5.4A&B). These data were surprising in this 
respect, as it was hypothesised that higher sigmaE activity observed from previous 
experiments (Chapter 4&5) would correlate with increased sigmaE expression. 
The data suggests sigmaE expression, in the mgrB mutant, is diminished rather than 
epistatic with the wildtype, which suggests that PhoP is a negative regulator of 
sigmaE expression  W an unanticipated result.  
These data and the previous observations suggest that PhoP regulates sigmaE both 
negatively and positively, increasing activity and diminishing expression. However, 
it would seem that the effect of decreasing expression is subsitory, since PhoP 
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causes overall sigmaE activity to increase. Therefore, PhoP should be considered a 
positive regulator of sigmaE. However, this conclusion is contingent on the cogency 
of the Western blot data presented herein. Several weaknesses, such as a high 
background signal or lack of a protein loading controls, increase the difficulty in 
making accurate assertions based on these data. These weaknesses are further 
discussed at the end of this chapter. 
If PhoP is a key regulator of sigmaE activity then a mechanism to inhibit excess 
expression might be expected. As PhoP is a transcription factor that indirectly 
regulates a large number of genes, the simplest hypothesis to explain this 
observation is that PhoP utilises two mechanisms of action to regulate sigmaE. 
These mechanisms may be direct and indirect, inhibiting expression but increasing 





































Figure 5.4B. Colour-corrected gel (400% saturation) of 24kDa band of 
Figure 5.4A. A colorimetric Western blot image using a sigmaE polyclonal 
antibody (donated by the Gross lab). Run in a Bis-Tris 10% MOPS buffer. 
Showing the sigmaE concentration in four samples, lane 1-10ug/ml of 
sigmaE protein(donated by the Ades lab), 3- (KCEC4420), 5-wildtype 
(CAG45115), 7- mgrB (KECE5340) and and M denotes the pre-stained 
molecular weight marker.   



















Figure 5.4A. Original gel. A colorimetric Western blot image using a sigmaE 
polyclonal antibody (donated by the Gross lab). Run in a Bis-Tris 10% MOPS 
buffer. Showing the sigmaE concentration in four samples, lane 1-10ug/ml of 
sigmaE protein (donated by the Ades lab), 3-(KCEC4420), 5-wildtype (CAG45115), 
7-mgrB (KECE5340) and M denotes the pre-stained molecular weight marker.   
1 3 5 7 M 
M 












5.4 PhoP influences sigmaE activity independent of 
RseA  
 
Unexpectedly, the increase in sigmaE activity was not corroborated when sigmaE 
protein concentration was measured directly (5.3). To further  characterise WŚŽW ?Ɛ
regulatory relationship with sigmaE, sigmaE activity was measured in an rseA,phoP 
double mutant. The aim of this experiment was to try and elucidate the mechanism 
ďǇǁŚŝĐŚWŚŽW ?ƐƌĞŐƵůĂƚŝŽŶŽĨƐŝŐŵĂŽĐĐƵƌƐ ?ZƐĞŝƐƚŚĞĐŚŝĞĨƌĞŐƵůĂƚŽƌŽĨƐŝŐŵĂ
activity, and so it would be expected that sigmaE activity in an rseA,phoP double 
mutant would be epistatic with an rseA ŵƵƚĂŶƚ ?ǁŚŝĐŚǁŽƵůĚŚĞůƉĐůĂƐƐŝĨǇWŚŽW ?Ɛ
ƉůĂĐĞŝŶƐŝŐŵĂ ?ƐƌĞŐƵůĂƚŽƌǇŚŝĞƌĂƌĐŚǇ ?
A phoP mutation (JW1116-1) was transduced into an rseA, rpoHP3-lacZ strain 
(KCEC4418) under standard conditions. This was possible because rseA was 
previously found to be a suppressor of the phoP ƚƌĂŶƐĚƵĐƚŝŽŶĚĞĨĞĐƚ ?ɴ-
galactosidase assay was carried out using the created rpoHP3-lacZ,rseA,phoP 
double mutant (Figure 5.5).   
Figure 5.4C. Z-score of the relative intensity of chemiluminescent bands 
observed from blot, Figure 5.3A, generated using the standardise function of 
the Excel software package. The population mean and standard deviation of 
these values are 19985.88 and 9134.86, respectively . 
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These data suggest that PhoP regulates sigmaE activity regardless of whether or not 
it is sequestered by RseA, which might suggest that PhoP is a key regulator of 
sigmaE activity. However, the previous experiment suggests that PhoP causes 
sigmaE protein concentration to fall. It is possible that PhoP directly causes an 
increase in sigmaE activity by increasing rpoE expression, while indirectly causing 
sigmaE total protein concentration to fall via an unknown FX factor. 
The assay shows that there is a slightly higher level of sigmaE activity in the 
rseA,phoP mutant, compared with the phoP mutant. This may be due to suppressor 
mutations, in a clean mutant the difference in sigmaE activity between rseA,phoP 
and phoP mutants could be insignificant. Suppressor mutations are expected to 
arise from increased envelope stress and lack of sigmaE activity in a PhoP mutant. 
However, it is unknown at what level of sigmaE activity suppressor mutations 
become prevalent, so they may or may not be expected in an rseA,phoP mutant. If 
there are no suppressor mutations in the rseA,phoP strain, the increase in sigmaE 
activity compared to the phoP mutant would be the result of another regulator that 
activates sigmaE in independent of phoP and rseA.  
   
 






5.5. Searching for a PhoP-Box in the rpoE promoter 
region, using in silico analysis 
 
It has been suggested that PhoP regulates sigmaE both positively and negatively, 
albeit through different mechanisms. One of these proposed mechanisms is direct 
transcriptional regulation of rpoE expression. Many in vitro and in vivo assays are 
used to detect transcription factor-binding sites, such as an electro-Mobility Shift 
Assay, ChIP-on-chip or promoter analysis. The advantages and disadvantages of 
these experiments depend on several factors, such as if the TF binding motif is 
known and the scope of the analysis. in silico experiments can be used to 
supplement in vitro and in vivo motif discovery assays by analysis and extrapolation. 
 
Figure 5.5. ɴ-galactosidase assay showing the effect of a rseA, phoP mutants on rpoHP3 
expression. Error bars show 95% confidence intervals (n=4). Wildtype- CAG45114. 
rpoHP3  ?lacZ,phoP (transduced at 28°C) - KCEC5127, rpoHP3  ?lacZ,rseA- KCEC4418, 
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PhoP binds to the consensus sequence (T/G)GTTTAnnnnn (T/G)GTTTA)[96]. Twenty-
six genes have been found that contain this hexanucletoide repeat with a 5- 
nucleotide spacer, within 500bp upstream of the start codon of the gene[96]. It was 
thought that by searching and finding possible PhoP binding sites associated with 
rpoE it would support the hypothesis that PhoP is a regulator of rpoE expression 
ĂŶĚŚĞůƉǀĂůŝĚĂƚĞƚŚĞĞǆŝƐƚĞŶĐĞŽĨĂƚůĞĂƐƚŽŶĞƌĞŐƵůĂƚŽƌǇĂƌŵŽĨWŚŽW ?ƐƉƌŽƉŽƐĞĚ
duel regulatory relationship with sigmaE. To further test the hypothesis that PhoP 
regulates rpoE expression, a comprehensive search was done for PhoP-box 
sequences, using a position weight matrix (PWM).  
In a consensus sequence, each position in the sequence is represented by a single 
character, which has the advantage of expressing a good deal of information as a 
simple string. However, although specific characters can be used to represent 
degeneracy, i.e. two or more bases, the sequence cannot be truly representative of 
the motifs used to create it, because information such as the frequency of 
nucleotides in each position is lost. A readily used alternative is to represent a set of 
aligned transcription factor binding motifs using a position weight matrix that 
shows which nucleotides are present   W and most prevalent  W in each position of a 
sequence and which positions are conserved.  
A PWM is a probabilistic model used to characterise and predict transcription factor 
binding motifs[232]. PWMs are generated from aligned sequences that are 
determined experimentally. Initially, aligned sequences from the PhoP Mg2+ 
stimulon were used as defined by Minagawa et al. (2003) (Appendix Table D.1)[42]. 
First, a position frequency matrix (PFM) was constructed, which is simply a count of 
each nucleotide in each position in the sequence alignment (Figure 5.6A). These 






























 Nucleotide frequency 
position A C G T 
1 0 0 2 7 
2 1 0 8 0 
3 0 0 1 8 
4 0 0 0 9 
5 0 0 0 9 
6 8 0 1 0 
7 1 0 4 4 
8 2 2 4 1 
9 3 1 3 2 
10 3 0 2 4 
11 1 3 1 4 
12 0 0 4 5 
13 2 0 7 0 
14 0 0 0 9 
15 0 0 1 8 
16 0 0 2 7 
17 9 0 0 0 
Figure 5.6A. Frequency matrix generated from the PhoP-
box consensus sequences of the genes in the Mg2+ 
stimulon, using UGENE software, based on Minagawa et 
al. (2003)[42]. 
Figure 5.6B. Position weight matrix represented 
graphically as a sequence logo, created using the 
PFM (Figure 5.6A) and UGENE software. 
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Converting a PFM to a PWM is calculated by using the following equation[233]:  
 
p(b) = background probability of base b; p(b,i) = corrected probability of base b in 
position i; Wb,i = PWM value of base b in position I  
This equation generates normalised nucleotide frequencies, which are then 
converted to log values. A PWM was constructed by inputting the PhoP-box 
consensus sequences of members of the Mg2+ stimulon into Unipro UGENE 












 Nucleotide frequency 
Position A C G T 
1 -2.64297 0.360729 -0.00391 0.329859 
2 -1.03353 -1.8365 1.13316 -1.67162 
3 -1.03353 0.360729 -1.22769 0.525604 
4 -0.44575 -1.8365 -2.83713 0.689233 
5 -2.64297 0.360729 -1.22769 0.610762 
6 1.248849 -0.22706 -0.6399 -3.28106 
7 -1.03353 -1.8365 0.65938 -0.06218 
8 0.190242 0.996718 0.207395 -1.08383 
9 0.401551 0.360729 -0.00391 -0.44785 
10 0.190242 -0.22706 0.207395 -0.23654 
11 -1.03353 1.20803 0.207395 -0.44785 
12 -1.03353 0.728454 -0.00391 0.086237 
13 0.190242 -0.22706 0.876445 -3.28106 
14 -0.44575 -1.8365 -2.83713 0.689233 
15 -0.07802 -1.8365 -1.22769 0.525604 
16 -2.64297 0.360729 0.207395 0.215449 
17 1.4679 -1.8365 -2.83713 -3.28106 
Figure 5.7. Position weight matrix generated using UGENE software from the Mg2+ 
stimulon PhoP-box consensus sequences (Minagawa et al. 2003[42]), represented by 
PWM  
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5.5.1 Optimising the PFM threshold for consensus 
sequence prediction  
 
 Many bioinformatics tools predict TF binding sites from known, experimentally, 
derived binding motifs that can be inputted in the form of a number of aligned 
sequences or scoring matrices such as PWMs. For the analysis below,  ‘find 
individual motif occurrences ? (FIMO), which is part of the MEME suite, was chosen 
because it was evaluated by Jayaram et al. and found to be one of the most 
comprehensive tools for identifying individual TF binding sites[235]. The MEME 
(Multiple EM for Motif Elicitation) suite is a software toolkit offering a number of 
different analyses, such as motif-sequence database searching, motif discovery and 
motif database searching. Many of these tools and analyses, such as FIMO, utilise 
the MEME algorithm  which uses a probabilistic method with expectation-
maximization[235]. One or several motifs can be input into FIMO as either a 
consensus sequence or a scoring matrix, following which the program calculates a 
log-likelihood ratio score for each motif with respect to each sequence position and 
background frequency and then convert them to P-values[236]. FIMO will detect all 
motifs with a P-value smaller than a chosen value, because P-values directly 
correlated to scores, they function as a scoring threshold.  
FIMO offers a number of different thresholds that can be chosen(Table 5.1). To 
choose a reasonable threshold for PhoP binding site discovery, the performance of 
a number of different P-value thresholds, <1.0E+00, <1.0E-01, <1.0E-02, <1.0E-03, 
<1.0E-04, and <1.0E-05, was evaluated using a confusion matrix, which uses test 
data to the evaluate a classifier by a number of different criteria. The test datasets 
used were experimentally derived binding sites to which the in silico predications 
could be compared. However, few PhoP binding sites have been determined using 
in vivo assays, and many are based on in silico predictions[96]. Discounting the 
original eight motifs, from genes constituting the Mg2+ stimulon, three others were 
found in the published literature, namely crcA- TATTAAggttaTGTTAA[98], treR- 
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GGTTTATcgttGGTTTAG[237] and ybjG- TCTTTAagtttTATTTA[98], which were found 
via either a promoter or ChIP analysis. To generate a test dataset, the gene 
sequence 600bp  W upstream of the ATG startcodon of the genes crcA, treR and ybjG 
 W was analysed with FIMO, using the least specific threshold P-value <1.0. Any motif 
that matched at least 75%, of experimentally derived, PhoP-Box was considered a 
correct match. For each of the three genes, crcA,treR and ybjG the analysis correctly 
identified the experimentally  derived PhoP binding motif and a number of false 
ones(Appendix Tables D.2-D.4). Using this, a confusion matrix was plotted to 
evaluate the performance of the six P-value thresholds.  
 
 Confusion matrices allow the comparison of the rate of true positives, true 
negatives, false positives and false negatives to evaluate the error rate, accuracy, 
sensitivity, specificity, precision and false positives rate of a classifier, in this case 
different scoring thresholds[238]. True positives (TPs) are instances in which the 
confusion matrix predicts a positive case correctly . True negatives (TNs) are 
instances in which a negative predicts correctly, while false positives (FPs) are 
predicted positive cases that are negative. Finally, false negatives (FNs) are 
predicted negative cases that are positive. To generate TP, TN, FP and FN 
predictions were made for each threshold using the test data (Table 5.1).  For 
example, the PhoP binding site for ybjG was identified with a P-value of 2.02E-05, 
which would fall into the threshold of a P-value <1.00E-4. At a threshold of a P-
value <1.00E-5, this motif would not  have been found making it a FN at  <1.00E-5 
























Using these predictions (Table 5.1), the error rate, accuracy, sensitivity, specificity, 
precision and false positives rate can be defined for each threshold value. The error 
rate is a number between zero and one, which represents the proportion of 
incorrect predictions at each threshold. It can be calculated by dividing the number 





The accuracy is the proportion of correct predictions. It is the inverse of the error 
rate and is represented by a number between zero and one, where the higher 
numbers represent greater accuracy. It can be calculated by either dividing the total 
positive predictions (TP and TN) by the total number of predictions (2) or by simply 





P-value  TP TN FP FN 
<1.0E+00 3 0 30 0 
<1.0E-01 3 16 14 0 
<1.0E-02 3 17 13 0 
<1.0E-03 3 26 4 0 
<1.0E-04 2 30 0 1 





Table 5.1. A summary of a confusion matrix plotted showing the number of 
true positives (TP), true negatives (TN), false positives (FP) and false negatives 
(FN) for each threshold value, using data generated from crcA, treR and ybjG         
(full data is available in Appendix Table D.5).  
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Sensitivity, also known as recall or the true positive rate, is the proportion of TP 
that has been identified correctly. It is represented by a number between zero and 
one, wherein numbers closer to one represent higher sensitivity.  It is calculated by 
dividing the number of correctly predicted positives (TP) by the total number of 





Specificity, also called the true negative rate, is the proportion of the number of 
correctly identified negative results. The most desirable specificity is one, while the 
least desirable is zero. It is calculated by dividing the number of TN by total 





Precision, also called the positive predictive value, is the proportion of predicted 
positives that are true positives. It is represented by a number between zero and 
one, wherein numbers closer to one signify  greater precision. It is calculated by 





The false positive rate is the inverse of specificity. It is the proportion of negatives 
incorrectly identified as positives and can be calculated by dividing the number of 
FP by total number of negatives (TN+FP) (6), or more simply by subtracting 1 from 
specificity:   










The <1.0E-00 and <1.0E-05 thresholds were the weakest, with the former having  
high accuracy but a large false positive rate, while <1.0E-05 detected none of the 
experimentally derived binding motifs. The <1.0E-01 and <1.0E-02 thresholds are 
marginally better than the <1.0E-00 threshold, due to a lower false positive rate, 

















The <1.0E-04 and <1.0E-03 thresholds are the strongest, but each offers distinct 
advantages and disadvantages. For instance, <1.0E-03 is more likely to return a 
correct motif but many false ones, while <1.0E-04 is less likely to find either a true 
or a false motif. However, the <1.0E-04 threshold was chosen, as it seemed to offer 
the most advantages over the others, namely that although it had a comparatively 
low sensitivity, it was more accurate and had much higher precision than the other 
thresholds (Figure 5.9).  








































Figure 5.8. Receiver Operating Characteristic (ROC) curve analysis showing the false positive 
rate and the true positive rate for each threshold value. 
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<1.0E+00 0.91 0.09 1 0 1 0.09 
<1.0E-01 0.42 0.58 1 0.53 0.47 0.18 
<1.0E-02 0.39 0.61 1 0.57 0.43 0.19 
<1.0E-03 0.12 0.88 1 0.87 0.13 0.43 
<1.0E-04 0.03 0.97 0.67 1 0 1 
<1.0E-05 0.09 0.91 0 1 0   
 
 
5.5.2 Searching for PhoP binding sites in the rpoE 
promoter region 
 
Using the PWM, generated from PhoP binding site motifs, and the P-value <1.0E-04 
threshold, FIMO was used to search the promoter region (600bp upstream of the 
ATG startcodon) of rpoE, in order to test the hypothesis that PhoP regulates rpoE 
transcription. This analysis returned three potential binding sites (Table 5.2). These 
motif scores had a range of 3.77477-1.04505, and although these scores seemed 
high, inferring high sequence similarity with known PhoP binding sites, it was 




















Table 5.2. PhoP binding motifs in the rpoE promoter predicted FIMO analysis 
showing the P-value and score.  
Figure 5.9. Error rate, accuracy, sensitivity, specificity, precision and false positives rate 
for each threshold value expressed as a heat map. 
 



















To determine the statistical significance of these scores, 1,000 random sequences 
600bp in length were generated with the same distribution of nucleotides as the 
rpoE promoter region (600bp upstream from ATP start codon), i.e. A-28.4% T-27.1% 
G-24.5% C-20%, using the software rMotifGen[239]. These 1,000 sequences were 
then analysed with FIMO, using the lowest threshold, namely P<1.0, to generate 
the largest number of possible scores. This analysis yielded 72,603 possible motif 
occurrences, with scores ranging between 17.3604 and -22.4955(Data not shown). 
 The probability distribution of these data was then calculated using the probability 
distribution function in the Minitab software package, assuming the data had a 
largest extreme value distribution, this was then plotted graphically (Figure 5.10). 
&ƌŽŵƚŚŝƐĚĂƚĂĂĐŽŶĨŝĚĞŶĐĞŝŶƚĞƌǀĂůĐŽƵůĚďĞĚĞƌŝǀĞĚ ?Ŷɲ-value of 0.05 requires a 
score of at least 2.9279 to be significant, which suggests the motif with a score of 




Figure 5.10. Probability distribution plot F(x), assuming a largest extreme value, of 
72603 FIMO-generated scores and the associated P-value. 
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Although only one motif had  a significant score, it was thought practical to access 
the biological significance of all three, with regard to the rpoE gene. Six promoters 
have been associated with rpoE, (P1 (-381), P2 (-327), P3 (-327/-326), P4 (-218), P5 
(-153) and P6(-78))[229].  
These promoters respond to different exogenous and endogenous signals, such as 
LPS defects, starvation (entry into stationary phase), osmolality stress, nitrogen 
starvation and overexpression of lipoproteins[229]. P2 and P3 share the same 
transcription start site. P2 has a sigmaN consensus sequence and a GlrR binding 
site. Both of these act as positive regulators of P2. GlrR is part of the GlrK TCS, 
which is associated with glucosamine-6-phosphate metabolism, and it positively 
regulates GlmY, which is a positive regulator of glmS. P3 has a sigma70 consensus 
sequence and is also thought to be regulated by RcsB and CRP and activated in 
response to the mislocalisation of lipoproteins such as YhdV, YghG, Spr and 
YceB[229]. RcsB is a response regulator and part of a multi-component 
phosphorelay system along with RcsF/RcsC/RcsD/RcsA[240]. P4 has a sigmaS 
consensus sequence, thereby suggesting an rpoE transcription increase upon entry 
into the stationary phase; however, this sequence is also consistent with many 
sigma70 consensuses[229]. P6 is autoregulated by sigmaE[229]. P1 and P5 have not 
been associated with any transcription factors and no consensus sequences have 
been predicated[229]. 
The potential PhoP binding sites that were predicted were compared to the rpoE 
promoters (Figure 5.11). Motif 2 is downstream of P2 and P3, and motif 3 is close to 
the ATG start codon. However, one possible PhoP binding site (motif 1) is within the 
P5 region  W this motif had the highest score and the only one of statistical 
significance based on the analysis conducted above. The regulator of P5 is 










5.6 SigmaS positively regulates sigmaE activity, 
independent of RseA 
 
A possible mechanism by which PhoP directly regulates rpoE expression was 
suggested in the previous experiments. However, it has been hypothesised that 
PhoP must regulate sigmaE through a number of different mechanisms, as it has 
been observed that PhoP increase sigmaE activity while leaving protein 
concentration reduced. It is likely that these mechanisms are separate, i.e. one 
direct and one indirect. A possible candidate for indirect regulation is sigmaS, as it 
has been suggested by Klein et al. that it regulates rpoEP4 expression [229],[102]. 
To explore this association, an rpoHP3-lacZ rpoS,rseA mutant (KCEC5354) was 
constructed. This strain was subject to a ɴ-galactosidase assay (Figure 5.12). 
Figure 5.11. A summary of the rpoE promoter region -499bp upstream of the ATG 
start codon. rpoE promoters (P1-P6)[229] are highlighted along with three potential 
PhoP binding sites (green) found by in silico analysis.  
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The data show that the wildtype and rpoS mutant are epistatic, rpoS only affects 
sigmaE activity in the absence of rseA. The effect of an rseA mutation on sigmaE 
activity was diminished in the absence of sigmaS, which mirrors the results found 
above (Figure 5.5). These data suggest that rseA ?Ɛ effect on sigmaE activity requires 
sigmaS, inferring that sigmaS enhances the expression of rpoE, a novel observation 
when this assay was carried out. However, there is no transduction defect 
associated with rpoS, which suggests that sigmaS is not the only mechanism by 































Figure 5.12. ɴ-galactosidase assay showing the effect of rpoS mutants on rpoHP3 
expression. Error bars show 95% confidence intervals (n=4). Strain wildtype rpoHP3-
lacZ- CAG45114, rpoHP3-lacZ-, rpoS - KCEC5349, rpoHP3-lacZ, rseA- KCEC4418, rpoHP3-
lacZ- rseA,rpoS KCEC5239 
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5.6.1 rpoS mutation acts as an anti-suppressor for the 
phoP Transduction defect  
 
To further explore the extent to which sigmaS contributes to the PhoPs, regulation 
of sigmaE an attempt was made to construct an rpoS,rseA,phoP triple mutant via P1 
transduction under standard conditions.   
Previously, it had been found that rseA was a suppressor of the phoP transduction 
defect (chapter 4). It was hypothesised that if rpoS was part of the regulatory 
mechanism by which PhoP enhanced sigmaE activity, an rseA,rpoS mutant would 
not suppress the phoP transduction defect. An rseA mutation (CAG25198) was 
transduced into an rpoS mutant under standard conditions (KCEC5354), following 
which an attempt was made to transduce a phoP (JW1116-1) mutation into this 
background, using phoQ (JW1115-1) as a control. Transduction into an rseA mutant 
was used as a secondary control, and two biological repeats were done for each 
condition. This was repeated twice (Table 5.3).  
It was not possible to transduce the phoP mutation successfully into an rseA,rpoS 
background, which suggests that without sigmaS, sigmaE can no longer reach 
activities high enough to suppress the transduction defect. This supports the 
findings of the previous assay, sigmaS enhances sigmaE activity in an rseA mutant. 
Moreover, these data  infer that sigmaS is not the only route by which PhoP 
regulates sigmaE, as it would be expected that if it were then  transduction of a 
phoP mutation would have been possible as it is with an rseA mutant. Although, 
this assertion cannot be made with confidence as PhoP is not the only activator of 
sigmaE. It may be possible that in the absence of phoP sigmaS still retains sufficient 
activity to allow transduction of a phoP mutation into an rseA mutant. Additionally, 
sigmaS and sigmaE are important for cellular function, and in the rseA,rpoS mutant, 
the function of both of these alternative sigma factors is disrupted, it is possible 
that the observation is the result of an accumulation of deleterious effects that are 
independent of the phoP transduction defect.  
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Additionally, this experiment strengthens the initial hypothesis that sigmaE 
suppresses the transduction defect, as it was possible to transduce phoP into an 
rseA mutant, wherein sigmaE is hyper-induced, but no longer possible in an 
rseA,rpoS strain where sigmaE activity is inhibited.  
 
Strain  Average number of phoP 
transductants  
Average number of phoQ 
transductants 
Repeat 1 Repeat 2 Average  Repeat 1 Repeat 2 Average 
rseA(KCEC4418) 11,14 14,13 13 7,11 8,10 9 
rseA,rpoS 
(KCEC5354) 
0,0 0,0 0 2,3 1,2 2 
Wildtype 
(CAG45114) 






It was hypothesised that PhoPQ is a positive regulator of sigmaE activity, this was 
strongly supported by several assays that showed a strong correlation between 
PhoP induction and sigmaE activity. It was observed that the loss of the phoP 
inhibitor MgrB led to an increased expression of sigmaE activity (5.2). Moreover, 
micA expression increased when phoP expression was induced from the lacUV5 
promoter using IPTG. Presumably, this increase in activity was caused by elevated 
sigmaE activity, dependent on PhoP. Furthermore, a model in which PhoP is a key 
regulator of sigmaE provides a cogent explanation for the observation that a micA 
mutant could act as a recipient strain for the transduction of phoP under otherwise 
standard conditions (4.4.1). It is likely the strain was pre-adapted because in a micA 
mutant, sigmaE activity would be expected to be higher due to a defective negative 
feedback loop between sigmaE, MicA and PhoP. 
Table 5.3. Showing the average number of phoPQ transductants transduced into the 
wildtype (CAG45114), rseA, rpoS (KCEC5354) and rseA (KCEC4418) over two 
experiments.  
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Interestingly  phoQ showed a lower incidence of sigmaE activity compared with 
phoP(5.2). However, no transduction defect associated with phoQ was found, which 
may suggest that the transduction defect is not associated with sigmaE, albeit this 
seems unlikely. As discussed previously, it is more likely that differences in sigmaE 
activity in the phoP and phoQ mutants are due to secondary suppressor mutations 
in the phoP mutant strain. However, if this is true and secondary suppressor 
mutations are a result of losing sigmaE, then it should logically follow that phoQ 
mutants must also contain secondary suppressor mutations. Alternatively, lack of 
suppressor mutations in phoQ mutant would support the hypothesis that PhoP 
regulates sigmaE independently of PhoQ, by either having activity in its 
unphosphorylated state or being activated by another sensor kinase. It is possible 
that in the absence of PhoQ, PhoP is still able to maintain limited regulatory control 
of sigmaE. This small concentration of active PhoP, in phoQ mutants, might be 
sufficient to yield transductants with fewer secondary suppressor mutations, which 
may also explain why there is no transduction defect in phoQ mutants.  
In this chapter two possible mechanisms by which PhoP may regulate sigmaE were 
explored, directly by regulating rpoE expression and indirectly via sigmaE. 
Considering it was shown that PhoPQ has a stimulatory effect on sigmaE activity 
(5.2, 5.2.1 and 5.2.2), it was surprising that increased phoP expression seemed to 
have a negative effect on sigmaE concentration (5.3). It is possible that sigmaE was 
affected by feedback inhibition; however, this seems unlikely. Firstly the Western 
blot assay showed that in an rseA mutant sigmaE protein concentration was 
increased compared to the wildtype. Secondly, It has been shown (5.2.1) how 
sigmaE activity rises, seemingly, without evidence for a feedback mechanism. 
However, because of several weakness in the Western blot data, the conclusions 
discussed above, namely that PhoP has a negative effect on total sigmaE protein 
concentration, may be questionable. 
One of the most apparent weaknesses of the Western blot data presented in this 
chapter is the lack of a protein loading control. Protein loading controls help 
demonstrate that the difference in protein concentration between samples is not 
due to any variance in the amount of sample loaded or in total protein 
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concentration between samples. Moreover, protein loading controls help ensure 
proteins have been transferred from gel to membrane efficiently and that signal 
detection is uniform across the gel. Proteins that are constitutively expressed at a 
high level and have a different molecular weight than the protein of interest are 
typically chosen[241].  
Although care was taken to measure and standardise the total protein 
concentration of each sample, as no protein loading control was used, the 
possibility that the apparent variation in sigmaE concentration between samples 
was an artefact of the experimental procedure cannot be definitively rejected.   
Moreover, it is evident that there was a high background signal present across the 
Western blot, for which there are a number of different possible causes, ranging 
from procedural errors, such as the incomplete blocking of the membrane or 
insufficient washing, to contamination of the reagents or the membrane itself, 
although the most likely explanation is the use of a polyclonal antibody. Unlike 
monoclonal antibodies, polyclonal antibodies bind to multiple epitopes, which may 
be shared by related proteins and in turn may lead to cross-reactivity and a high 
background signal, the latter of which may mask small differences in protein 
concentration, thereby increasing the difficulty in making accurate assertions 
regarding variability between samples[242].  
In an attempt to mitigate the effect of the background signal, the ImageJ plugin 
 “ƐƵďƚƌĂĐƚďĂĐŬŐƌŽƵŶĚ ?ǁĂƐƵƐĞĚ ?dŚŝƐƉůƵŐŝŶƵƐĞƐĂ “ƌŽůůŝŶŐďĂůů ?ĂůŐŽƌŝƚŚŵ ?ǁŚŝĐŚ
can help to compensate for irregular intensity distribution within an image[231]. 
The workings of the algorithm can be understood by envisioning a three-
dimensional representation of the image, with the third dimension corresponding 
to pixel intensity. dŚĞďĂĐŬŐƌŽƵŶĚŝƐĐĂůĐƵůĂƚĞĚďǇ “ƌŽůůŝŶŐ ?ĂƐƉŚĞƌĞ W of a user ?
defined radius  W across the underside of the surface. The sphere may invade peaks 
with larger radii than itself. The area of the peak that the sphere touches is 
determined as the background and removed from the image[231], [243]. Since a 
sphere cannot penetrate peaks with smaller or narrower radii than itself, a radius 
was chosen that was approximately equal to that of the bands to be analysed.  
172 | P a g e  
 
While using this process helped mitigate the effect of the high background signal, 
several minor bands were detected in between the sample lanes, at 35kDa and 
above, and one major band detected at 23kDa-28kDa could not be subtracted, 
because their radii and intensity were similar to those of the bands to be analysed.   
While multiple bands of varying molecular weights might be expected when using a 
polyclonal antibody, a large band in between lanes is likely to be indicative of 
sample leakage into adjacent lanes. It is possible that this may have led to rseA and 
protein control, in between which the major band is located, not being 
representative of sigmaE protein concentrations. 
In an attempt to circumvent leakage from outside of the sample and subsequent 
overlapping bands during quantification, the region of analysis was carefully 
selected. For all bands, a rectangle with the same dimensions was drawn, thus 
constituting the region of analysis. As stated in the protocol[230], the region of 
analysis should be larger than the band to be analysed, as this ensures that the 
band signal can be analysed in its entirety and a consistent border of quantification 
is maintained for all bands, even if they might be somewhat ill-defined.  
When choosing the region of analysis for the protein control and resA bands, care 
was taken to avoid any major and minor bands outside of the sample lanes. To 
achieve this aim, a region of analysis was chosen that omitted the outermost left 
and right borders of the protein control and resA bands but still extended slightly 
vertically into the sample lane. Although doing this removed approximately 5% of 
the band from the region of analysis, it nevertheless increased the likelihood that 
sample leakage would not be included in the analysis of the sigmaE protein control 
and rseA bands. This was done for all bands, in order to maintain consistency.  
However, if band leakage had occurred, then saturation may be expected. Band 
intensity is expected to be proportional to protein concentration, but at very high 
protein concentrations it is no longer linearly proportional to protein abundance, 
and accurate quantification is therefore not possible[241]. If saturation had 
occurred, very little variation between the protein control and the rseA bands 
would be expected. Nevertheless, the relative intensities of the protein control and 
173 | P a g e  
 
rseA bands are dissimilar, which would suggest that the samples were not saturated 
and increases the likelihood that the protein control and rseA samples are 
representative of protein concentration.  
The data presented in this chapter infers WŚŽW ?ƐƌĞŐƵůĂƚŝŽŶŽǀĞƌƐŝŐŵĂŝƐĐŽŵƉůĞǆ
and multi-factorial. The results suggest a duel mechanism of action for PhoP, both 
lowering the protein concentration of the cell and increasing activity. It is likely that 
these mechanisms are both direct and indirect. Direct regulatory control of 
expression was suggested by the observation that the effect of PhoP on sigmaE is 
independent of RseA. Further evidence of direct transcriptional regulation was 
inferred by the discovery of a PhoP binding site inside rpoEP5. Indirect regulation 
was observed when measuring sigmaE activity in an rpoS,rseA mutant, suggesting 
that sigmaS is one way in which PhoP exerts control of sigmaE. These ideas are 
explored and expanded on in the final chapter of this thesis. 
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6.1 Background Summary 
 
The PhoPQ two-component system assists E. coli in proliferating in an Mg2+ starved 
ĞŶǀŝƌŽŶŵĞŶƚ ?dŚŝƐŝƐĨĂĐŝůŝƚĂƚĞĚďǇWŚŽWY ?ƐĂďŝůŝƚǇƚŽƐĞŶƐĞĂŶĚƌĞƐƉŽŶĚƚŽĨĂůůŝŶŐ
concentrations of extracytoplasmic Mg2+ [76][102]. Moreover, proteins regulated 
indirectly and directly by PhoPQ, such as OmpT, EptB, CrcA and SigmaS, reveal a 
secondary role of PhoPQ, distinct from (and yet related) to its ability to modulate 
divalent cation, which places it as a regulatory interlinkage between OM 
modification and stabilisation and the general stress response. SigmaE is a key 
regulator of extracytoplasmic stress, and the majority of sigmaE-regulated genes 
function to regulate and respond to OM damage. Furthermore, sigmaE regulates 
PhoP post-transcriptionally via the sRNA MicA. The primary hypothesis of this work 
is that PhoPQ is required for full sigmaE induction, under Mg2+ limited conditions, 
which would solidify its position as a key regulator of stress.  
In the initial stages of this project, it was found that phoP was associated with a 
transduction defect. With rĞŐĂƌĚƚŽWŚŽW ?ƐŵŽƐƚǁĞůůƐƚƵĚŝĞĚƌŽůĞŝŶĐĞůůƵůĂƌ
metabolism, responding to Mg2+ starvation, it was initially hypothesised that this 
defect was the result of cytoplasmic Mg2+ starvation. However, it was 
demonstrated that no transduction defect was linked to mgtA, the PhoP-regulated 
divalent ion transporter. A body of evidence was presented that suggested that 
phoP mutants suffer from extracytoplasmic stress, which is the probable cause of 
the inviability of phoP transductants, this led to the observation that PhoP 
ƉŽƐŝƚŝǀĞůǇƌĞŐƵůĂƚĞƐƐŝŐŵĂĂĐƚŝǀŝƚǇŝŶĚĞƉĞŶĚĞŶƚůǇŽĨƚŚĞƐŝŐŵĂ ?ƐĐŚŝĞĨƌĞŐƵůĂƚŽƌ
RseA.  
The proposed mechanism by which PhoP regulates sigmaE is complex, and multi-
factorial (Figure 6.1), but evidence suggests a dual role in which PhoP has a negative 
effect on sigmaE protein concentration but promotes sigmaE activity. Moreover, 
evidence was presented to support the hypothesis of both indirect and direct 
regulatory effects. Although the precise mechanism by which PhoP regulates 
sigmaE could not be  identified completely with confidence, the data present a 
number of possibilities.  
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The data suggest that PhoP positively regulates sigmaE via at least two different 
mechanisms. It was shown that sigmaS, a known regulator of rpoE expression[229], 
enhances sigmaE activity in the absence of rseA. Furthermore, it remains a 
possibility that it is via sigmaS that PhoP exerts rseA-independent control over 
sigmaE activity; however, because rpoS is not associated with a transduction defect, 
it is probable that PhoP exploits an alternative mechanism by which to promote 
sigmaE activity. 
 An in silico analysis revealed that a possible PhoP box exists inside rpoEP5. Support 
for the notion that this is a mechanism of positive regulation was provided by data 
demonstrating that sigmaE activity falls dramatically in both phoP and phoP,rseA 
mutants, thereby suggesting transcriptional regulation. However, it is possible that 
RseA-sigmaE proteolysis is dependent on PhoP, and, if true, PhoP may negativity 
effect rpoE expression. Regardless of the mechanism this work has shown that PhoP 

















Figure 6.1, showing a proposed model in which PhoP regulates sigmaE. Red arrows represent 
negative regulatory relationships, green represent positive regulatory relationships.  Solid 
arrows represent regulatory relationships from published literature, while dashed arrows 
represent regulatory relationships proposed by this work. Grey ovals represent proteins or 
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6.2 phoP is necessary for successful P1vir transduction 
under standard conditions  
 
It was demonstrated that phoP cannot be transduced efficiently or with confidence 
under standard conditions using P1vir transduction. This was surprising as no such 
incapacity had been reported previously. The transduction defect was found to be 
non-specific to the K-12 wildtype used, with both MG1655 and W3110 being 
susceptible. Neither was this defect confined to either of the two donor strain used 
to create the phoP lysate, suggesting it not affected by the method of creating the 
phoP deletion. In addition, the complementation of phoP, placing an ectopic copy of 
phoP under the control of the lacUV5-promoter, provided confidence that 
transduction of the native phoP gene could only be achieved when the ectopic 
allele was being expressed. 
The most pertinent question to ask is why has no phoP transduction defect been 
reported? It is possible, as stated previously, that transduction is seldom the tool of 
choice for creating mutants when other, more modern, methods are available. 
Another reason for this may be that many phoP mutants are not created but 
obtained from other laboratories, and several highly cited papers have used the 
same phoP mutants (Appendix Table E.1). Although this is not unusual, it does 
preclude the possibility of encountering the phoP transduction defect and may be 
one reason why the defect is not widely reported. Nevertheless phoP transductants 
are cited in the published literature (Appendix Table E.1). This work, however, does 
not argue the impossibility of creating phoP mutants, as it has been observed that 
they have been created under a variety of conditions; instead, this work argues that 
they cannot be made without acquiring additional suppressor mutations under 
standard conditions. 
  The existence of phoP mutants created via P1vir transduction, cited in the 
literature, suggests a number of possibilities: 
I) The phoP transduction defect, as defined by this work, is specious. 
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II) phoP mutants reported in the published literature were not constructed 
under standard conditions.  
III) phoP mutants reported in the published literature contain suppressor 
mutations  
The first hypothesis outlined above can be dismissed with some confidence, 
because although there are a number of factors that could lead to the fallacious 
characterisation of a transduction defect, several observations and assays 
conducted in this work make this possibility unlikely.  
In nature, there are many bacteria that are able to resist infection by 
bacteriophage.  Bacteriophages can be blocked from absorption into the cell, by 
modifying the host-cell receptor or by utilising a competitive inhibitor[244]. For 
example, E. coli can synthesise a lipoprotein, Llp, which block the T5 phage 
receptor, FhuA[244]. Moreover, molecules that are present or added to the host-
cell environment can also be used to inhibit bacteriophage entry; for example, the 
antibacterial peptide microcin J25 can also be used to block FhuA and subsequent 
bacteriophage entry[244]. Further, some genes have a naturally low frequency of 
transduction, due to their locus. Some DNA sequences are poor substrates for 
recombination, and this can cause the frequency of gene transduction to be 
reduced up to 25-fold[245]. 
Two K-12 wildtype, MG1655 and W3310 were used as recipient strains for the 
transduction of a number mutations, including phoQ, so it is unlikely that they were 
both defective. Similarly, it is unlikely that the strain of P1 used herein was 
defective, because it was employed extensively in the creation of many strains in 
this work. Furthermore, it is unlikely that phoP has a naturally low transduction 
frequency, because phoP transductants were obtained in strains with a number of 
different genetic backgrounds. However, the observation that the transduction 
defect can be suppressed by sigmaE induction suggests that loss of phoP is the 
cause of rather than a defect in recipient, donor or viral vector. 
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Strain name  Origin of strain  recipient 
strain  
recipient strain genotype  
EG12976 
phoP::KanR 
Dissecting the PhoP 
regulatory network of 
Escherichia coli and 
Salmonella enterica[96] 





of the Mg2+ Stimulon of 
Escherichia coli[42] 
W3110 F- ʄ- rph-1 INV(rrnD, rrnE) 
MG1446 
phoP::KanR 
MicA sRNA links the PhoP 
regulon to cell envelope 
stress[112] 




of the PhoP-PhoQ Two-
Component System in 




MC4100 &ALȴ ?ĂƌŐ&-lac)U169 araD139 rpsL150 
ptsF25 fibB5301 rbsR deoC relA1 
FS1000 
phoP::KanR 
Molecular Genetic Analysis 
of the Escherichia coli phoP 
Locus[102] 
MC1061 F- araD139 Del(araA-leu)7697 
Del(lac)X74 galK16 galE15(GalS) 
lambda- e14- mcrA0 relA1 
rpsL150(strR) spoT1 mcrB1 hsdR2 
FS1002 
phoP::KanR 
Molecular Genetic Analysis 
of the Escherichia coli phoP 
Locus[102] 
MC4100 F- araDJ39 A(lac)U169 rpsL150 relAl 





between Salmonella and 
Escherichia coli resulting 
from the disparate 






between Salmonella and 
Escherichia coli resulting 
from the disparate 






differential regulation in 
the Escherichia coli PhoQ W
PhoP system[246] 






of drug efflux genes by 
EvgAS, a two-component 
system in Escherichia 
coli[247] 
KMY1 FAL ȴ ?argF-lac)U169 araD139 rpsL150 






of drug efflux genes by 
EvgAS, a two-component 
system in Escherichia 
coli[247] 
KMY2001 FAL ȴ ?argF-lac)U169 araD139 rpsL150 




Table 6.1. phoP transductants generated in published articles, including the recipient strain. Strain 
name and genome transcribed from the papers in which they were originally cited.  
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To investigate the validity of phoP mutants created by other groups, a 
comprehensive search was undertaken of 20 of the most highly cited papers 
reporting the creation of phoP mutants (Appendix Table E.1), and of these, a total 
of 28 phoP mutants were cited. Of these 28, 18 were created via P1vir transduction. 
However, only 11 of them were originally generated in the study in which they were 
cited (Table 6.1). 
Nine out of eleven phoP transductants were transduced into derivative strains 
containing mutations (Table 6.1), which is especially important because in this work 
it was shown that phoP transductants can be created if the recipient strain has 
adapted accordingly (Chapter 4), and sigmaE induced either chemically or via 
mutations that cause extracytoplasmic stress. However, there are no obvious 
mutations within the recipient strains that would increase sigmaE activity and allow 
for the transduction of phoP.  
Alternatively, it is possible that the phoP transductants citied in the published 
literature were not created under standard conditions. When searching for 
examples of phoP transductants in the published literature, the transduction 
methodology was seldom referenced, with only a minority of articles directly 
referencing the original procedure (Miller 1972)[183]. This may suggest a 
procedural drift between laboratories; indeed, subtle changes in procedures can be 
seen when looking at P1vir transduction protocols from different sources. For 
example, the procedure published by the Roa Research Group uses 10mM CaCl2 
and 5mM MgSO4[248] to enhance bacteriophage infectivity, while a procedure 
published by Kranz Lab suggests using 5mM CaCl2 and 100mM MgSO4[249] and yet 
another source suggests using 50mM CaCl2 only[250]. Although these differences 
are minor, it was shown in this work that the addition of transduction reagents, 
presumably CaCl2 and MgSO4, had a statistically significantly impact on the 
survivability of phoP mutants (Chapter 4). Therefore, it is convincible that small 
changes in the published methodology that may go unreported will influence the 
ability to create phoP mutants.  
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However, without data pertaining to the precise conditions under which phoP 
transductants, citied in the published literature, were constructed, it is difficult to 
expound upon their creation. Correspondingly, the hypothesis that phoP 
transductants cited in the literature contain suppressor mutations cannot be 
confirmed or rejected without the genomic data of these strains.  
Finally, it is difficult to reconcile the observations of this work with the fact that 
phoP transductants have been generated in the past by many different groups. 
Nonetheless, the idea that transduction is not the favoured method of creating 
phoP mutants, coupled with the variations in procedures cited above, provided a 
possible means by which the phoP transduction defect may have gone unreported 
until this point.   
6.3 The mechanism of the phoP transduction defect 
 
PhoPQ helps mitigate Mg2+ starvation by positively regulating the expression of 
mgtA. Because P1vir transduction requires Mg2+ chelation it was initially thought 
that the phoP transduction defect was due to cytoplasmic Mg2+ starvation. It was 
hypothesised that mgtA mutants would be epistatic with phoP, exhibiting the same 
transduction defect as phoP. However it was found that mgtA could be transduced 
normally under standard conditions, which suggests that cytoplasmic Mg2+ 
starvation is unlikely to be the cause of the phoP transduction defect. Despite this 
finding, phoP mutants were found to be hypersensitive to citrate (4.2.1 & 4.2.2).  
Moreover, it has been shown that the transduction defect can be mitigated by 
sigmaE induction (4.4.1 & 4.4.2). Together these data suggests that the phoP 
transduction defect could be caused by extracytoplasmic Mg2+ starvation which 
leads to OM disruption and consequently inviability.  
SigmaE is an essential protein in E. coli[134]. SigmaE inhibition or inactivation will 
ůĞĂĚƚŽĐĞůůůǇƐŝƐĂŶĚKDĚĞĨŽƌŵĂƚŝŽŶƐƵĐŚĂƐ ‘ďůĞďďŝŶŐ ? ?ŝ ?Ğ ?ůĂƌŐĞďƵůŐĞƐŝŶƚŚĞĐĞůů
envelope containing cytoplasmic materials[138]. Considering that sigmaE activity is 
reduced in the phoP mutant, sigmaE activity deficiency is an appealing explanation 
for the transduction defect. However, extremely low SigmaE activity levels, as seen 
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in an rseA,rpoS mutant, lead to neither death nor a transduction defect (chapter 
5.6). This suggests that low sigmaE activity alone is insufficient to explain the 
transduction defect. It is likely that phoP mutants are uniquely sensitive to 
conditions of transduction, particularly chelation and permeabilisation of the OM, 
due to PhoP mediated LPS modification [194], [251]. This sensitivity, presumably, 
results in a transduction defect when sigmaE cannot be appropriately induced to 
respond to the damage.  
Negatively charged phosphate and carboxylate groups attached to glucosamines of 
lipid A, and the Kdo residue found in the inner core, are important for OM 
stability[36]. These negative charges are bound by divalent cations and allow LPS 
molecules to form tight cross-links[224]. Removing divalent cations can cause large 
disruptions in the LPS and the permeabilisation of the OM[207]. However, under 
the divalent cation-limited conditions of transduction, excessive negative charges 
on the LPS would presumably cause increased electrostatic repulsion between the 
molecules and greater OM instability. Furthermore, it has been found that 
treatment with EDTA can result in LPS shedding and the formation of large holes in 
the inner and outer leaflets of the OM[207]. It has been identified that the effects 
of EDTA on the OM can be abated by adding divalent cations in a concentration-
dependent manner[252]. Presumably, then, increased LPS shedding would be 
observed if the electrostatic repulsion between LPS molecules were to increase by 
removing divalent cations and increasing the negative charges associated with the 
LPS. 
 Yet, permeabilisers, namely compounds that disrupt the LPS and OM, are not 
known to be bactericidal in the concentrations used in transduction[207]. Further, it 
is true that cells are often exposed to citrate and other divalent metal ion chelators 
and remain viable. Moreover, it has also been shown in this work that an eptB 
mutant is not able to suppress the phoP transduction defect, nor is there a 
transduction defect associated with mgrR, eptB ?ƐŶĞŐĂƚŝǀĞƌĞŐƵůĂƚŽƌ ?This suggests 
that LPS electrostatic repulsion caused by unregulated  EptB, alone, is not sufficient 
to cause the transduction defect. However, it seems probable that in a phoP 
mutant, in which, EptB is not inhibited by MgrR, increased LPS shedding and OM 
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permeabilisation would be observed. Many OMPs rely on LPS for insertion and 
trimersation, LPS disruption will cause the accumulation of unfolded OMP and OMP 
intermediates[166]. Therefore it is unsurprising that the cell will respond to LPS 
shedding by inducing sigmaE. This will mitigate the effect of misfolded OMPs and 
increased LPS synthesis[252].   
 SigmaE regulates approximately 90 genes[166], which can be divided into core and 
extended regulons. The core regulon consists of 23 proteins, 20 of which have 
known functions, and the majority of these genes contribute to the synthesis and 
correct assembly of LPS and OMPs[166]. lpxABD, plsB and bacA are core sigmaE 
regulon genes that contribute to LPS synthesis and assembly[166]. So, while it 
would be expected that under normal conditions the cell is able to respond to the 
effect of LPS shedding and OM disruption by increasing sigmaE activity, this is not 
possible in a phoP mutant and it is likely that this is what causes the inability to 
transduce phoP under standard conditions.  
The hypothesis, that a disruption of LPS assembly and synthesis causes phoP 
transduction defect is supported by the observation that phoP mutants can be 
cultivated at low temperatures. Both sigmaE activity and LPS synthesis is increases 
at lower temperatures[219]. Moreover, as the temperature drops the cell 
membrane will go through a process of homeoviscous adaption in which membrane 
composition and fluidity are altered in response to the environment[253]. 
Phosphatidylethanolamine constitutes the largest proportion of phospholipid in the 
OM, followed by phosphatidylglycerol and diphosphatidylglycerol[253]. The ratio of 
these phospholipid changes in response to lower temperatures, increasing the 
concentration of unsaturated fatty acid found in phospholipids, which in turn 
increases membrane fluidity[253]. The concentration of unsaturated fatty acid can 
affect the synthesis of LPS[254]. LpxK is an integral membrane protein and 
necessary for the synthesis of lipid A[254], and lower membrane fluidity can 
increase its activity[254].  
Another hypothesis, which could not be rejected by this work, is that phoP mutants 
may be sensitive to kanamycin. Both chloramphenicol and kanamycin interfere with 
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protein synthesis; however, while chloramphenicol inhibits protein synthesis by 
inhibiting the action of peptidyl transferase[255], kanamycin interacts directly with 
30s ribosome, causing an increase in mistranslated proteins[256]. It is possible that 
the diminished sigmaE activity found in phoP mutants causes the cell additional 
stress, as the cell is not able to respond to the increased concentration of 
mistranslated OMPs, thereby providing a cogent hypothesis for the hyposensitivity 
of phoP mutants to kanamycin. The creation of a phoP:CamR mutant, via lambda 
red, may support this hypothesis.  
6.4 The Absence of a phoQ transduction defect 
 
 If the phoP transduction defect, as presented by this work, is genuine there can be 
two hypotheses to explain the lack of a phoQ transduction:  
i) There is a non-apparent transduction defect associated with phoQ  
ii) PhoP is active in the absence of phoQ  
The observations of this work suggest that phoQ can be transduced normally under 
standard conditions (3.2). So, the former hypothesis can be dismissed with some 
confidence. Conversely, the literature supports a model in which phoP is active in 
its unphosphorylated state or that it can be activated by alternative non-cognate 
sensor kinase. Therefore, the latter hypothesis is anticipated by this work to be the 
most likely.  
Several studies have shown that PhoP activity is independent of PhoQ, in S. 
enterica[189], [257]. Lejona et al. demonstrated that unphosphorylated PhoP could 
activate various targets in a concentration-dependent manner[257]. It is possible 
that this is also true for E. coli, but there is nothing in the published literature to 
support this assertion, aside from the similarity of the PhoP protein in both 
organisms.  
Alternatively, it is possible that PhoP is phosphorylated by a non-cognate sensor 
kinase. Yamamoto et al. investigated incidence of the trans-phosphorylation for the 
majority of response regulators in E. coli, and evidence was found that PhoP could 
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be activated by a non-cognate sensor kinase[190]. The authors asserted that PhoP 
enhances the dephosphorylate of non-cognate sensor kinase EnvZ, which is 
important, because it may suggest that EnvZ has the ability to phosphorylate and 
activate PhoP in vivo. Finally, many papers have characterised the cross regulation 
of PhoPQ and EvgSA targets[98], [190]. Although there is no substantial evidence 
that EvgS can phosphorylate PhoP, the high correlation coefficient of their 
expression profiles might suggest this is possible. 
6.5 Postulations on the mechanism by which PhoP 
regulates sigmaE 
 
The observation was made that all phoP mutants, when assayed, exhibited a drop 
in sigmaE activity compared to the wildtype(CAG45114). Although this was initially 
thought to be a result of the accumulation of secondary suppressor mutations, the 
observation was confirmed by assaying several other backgrounds  (mgrB, lacUV5-
phoP), which would presumably be suppressor-free. These data assert that PhoP is 
a key promoter of sigmaE activity. This regulatory relationship is logical when 
considering the role Mg2+ has in stabilising the OM, divalent cation starvation would 
be an advantageous signal to be integrated into the sigmaE expression network.  
Conversely, it was also found in this work that PhoP causes a decrease in total 
sigmaE protein concentration. Although surprising, this observation supports the 
assertion that PhoP is a positive regulator of sigmaE activity. While it is known that 
sigmaE inhibition causes cell lysis[192], it has been shown that excessive sigmaE 
activity can also be detrimental to the viability of the cell and that sigmaE induction 
must be appropriately modulated[57], [258]. Ades et al. suggest that this is because 
many sigmaE-regulated genes require translocation through the periplasm, and the 
increased expression of these genes may oversaturate and overwhelm the 
periplasmic chaperones, thereby leading to improperly folded OMP, which in turn 
increases sigmaE induction, forming a positive feedback loop[213]. Therefore, if 
PhoP is a key inducer of sigmaE activity, then a mechanism to constrain the hyper-
induction of sigmaE would be expected.  
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A clear and unambiguous method by which PhoP regulates sigmaE was not 
explicated experimentally by this work, but assertions can be made from both the 
published literature and observations made herein. The discovery of three potential 
PhoP box consensus sequences in the rpoE promoter region offers a potential 
mechanism through which PhoP could positively regulate sigmaE, acting as 
transcriptional activator for rpoE.  However, the observation that PhoP causes a 
decrease in total sigmaE protein concentration remains unexplained. An alternative 
hypothesis is that PhoP is a direct transcriptional repressor of rpoE expression and 
increases sigmaE activity indirectly. One way in which PhoP indirectly increases 
sigmaE activity is via sigmaS[229]. Recently, it was found that sigmaS has a positive 
effect on rpoE expression[229], which was supported by observations in section 5.6.  
However, if sigmaS was the only mechanism by which PhoP regulated sigmaE, then 
it would be expected that there would be a transduction defect associated with 
rpoS and none was observed. Therefore, it is likely that there is at least one other 
mechanism by which PhoP positively regulates sigmaE activity. It is posited by this 
work that PhoP increases the rate of sigmaE-RseA proteolysis by increasing the rate 
of LPS synthesis and concentration of LPS precursor molecules, which it has been 
suggested enhances sigmaE activity[259]. 
SigmaE-RseA proteolysis is a multi-step event involving several enzymes. Misfolded 
outer membrane proteins activate DegS[259], which cleaves the periplasmic 
domain of RseA. The cytoplasmic domain of RseA is cleaved by RseP, and then the 
free RseA-sigmaE complex is finally degraded by ClpXP, to release free sigmaE[259].  
The action of DegS can be inhibited by RseB[259], which binds to the periplasmic 
domain of RseA[260]. BO et al. identified that RseB can bind LPS, or LPS derivatives 
such as lipid A or Kdo2-lipid A, causing the subsequent displacement of RseB from 
RseA[260]. Further, they concluded that RseB-LPS binding only requires the 
phosphorylated N-acetylglucosamine (GlcNAC) disaccharide and N-linked acyl 
chains of the lipid-A moiety[260].  
LPS synthesis is a complex process that takes place in the periplasm and the 
cytoplasm and involves more than 20 enzymatic reactions[37]. However, the 
starting molecule for the LPS  precursor lipid A is UDP-N-acetylglucosamine, which 
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is important for other cell processes such as peptidoglycan synthesis[37]. The 
synthesis and catabolism of UDP-N-acetylglucosamine involves several pathways 
and many different enzymes. UDP-N-acetylglucosamine can be synthesised from 
several precursors such as glucosamine (GlcN),GlcNac or lactose[37]. The glm 
operon regulates the synthesis of UDP-N-acetylglucosamine from fructose-6-P, 
while the nag operon regulates the transport and catabolism of GlcNAc[29]. NagA 
(GlcNac-6-P deacetylase), negatively regulated by PhoP, converts GlcNAc-6-P to 
GlcN-6-P.  
In a phoP mutant, there would presumably be increased concentrations of LPS 
precursors available, which would allow for the increased synthesis of LPS. 
Therefore, it is possible that PhoPQ may indirectly regulate sigmaE by regulating the 
availability of LPS or LPS precursors such as UDP-N-acetylglucosamine, by negatively 
regulating NagA and increasing the available concentration of GlcNac-6-P available 
for LPS synthesis, which causes inhibition of RseB and an increased rate of DegS 
























Figure 6.2. Showing a proposed model in which PhoP regulates sigmaE. Red arrows 
represent negative regulatory relationships, green represent positive regulatory 
relationships.  Solid arrows represent regulatory relationships from the published 
literature, while the dashed arrow represent a regulatory relationship proposed by 
this work. The PhoP box, posited by this work to exist in the rpoE promoter region 
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6.6 Final model   
 
This work has aimed to demonstrate the existence of, and then explain, a 
transduction defect associated with phoP. Characterisation of this defect has shown 
that it can be suppressed by the genetic (4.5), chemical (5.6) or environmental (4.4) 
induction of sigmaE, through adaption, ostensibly mediated via stress-induced 
mutation (4.3) and presumably by increasing the availability of divalent metal ions 
during transduction (4.2).  
The most likely explanation for the primary observation of this work, i.e. that it is 
not possible to transduce phoP under the standard conditions used for P1vir 
transduction[153], is that PhoP is a primary activator of sigmaE and is indeed 
necessary for the full induction of sigmaE. However, it is clear that, unlike rpoE, 
phoP is not an essential gene. This suggests that the loss of phoP does not cause 
sigmaE activity to drop to a point at which the cell becomes inviable under 
optimum conditions. It is expected that the unique stresses of transduction, 
divalent metal ion chelation and treatment with SDS, cause levels of sigmaE activity 
in phoP mutants to become insufficient for the continued survival of the cell.   
The method by which PhoP regulates sigmaE is complex and multifactorial. Recent 
work has highlighted new details of the transcriptional regulation of rpoE, such as 
the effect of sigmaS[229], providing one mechanism through which PhoP regulates 
sigmaE activity. Moreover, the discovery of a potential PhoP binding site, located 
inside rpoEP5, provides another convincing mechanism through which PhoP may 
regulate rpoE expression directly and causes a drop in the total sigmaE protein 
concentration. Finally, it is posited by this work, that there exists another 
mechanism by which PhoP positively regulates sigmaE activity, by increasing the 
availability of LPS precursor molecules thereby enhancing sigmaE-RseA proteolysis 


































































































Figure 6.3. Proposed model in which PhoP regulates sigmaE and the effect on the 
OM. Red arrows represent negative regulatory relationships, and green represent 
positive regulatory relationships. Solid arrows represent regulatory relationships 
from the published literature, while dashed arrows represent regulatory 
relationships proposed by this work. Grey ovals represent proteins or mature 
sRNAs. The rpoE gene, along with promoter 4 (P4) and promoter 5 (P5), is depicted 
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6.7 Future work 
 
Although many experiments were carried out in this work, in an attempt to better 
understand the transduction defect associated with phoP and the underlying 
mechanism, there were still many more that were not done, due to either time 
constraints or resources. The assays detailed below aim to reinforce the validity of 
observations already made and perhaps reveal new avenues of study.  
 6.7.1 Characterising phoP mutants from the published 
literature  
 
Various phoP mutants in the literature have been made via transduction (Appendix 
Table E.1). The primary thesis of this work is that no, suppressor free, phoP mutant 
can be created via transduction under normal conditions, and so testing the validity 
of phoP mutants created via transduction and procedures used from the published 
literature would be a primary aim of any future work. It would be hypothesised that 
any phoP mutants created via transduction would contain secondary suppressor 
mutations, or the recipient strain would have been prepared in such a way as to 
make transduction possible; for example, strains were physiologically adapted to 
accomplish the transduction of phoP in this work through exposure to procaine and 
transduction at 28°C.  
Initially, several phoP mutants and their original parent strains would be sequenced 
(Table 6.1), and it would be expected that the parent strain or the phoP mutant 
would contain additional suppressor mutations. If this was not so, then it might 
suggest that either the recipient strains were predated or that some aspect of the 
precise procedure used allowed for the creation of a phoP mutant. Consequently, it 
would be advantages to attempt to recreate the phoP mutants by using the 
recipient and donor strains specified in the published literature. If any 
transductants could be created, then they would be sequenced to confirm that they 
lack any additional suppressor mutations. If no suppressor mutations could be 
found, it would suggest that creating phoP mutants is possible but something about 
the strains or the procedure used in this work prevented it.  
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This idea could be explored further by transducing different combinations of donor 
and recipient strains from the published literature and the Blomfield laboratory 
stock. This would allow for isolating the defective strain and permit the further 
characterisation of the transduction defect as either a pervasive defect effecting 
the creation of phoP mutants or the result of a genetic artefact in the laboratory 
strains.  
6.7.2 Exploring the Absence of a phoQ transduction 
defect 
 
The literature suggests that the most likely explanation as to why there is no 
transduction defect associated with phoQ is because PhoP is active in the absence 
of phoQ. It has been suggested previously in this chapter that the sensor kinases 
EnvZ or EvgS may have the ability to trans-phosphorylate PhoP. To test if either one 
of these response regulators has the ability to phosphorylate PhoP, both evgS and 
envZ could be transduced in phoQ mutants under standard conditions. If the 
transductions were possible, then it would rule out the most likely candidates for 
non-cognate trans-phosphorylation of PhoP and suggest that PhoP is not being 
activated by an alternative sensor kinase.  
Second, it would be advantageous to test if PhoP is active in its unphosphorylated 
state, in E. coli. Lejona et al. definitely showed that PhoP is able to activate its target 
genes in a concentration-dependent manner, independently of phosphorylation by 
PhoQ in S. enterica[257]. The procedure that was used could be replicated in E. coli, 
wherein expression of PhoP targets was measured in a strain which PhoP had been 
modified to prevent phosphorylation. 
Finally, testing for a non-apparent phoQ transduction defect could be done in a 
number of ways. It would be expected that a phoQ transduction defect would be 
associated with suppressor mutations, as observed in phoP mutants, so the assay in 
which phoP was transduced into the rpoHP3-lacZ reporter fusion could be repeated 
for phoQ. If the expression of rpoHP3 was heterogenous, then this would indicate 
the presence of suppressor mutations. However, a far more definitive way to test 
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for suppressor mutations would be simply to sequence a number of phoQ mutants 
made via transduction.  
6.7.3 Further tests required to characterise the phoP 
transduction defect 
  
The most expedient way to characterise the transduction defect would be to 
sequence a number of phoP mutants. Whole-genome sequencing would be carried 
out on a number of phoP transductants, and it would be hypothesised that a 
number of secondary mutations would be in systems that either increase sigmaE 
activity, through increased expression or induction or mutations that relive 
envelope stress, perhaps by modifying the LPS in such a way as to decrease 
electrostatic repulsion. Categorising these mutants and the systems they affect may 
help to elucidate the mechanism underlining the phoP transduction defect.  
Moreover, sequencing could also be used to confirm the hypothesis that phoP 
mutants have secondary mutations because they undergo transduction  W this 
seems a probable assertion, but it is possible that phoP mutants are generally more 
likely to undergo mutation, perhaps because of an impaired ability to respond to 
DNA damage. Indeed, the phoP-regulated HemL has been implicated in playing a 
role in SOS DNA damage response, which has been linked to mutational rate, the 
frequency at which new mutations arise[261]. To confirm the hypothesis that 
transduction causes phoP mutants to accumulate suppresser mutations, several 
phoP mutants created via lambda red could be subjected to whole-genome 
sequencing. These data could then be compared to those of the mutants that have 
been created via transduction. Mutations in different systems or at different rates 
would suggest that transduction is the cause of suppresser mutation accumulation 
rather than simply the loss of phoP.  
W ? ?ƐĐŽŶƚƌŝďƵƚŝŽŶƚŽƚŚĞƚƌĂŶƐĚƵĐƚŝŽŶĚĞĨĞĐƚĐŽƵůĚ be explored in greater detail. 
One possible cause of the transduction defect may have been a low titre of P1 in 
the lysates used. Although three different preparations of lysates were used when 
validating the initial observation (3.2) it is possible that a low titre of P1 resulted 
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from the particular method used to create the phoP P1 lysate. This seems unlikely, 
though, there were no transduction defects noted when the P1 lysates were 
prepared from other donor strains using the same strain of P1, albeit it does remain 
a possibility. Lysate concentration could be discerned by doing a plague assay, using 
phoP P1 lysate and E. coli. If the concentration of P1 was particularly low, this could 
be a cogent explanation for the observed transduction defect.  
Further, it would also be advantageous to assess phoP ŵƵƚĂŶƚƐ ?ƐĞŶƐŝƚŝǀŝƚǇƚŽW ?
killing. Although P1 killing seemed unlikely to be the cause of the phoP transduction 
defect, it was not definitely dismissed. A simply assay using varying concentrations 
of P1 could be done to compare survival rates between the wildtype and phoP 
mutants created via both transduction and lambda red. It would be expected that 
phoP mutants would not be more sensitive to P1 killing than the wildtype, although 
because phoP mutants are expected to suffer from OM disruption, it is a possibility. 
If sensitivity to P1 was the cause of or at least a contributor to the phoP 
transduction defect, it would suggest that phoP mutants that contain additional 
suppressor mutations gained immunity to P1, as phoP mutants that had undergone 
P1 transduction could be transduced normally. If this were true, then it would be 
interesting to examine the LPS, P1 absorption receptor to look for any structural 
anomalies.  
6.7.4 Further characterising the relationship between 
PhoP and sigmaE 
 
The observation that PhoP induction caused a fall in sigmaE protein concentration 
was unexpected, so in any future work, importance should be placed on replicating 
this data along with a particular emphasis on clarity and quantifiability. A protein 
loading control, for example the constitutively expressed 60kDa chaperonin 
GroEL[262], could be used to increase confidence and reproducibility in subsequent 
experiments. Moreover, to increase confidence in this observation, several other 
assays could be done to quantify the sigmaE protein concentration in cells in which 
phoP expression is induced. Several variations of the original western blot could be 
done. In the original Western blot procedure, a polyclonal antibody was used, but 
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although inexpensive, using this method has the disadvantage of detecting multiple 
epitopes, due to a high chance of cross-reactivity. The lack of clarity was a weakness 
of the original assay, but this could be improved by using a sigmaE monoclonal 
antibody, which would be highly specific to the sigmaE epitope and therefore much 
easier to use for the quantification of protein levels. Alternatively, a recombinant 
histidine-tagged, a poly-histidine tail, sigmaE protein could be designed and used to 
perform another Western blot, with the aim of identifying his-tagged proteins. 
These proteins could also be easily purified and quantified by either measuring 
absorbance, via a BCA or Branford assay, or performing an immunoassay, such as 
ELISA.    
Throughout this work, evidence has been put forward to support the hypothesis 
that PhoP regulates sigmaE. Specifically, observations were made that suggest a 
model in which PhoP has a negative effect on sigmaE concentration but a 
stimulatory effect on activity. It was hypothesised that this was due to two different 
mechanisms of regulation, namely direct and indirect, so it would be valuable to 
explore these hypothesised mechanism of regulation further.  
To examine the hypothesised direct effect of PhoP on rpoE expression, several 
assays could be completed, one of which is a gel shift, electrophoretic mobility 
assay, used commonly to detect TF-DNA binding based on the principle that 
typically the electrophoretic mobility of a TF-DNA complex is less than the 
corresponding unbound DNA. If no binding occurs, a single band will be seen that is 
expected to migrate through the gel at the same speed to a DNA alone control. TF-
DNA interaction would normally be indicated by a slower migration through the gel 
compared to DNA alone. This is visualised as either one or two bands, namely one 
band nearer the cathode signifying a DNA-TF complex, and possibly a second band 
nearer the anode representing excess unbound DNA. Alternatively, a promoter 
analysis could be done. Promoter analyses require incorporating a gene of interest, 
along with upstream regulatory sites, into a plasmid containing a reporter, such as a 
green fluorescent protein or luciferase, which is then transformed into the cell. If 
the gene of interest is regulated by a TF, the expression of the reporter will be 
dependent on the activity of the TF. Point mutations can be introduced into the 
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suspected TF binding site, affecting the TF-DNA binding, and in this way the binding 
site and crucial nucleotides can be interpreted. Either of these assays could 
demonstrate PhoP binding the rpoE promoter region, thus indicating a direct 
regulatory relationship. 
It has been proposed that PhoP regulates sigmaE via direct transcriptional control 
and RseA-sigmaE proteolysis. The regulation of sigmaE via proteolysis has been 
hypothesised to be mediated via RseB, specifically its ability to bind LPS. If this is 
correct, then RseB may share a transduction defect; hoǁĞǀĞƌ ?WŚŽW ?ƐĞĨĨĞĐƚŽŶ
sigmaE has not been postulated to be entirely dependent on RseB, so measuring 
sigmaE activity in an rseB mutant would not provide sufficient evidence to support 
this hypothesis. However, PhoP regulation of sigmaE proteolysis, mediated via RseB 
is asserted to be dependent on the available concentration of lipid A precursors, 
specifically GlcN-6-P. Therefore, this hypothesis could be tested by creating an 
inducible nagA construct. Increasing the endogenous concentration of GlcN-6-P by 
controlling the expression of nagA and monitoring the effect of sigmaE activity 
would show that this is a valid mechanism through which PhoP may regulate 
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Appendix  A 
 
 ? ? ?dŽ ĂƐƐĞƐƐƚŚĞƐƵĐĐĞƐƐŽĨĂllelic exchange between gshA,phoPȴlacɏsacB-KanR 
and pA001, two PCR assays were performed. The aim of the first assay was to 
amplify a phoP gene fragment using the same internal primers employed to create 
the original fragment used to create pA001 ( Figure A.1A). This showed that the 
isolates contained a phoP allele. Although successful, this assay could not be used 
to differentiate between the wildtype and the ectopic phoP gene. A second PCR 
assay (data not shown) was done, using external primers (Figure A.1B), the aim of 
which was to amplify a gene fragment with primers that annealed to regions 
flanking the phoP open reading frames, 94Bp and 57Bp, up- and downstream of the 
ATG start codon and the TGA stop codon, respectively. However, the PCR assay 
failed to yield any results, which suggests that isolates contained the ectopic copy 
























Figure A.1A. Gel electrophoresis. 1% agarose gel. Multiplex PCR assay performed on 
lacUV5-phoP, phoP isolates (section 3.2.1). Showing phoP fragment generated 687BP 
from internal primers in the first, third sixth and seventh lanes, while lanes two, four and 
five represent unsuccessful constructs. The legend represents the molecular ladder 
ranging from 250Bp to 2500Bp. 
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PhoP internal primer forward (Vector_phop- forward ) 
  
PhoP internal primer reverse (Insert_phop2- reverse) 
   
PhoP external primer forward (phop-forward) 
 
PhoP external primer reverse (phoP-reverse) 
Figure A.1B. Showing the phoP gene sequence and position of the internal (purple) and 
external (green) primers used in an attempt to amplify the ectopic lacUV5-phoP construct 
generated in section 3.2. The green highlighting indicates the transcription start site. The blue 
highlighting indicates the Shine-Dalgarno sequence[112]. The red highlighting indicates the 
start codon. The grey highlighting indicates an area upstream of the ATG start codon and 
downstream of the TGA stop codon. 
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A.2 Two PCR assays were done on the isolates generated in section 3.2.3.The aim of 
the first example was to amplify the wildtype phoP gene (using the ƉƌŝŵĞƌƐƉŚŽW-
ĨŽƌǁĂƌĚĂŶĚƉŚŽW-ƌĞǀĞƌƐĞ ?ĚĂƚĂŶŽƚƐŚŽǁŶ ) ?ŚŽǁĞǀĞƌ ?ŶŽĂŵƉůŝĐŽŶǁĂƐĚĞƚĞĐƚĞĚďǇ
ŐĞůĞůĞĐƚƌŽƉŚŽƌĞƐŝƐ ?ǁŚŝĐŚƐƵŐŐĞƐƚĞĚƚŚĂƚƚŚĞǁŝůĚƚǇƉĞƉŚŽWŐĞŶĞǁĂƐŶŽƚƉƌĞƐĞŶƚ ?
ƐĞĐŽŶĚWZĂƐƐĂǇ(Figure A.2) ǁĂƐƉĞƌĨŽƌŵĞĚǁŝƚŚƚŚĞĂŝŵŽĨĂŵƉůŝĨǇŝŶŐĂ ? ? ?Ɖ
ĨƌĂŐŵĞŶƚŽĨƚŚĞĐĂƚŐĞŶĞ ?ǁŚŝĐŚĞŶĐŽĚĞƐchloramphenicol acetyltransferase, using 
the primers CamR-reverse and CamR-forward. pKD (lane 1) was used as a control, as 
it was from this plasmid that the cat gene was originally cloned. Lanes 2-5 show the 
successful amplification of the cat gene from several isolates, and these two assays 




















Figure A.2. Gel electrophoresis. 1% agarose gel. PCR assay performed one reference 
sample, control, and four experimental isolates. Lane 1, cat gene (530Bp ) fragment 
amplified from pkD3, lane 2-5 cat fragment (530Bp ) amplified phoP:CamR isolates, created 
using lambda red (section 3.2.3), using primers CamR-reverse and CamR-forward. The 
marker (M) represents the molecular ladder ranging from 250Bp to 3000Bp. 
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Figure A.3. Gel electrophoresis. 1% agarose gel. Showing  phoP mutants generated in 4.4.2 
using primers phoP-forward and phoP-reverse . The legend represents the molecular ladder 
ranging from 200Bp to 1000Bp. A 795Bp  fragment containing kanamycin resistance cassette 
can be seen in lanes 2-6, while lane 1 contains a positive control, an amplified gene fragment 
containing the kanamycin resistance cassette.  
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% The dataset (Appendix B.1A and B.1B) represents 25 paired transduction 
assays, in each of which (repeats 1-25) attempts were made to transduce phoP and 
phoQ at the same time for two different lysate concentrations, i.e. 10µl and 50µl. 
Thus, each repeat consisted of four transduction reactions. After the final 
incubation step of 2.5 hours, two replicates were plated out for each reaction. The 
numbers of transductants generated in each replicate for each lysate 
concentration, per repeat, are given below. In addition, the average of each 
replicate and the total average of all replicates and repeats for each lysate 
concentration are given. 
Furthermore, the total average number of transductants per 50µl per repeat is 
given. This value represents the average number of transductants per repeat for 
both lysate volumes, normalised to 50µl. This was calculated by first dividing the 
average number of transductants, the average of each replicate pair, for each lysate 
concentration, 10µl and 50µl, by 10 and 50, respectively, which yielded the average 
number of transductants per microlitre for each lysate concentration. Next, the 
total number of transductants per microlitre, per repeat, was calculated. This was 
the averaged value of the number of transductants per microlitre of both lysate 
concentrations. Finally, the total average number of transductants per microlitre, 
per repeat, was multiplied by 50, which provided the total average number of 
transductants per 50µl.  
During these experiments, several different preparations of phoP and phoQ lysates 




























1 1 2 1.5 18 16 17 12.25 
 
2 0 2 1 11 10 10.5 7.75 
3 0 0 0 36 29 32.5 16.25 
4 11 12 11.5 45 38 41.5 49.5 
5 2 6 4 33 30 31.5 25.75 
6 0 2 1 30 34 32 18.5 
7 1 0 0.5 30 24 27 14.75 
8 1 2 1.5 10 7 8.5 8 
9 0 0 0 9 7 8 4 
10 1 0 0.5 28 30 29 15.75 
11 1 2 1.5 18 11 14.5 11 
phoQ::KanR  
(2) 
12 1 2 1.5 43 36 39.5 23.5 
 
13 1 1 1 24 30 27 16 
14 0 1 0.5 20 22 21 11.75 
15 0 1 0.5 45 40 42.5 22.5 
16 3 1 2 15 15 15 12.5 
17 2 2 2 8 10 9 9.5 
18 6 3 4.5 28 35 31.5 27 
19 0 0 0 7 5 6 3 
phoQ::KanR  
(3) 
20 0 0 0 9 5 7 3.5 
 21 1 1 1 20 21 20.5 12.75 
22 8 1 4.5 26 29 27.5 25 
23 3 6 4.5 30 33 31.5 27 
24 5 3 4 28 26 27 23.5 
25 1 0 0.5 7 6 6.5 4.5 
Total 
Average 
  2.0 
 
  22.5 
 
16.22 









Figure B.1A. The number of phoQ transductants isolated in the wildtype (MG1655) over 25 
assays using both 10µl and 50µl of P1 lysate. The average of the two replicates done for each 
assay and total average for each lysate concentration is given. Additionally, the total average 
number of transductants, per 50µl, per repeat is shown which represents the average number of 
transductants per repeat, for both lysate volumes, normalised to 50µl of lysate. 
 




























1 0 0 0 0 0 0 0 
 2 0 0 0 0 0 0 0 
3 0 0 0 0 0 0 0 
4 0 0 0 0 0 0 0 
5 0 0 0 0 0 0 0 
6 0 0 0 0 0 0 0 
7 0 0 0 0 0 0 0 
8 0 0 0 0 0 0 0 
9 0 0 0 0 0 0 0 
10 0 0 0 0 0 0 0 
11 0 0 0 0 0 0 0 
phoP::KanR  
(2) 
12 0 0 0 0 0 0 0 
 13 0 0 0 0 0 0 0 
14 0 0 0 0 0 0 0 
15 0 0 0 0 0 0 0 
16 0 0 0 0 0 0 0 
17 0 0 0 0 0 0 0 
18 0 0 0 0 0 0 0 
19 0 0 0 0 0 0 0 
phoP::KanR  
(3) 
20 0 0 0 0 0 0 0 
 21 0 0 0 0 0 0 0 
22 0 0 0 0 0 0 0 
23 0 0 0 0 0 0 0 
24 0 0 0 0 0 0 0 
25 0 0 0 0 0 0 0 
Total 
Average 
  0 
 
  0 
 
0 
StDev   0   0 
 
- 
Figure B.1B. The number of phoP transductants isolated in the wildtype (MG1655) over 25 
assays using both 10µl and 50µl of P1 lysate. The average of the two replicates done for each 
assay and total average for each lysate concentration is given. Additionally, the total average 
number of transductants, per 50µl, per repeat is shown which represents the average number 
of transductants per repeat, for both lysate volumes, normalised to 50µl of lysate. 
 





PhoP experimental -5 -5 Average  phoP control -5 -5 Average Av diff 
(control- 
experimental 
Repeat 1 13 19 16 Repeat 1 60 54 57 41 
Repeat 2 23 24 23.5 Repeat 2 53 55 54 30.5 
Repeat 3 17 18 17.5 Repeat 3 47 51 49 31.5 
Total Average    19 Total Average    53.33 34.33 
 
Wt experimental -5 -5 Average  Wt control -5 -5 Average Av diff 
(control- 
experimental 
Repeat 1 101 104 102.5 Repeat 1 118 127 122.5 20 
Repeat 2 105 91 98 Repeat 2 121 119 120 22 
Repeat 3 93 98 95.5 Repeat 3 116 113 114.5 19 




-6 -6 Average  phoP 
control  
-6 -6 Average Av diff 
(control- 
experimental 
Repeat 1 2 3 2.5 Repeat 1 15 14 14.5 12 
Repeat 2 8 5 6.5 Repeat 2 13 11 12 5.5 
Repeat 3 2 2 2 Repeat 3 13 12 12.5 10.5 
Total Average    3.67 Total 
Average  




-6 -6 Average   Wt 
control 
-6 -6 Average Av diff 
(control- 
experimental 
Repeat 1 11 12 11.5 Repeat 1 39* 15 27 15.5 
Repeat 2 11 10 10.5 Repeat 2 13 12 12.5 2 
Repeat 3 12 14 13 Repeat 3 14 13 13.5 0.5 
Total Average    11.67 Total 
Average  




Table C.1 - Average number of (AAEC261A) and phoP  (KCEC4302)  colonies after  being 
subjected to transduction reagents, incubated overnight then diluted to -5 and -6. Results 
denoted with an asterix (*) were assumed to be contamination and so all -6 results were 
rejected from the main body of work.  
 








Number of phoP transductants  Number of phoQ transductants 
Repeat 1 Repeat 2 Repeat 3 Average  Repeat 1 Repeat 2 Repeat 3 Average  





























8,11 9,6  
(59) 
11 
Table C.2. The number of phoP (JW1116-1) and phoQ (JW1115-1)  transductants generated in the 
wildtype (AAEC261A), using 50µl of lysate. Replicate pairs are shown with the average of the three 
replicates in parenthesis, as well as total averages generated from the three repeated experiments.  














































treR 2 0.254 GGGTAAAGTCTGGTTTA 
treR 3 0.281 GGGTAAAAATTTCTTTA 
treR 4 0.496 CATTTCTGTACTGTTTC 
treR 5 0.496 TGTTTAAAGAAATTTTT 
treR 6 0.496 TGTTGTTTAATTATTTG 
treR 7 0.496 GGGTTAAATCAGGCGGA 
treR 8 0.513 TGGGTAAAGTCTGGTTT 
treR 9 0.513 GTTTAAAGAAATTTTTA 
treR 10 0.591 GGCTCATTCGCCATTTA 
treR 11 0.591 TGGGTGTCGAACGTTTT 
treR 12 0.591 GTTTTAATCTCCGTCGA 
treR 13 0.647 TGGTTTATCGTTGGTTT 
treR 14 0.647 GCGTTACCGGATGCGTA 
treR 15 0.647 GATATAATACCTGCTGA 
treR 16 0.647 GTTTCAGACAGTGCGGA 
treR 17 0.647 TGGTTCATCGTGATCCA 
 
 
Table D.1  ? The PhoP binding motifs for the Mg2+ stimulon outlined 
by Minagawa et al. (2003)[42] 
Table D.2  ? List of treR PhoP binding motifs predicted by FIMO, 
experimentally validated motifs are highlighted in green.  
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Gene P-Value  Motif  
ybjG 1 2.02E-05 Tctttaagttttattta 
ybjG 2 0.000347 TGCTTAACCGTGGTTTC 
ybjG 3 0.00179 TGTTTACGGTGGGTGAT 
ybjG 4 0.00231 ATGTTGGCCGTGGTGGA 
ybjG 5 0.00315 TCGTTAGCTGCGCTTTT 
ybjG 6 0.00322 GGGAGTGGTGTGGTTTA 
ybjG 7 0.00407 Tagctacgctttcttta 
ybjG 8 0.00475 Gctttctttaagtttta 
ybjG 9 0.0062 AGGTTAAACTGGGTAAA 
ybjG 10 0.00881 AGGTTAAATAAAACTTA 
ybjG 11 0.00892 Agtatagctacgctttc 
ybjG 12 0.01 GGTATGTTGGCCGTGGT 
 
 
Gene P-Value  Motif  
crcA 0.000133 GCTTTAGGAATTTTTTA 
crcA 0.000157 Tctttatgttgggtcta 
crcA 0.000202 GTTTTGTTATCTATGTA 















Table D.3  ? List of ybjG PhoP binding motifs predicted by FIMO, 
experimentally validated motifs are highlighted in green. 
 
Table D.4  ? List of crcA PhoP binding motifs predicted by FIMO, 
experimentally validated motifs are highlighted in green. 
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Gene P- value Observed 1.00E-05 1.00E-04 1.00E-03 1.00E-02 1.00E-01 1.00E+00 
treR 1 5.65E-05 p N P P P p p 
ybjG 1 2.02E-05 p N P P P p p 
crcA 1 0.000133 N N N P P p p 
crcA 2 0.000157 N N N P P p p 
crcA 3 0.000202 N N N P P p p 
ybjG 2 0.000347 N N N P P p p 
crcA 4 0.00037 p N N P P p p 
ybjG 3 0.00179 N N N N P p p 
ybjG 4 0.00231 N N N N p p p 
ybjG 5 0.00315 N N N N p p p 
ybjG 6 0.00322 N N N N p p p 
ybjG 7 0.00407 N N N N p p p 
ybjG 8 0.00475 N N N N p p p 
ybjG 9 0.0062 N N N N p p p 
ybjG 10 0.00881 N N N N p p p 
ybjG 11 0.00892 N N N N p p P 
ybjG 12 0.01 N N N N N p P 
treR 2 0.254 N N N N N N P 
treR 3 0.281 N N N N N N P 
treR 4 0.496 N N N N N N P 
treR 5 0.496 N N N N N N P 
treR 6 0.496 N N N N N N P 
treR 7 0.496 N N N N N N p 
treR 8 0.513 N N N N N N p 
treR 9 0.513 N N N N N N P 
treR 10 0.591 N N N N N N P 
treR 11 0.591 N N N N N N P 
treR 12 0.591 N N N N N N P 
treR 13 0.647 N N N N N N P 
treR 14 0.647 N N N N N N P 
treR 15 0.647 N N N N N N P 
treR 16 0.647 N N N N N N P 








Table D.5 .Confusion matrix predictions for P-value thresholds. Motifs predicted by FIMO, 
testing the efficacy of P-value thresholds showing the number of correct (P) and incorrect (N) 
predictions.  
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Paper  Strain  Origin of strain  recipient 
strain  




small RNA Regulates 
Sensitivity of Escherichia 




Dissecting the PhoP 
regulatory network of 
Escherichia coli and 
Salmonella enterica 
MG1655 F-, lambda-, rph-1 P1vir 
transduction 
 
No reference given 










of the PhoP-PhoQ Two-
Component System in 








Escherichia coli K-12 in-
frame, single-gene 




Construction of Escherichia 
coli K-12 in-frame, single-
gene knockout mutants: 
the Keio collection 
BW25113 rrnB ?ȴlacZ4787 hsdR514 
ȴ ?ĂƌĂ ) ? ? ?ȴ ?ƌŚĂ ) ? ? ?
rph-1. 
Transformation  - 
Dissecting the PhoP 
regulatory network of 




Dissecting the PhoP 
regulatory network of 
Escherichia coli and 
Salmonella enterica 
MG1655 F-, lambda-, rph-1 P1vir 
transduction 
 
No reference given 
Genomic SELEX Search 
for Target Promoters 





Genomic SELEX Search for 
Target Promoters under 
the Control of the PhoQP-
RstBA Signal Relay Cascade 











of the PhoP-PhoQ two-
component system in 
MC4100 &ALȴ ?ĂƌŐ&-lac)U169 araD139 
rpsL150 ptsF25 fibB5301 




212 | P a g e  
 












Characterization of the 






of the Mg2+ Stimulon of 
Escherichia coli 
W3110 F- ʄ- rph-1 INV(rrnD, rrnE) P1vir 
transduction 
 
No reference given  
Lipid Trafficking Controls 
Endotoxin Acylation in 




Molecular Genetic Analysis 
of the Escherichia coli phoP 
Locus 
MC1061 araD139 Del(araA-leu)7697 
Del(lac)X74 galK16 
galE15(GalS) lambda- e14- 
mcrA0 relA1 rpsL150(strR) 




Experiments in molecular 
genetics Jeffrey H. Miller 
MicA sRNA links the PhoP 




MicA sRNA links the PhoP 
regulon to cell envelope 
stress 
MG1188  tn10 
mutagenesis 
- 
MicA sRNA links the PhoP 




MicA sRNA links the PhoP 
regulon to cell envelope 
stress 





No reference given 
Molecular 
Characterization of the 
PhoP-PhoQ Two-
Component System in 








of the PhoP-PhoQ Two-
Component System in 




MC4100 &ALȴ ?ĂƌŐ&-lac)U169 araD139 
rpsL150 ptsF25 fibB5301 





No reference given 
Molecular 




of the PhoP-PhoQ Two-
MG1601 mgtA P PʄƉůĂĐDƵ ? ? tn10 
mutagenesis 
- 
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PhoP-PhoQ Two-
Component System in 





Component System in 





Analysis of the 




Molecular Genetic Analysis 
of the Escherichia coli phoP 
Locus 
MC1061 F- araD139 Del(araA-
leu)7697 Del(lac)X74 galK16 
galE15(GalS) lambda- e14- 
mcrA0 relA1 rpsL150(strR) 




Experiments in molecular 
genetics Jeffrey H. Miller 
Molecular Genetic 
Analysis of the 




Molecular Genetic Analysis 
of the Escherichia coli phoP 
Locus 
MC4100 F- araDJ39 A(lac)U169 
rpsL150 relAl thiflbBS301 





Experiments in molecular 
genetics Jeffrey H. Miller 
Molecular Genetic 
Analysis of the 




Genetic recombination in 
Escherichia coli: role of 
exonuclease I 
JC7623 thr-l ara-14 leuB6 A(gpt- 
proA)62 lacYl sbcC201 tsx- 
33 supE44 galK2 lambdarac 
sbcBIS hisG4 rfbDl recB21 
recC22 rpsL31 kdgK51 xyl-S 
mtl-l argE3 thi-i 
Transformation  - 
Multiple pathways for 
ƌĞŐƵůĂƚŝŽŶŽĨʍ^ ?ZƉŽ^ )
stability in Escherichia 





Dissecting the PhoP 
regulatory network of 
Escherichia coli and 
Salmonella enterica 
MG1655 F-, lambda-, rph-1 P1vir 
transduction 
 
No reference given 
Novel Aspects of the Acid 
Response Network of E. 
coli K-12 Are Revealed by 
ȴphoP 
MG1655 
phoP׸CmR Novel Aspects of the Acid Response Network of E. coli K-12 Are Revealed by a MG1655  transformation  - 
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a Study of 
Transcriptional[265] 
Study of Transcriptional 
Phenotypic differences 
between Salmonella and 
Escherichia coli resulting 






between Salmonella and 
Escherichia coli resulting 
from the disparate 
regulation of homologous 
genes 
EG13709 pmrD+-lacZY+ KmR P1vir 
transduction 
 
Experiments in molecular 
genetics Jeffrey H. Miller 
Phenotypic differences 
between Salmonella and 
Escherichia coli resulting 






between Salmonella and 
Escherichia coli resulting 
from the disparate 
regulation of homologous 
genes 
EG13709 pmrD+-lacZY+ KmR P1vir 
transduction 
 
Experiments in molecular 
genetics Jeffrey H. Miller 
Post-Transcriptional 
Control of the Escherichia 
coli PhoQ-PhoP Two-
Component System by 
Multiple sRNAs Involves 




MicA sRNA links the PhoP 
regulon to cell envelope 
stress 





No reference given 
Regulation of Acid 
Resistance by Connectors 
of Two-Component 
Signal Transduction 





Construction of Escherichia 
coli K-12 in-frame, single-
gene knockout mutants: 
the Keio collection 
BW25113 rrnB ?ȴlacZ4787 hsdR514 
ȴ ?ĂƌĂ ) ? ? ?ȴ ?ƌŚĂ ) ? ? ?
rph-1. 








of drug efflux genes by 
EvgAS, a two-component 
system in Escherichia coli 
KMY1 MK12 lRS45[Ɍ(emrK9-lacZ)] P1vir 
transduction 
 
No reference given 
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of drug efflux genes by 
EvgAS, a two-component 
system in Escherichia coli 





No reference given 
Stimulus-dependent 
differential regulation in 
the Escherichia coli 




differential regulation in 
the Escherichia coli PhoQ W
PhoP system 







Experiments in molecular 
genetics Jeffrey H. Miller 
Transcriptional 
regulation of drug efflux 
genes by EvgAS, a two-





of drug efflux genes by 
EvgAS, a two-component 
system in Escherichia coli 
KMY1 MK12 lRS45[Ɍ(emrK9-lacZ)] P1vir 
transduction 
 
No reference given 
Transcriptional 
regulation of drug efflux 
genes by EvgAS, a two-





of drug efflux genes by 
EvgAS, a two-component 
system in Escherichia coli 





No reference given 
 Transcriptome analysis 
of all two-component 
regulatory system 





Transcriptome analysis of 
all two-component 
regulatory system mutants 
of Escherichia coli K-12 
BW25113 rrnB ?ȴůĂĐ ? ? ? ? hsdR514 





Virulence, resistance to 
magainin II, and 
expression of pectate 
lyase are controlled by 
FS1000 
phoP::KanR 
Molecular Genetic Analysis 
of the Escherichia coli phoP 
Locus 
MC1061 araD139 Del(araA-leu)7697 
Del(lac)X74 galK16 
galE15(GalS) lambda- e14- 




Experiments in molecular 
genetics Jeffrey H. Miller 




system responding to pH 
and magnesium in 
Erwinia chrysanthemi 
3937[268] 





Table E.1. phoP mutants generated in published articles, showing the method and recipient strain used to generate them and, for P1vir transduction, the   
original methodology reference (Experiments in molecular genetics Jeffrey H. Miller[183]), if cited in the text. Strain name and genotype are transcribed directly 
from the citing literature.  





Four sequence logos were created, using the aligned sequences generated from the 
HMMER search using the PhoP and PhoQ sequence from E. coli K12-MG1655. 
HMMER is a tool that searches for protein homologues based on a chosen 
threshold. Thresholds can be set using either E-values or scores, and in this 
instance, a threshold of E< 1E-30 was chosen so that all sequences would have at 
least 67% similarity to the E. coli K12-MG1655 sequence. Moreover, this was done 
to ensure true homologues were found, as several domains and regions in both 
PhoP and PhoQ,  such as the receiver domain of PhoP and the HAMP domain, which 
are parts of the sensor kinase domain in PhoQ, are similar to other sensor 
kinases[75].  
The search yielded a total of 5,315 and 6,036 homologues for PhoQ and PhoP, 
respectively, suggesting that PhoQ may be less conserved than PhoP. The majority 
of these were from the order enterobacteriales, but a minority were from other 
members of the Gammaproteobacteria class, such as the orders vibrionales and 
Pseudomadales, specifically Vibrio navarrensis and Pseudomonas stutzeri (Data not 
shown). In total, 2,022 and 2,012 of the search results for PhoQ and PhoP, 
respectively, were from the Escherichia genus, the majority of which were E. coli 
isolates.  
PhoP (Figure F.2) is more conserved than PhoQ (Figure F.4), with a greater degree 
of variation present in the HAMP domain of PhoQ homologues. However, like PhoP 
(Figure F.3), PhoQ (Figure F.5) is quite conserved among E. coli isolates. 
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Figure F.1. Curated list of PhoP homologs found in different E. coli isolates(1aa-105aa).  Aligned sequences generated from a HMMER analysis of PhoP sequences from 
MG1655, representing the sequence conservation of the 223 residue PhoP sequence for E. coli isolates with an E-value <1E-30 in the Ensembl bacteria database. 
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Figure F.1 cont (106aa-223aa). Curated list of PhoP homologs found in different E. coli isolates. Aligned sequences generated from a HMMER analysis of PhoP sequences 
from MG1655, representing the sequence conservation of the 223 residue PhoP sequence for E. coli isolates with an E-value <1E-30 in the Ensembl bacteria database. 













Figure F.2. Sequence logo created from aligned sequences generated from a HMMER analysis 
of PhoP sequences from MG1655, representing the sequence conservation of the 223 residue 
PhoP sequence for all PhoP homologues with an E-value <1E-30 in the Ensembl bacteria 
database. HMMER analysis was performed using tools available at ebi.ac.uk/Tools/hmmer, 
using an E-value threshold of 1E-30. 
 








 Figure F.3. Sequence logo created from aligned sequences generated from a HMMER 
analysis of PhoP sequences from MG1655, representing the sequence conservation of the 
223 residue PhoP sequence for E. coli isolates with an E-value <1E-30 in the Ensembl 
bacteria database. HMMER analysis was performed using tools available at 
ebi.ac.uk/Tools/hmmer, using an E-value threshold of 1E-30. 
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Figure F.4. Sequence logo created from aligned sequences generated from a 
HMMER analysis of PhoQ sequences from MG1655, representing the sequence 
conservation of the 486 residue PhoQ sequence for all PhoQ homologues with 
an E-value <1E-30 in the Ensembl bacteria database. HMMER analysis was 
performed using tools available at ebi.ac.uk/Tools/hmmer, using an E-value 
threshold of 1E-30. 





















 Figure F.5. Sequence logo created from aligned sequences generated from a 
HMMER analysis of PhoQ sequences from MG1655, representing the sequence 
conservation of the 486 residue PhoQ sequence for E. coli isolates with an E-value 
<1E-30 in the Ensembl bacteria database. HMMER analysis was performed using 
tools available at ebi.ac.uk/Tools/hmmer, using an E-value threshold of 1E-30. 
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